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Abstract
Cardiac and skeletal muscle function relies on a continuous energy production via fatty acid
metabolism and mitochondrial oxidation of pyruvate, with a fine balance between substrate
delivery and utilization. Changes in metabolism are increasingly being implicated as playing
an intrinsic role in many diseases, such as diabetes, cancer, and heart failure. Investigating and
identifying fundamental metabolic processes are paramount to understanding pathologies.
Beyond morphology and functional information, magnetic resonance can provide insights
at a metabolic level using spectroscopic techniques such as 13C NMR. The low natural abun-
dance and sensitivity of the 13C nucleus makes 13C NMR in biological systems challenging. In
addressing this issue, hyperpolarized methods have emerged as a very promising tool, obtain-
ing signal enhancements up to 10,000 fold. Spectra of hyperpolarized 13C labeled substrates
and their downstream metabolic products offer insight into metabolic processes occurring in
vivo within seconds after the injection.
This thesis focused on the development of MR hyperpolarization methods and applications
to study energy metabolism in cardiac and skeletal muscle in vivo. This ranged from devel-
opment of the experimental frame work to mathematical tools to characterize the observed
metabolic processes.
Methods were developed to visualize 13C labeling kinetics of acetylcarnitine in vivo in
resting skeletal muscle following the administration of hyperpolarized [1-13C]acetate. Two
different, novel mathematical models were constructed to quantify the kinetic rate constants.
Although separated by two enzymatic reactions, the conversion of acetate to acetylcarnitine
was uniquely defined by the enzymatic activity of acetylCoA synthetase (ACS).
A 13C MRS protocol was developed and implemented for hyperpolarized studies in the heart,
which included selecting appropriate cardiac triggers to align the measurements with the
cardiac phase. The 13C label propagation into acetylcarnitine and citrate could be measured in
real time in the beating rat heart following the infusion of hyperpolarized [1-13C]acetate, using
a newly constructed 13C RF coil which improved the detection sensitivity. The substantial
spectral resolution at 9.4T and a triggered shimming and MR acquisition protocol allowed for
the detection of citrate for the first time in vivo after injection of hyperpolarized [1-13C]acetate.
Mathematical models were successfully extended to include mitochondrial oxidation and
analytical expressions were derived to interpret the dynamic 13C labeling of citrate.
Cardiac dysfunction is often associated with a shift in substrate preference, while diag-
nostic methods such as PET provide only information on substrate uptake. The potential of
hyperpolarized 13C MRS to measure simultaneously lipid and carbohydrate oxidation was
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demonstrated in vivo, and the sensitivity of the method to a metabolic perturbation was
assessed. Hyperpolarized [1-13C]butyrate and [1-13C]pyruvate were used as representatives
of carbohydrate and lipid oxidation. Fasting led to significant changes in preference for the
injected substrates. The appearance of a cohort of downstream metabolites (bicarbonate, lac-
tate, alanine, glutamate, citrate, acetylcarnitine, β-hydroxybutyrate and acetoacetate) allowed
the independent and simultaneous monitoring of myocardial oxidation of both fatty acid and
carbohydrates in vivo and is a sensitive indicator of metabolic shift.
Lactate is an important metabolic intermediate for mitochondrial oxidation. Carbohydrate
metabolism in healthy rat skeletal muscle at rest was studied in different nutritional states
using hyperpolarized [1-13C]lactate, which can be injected at physiological concentrations
and leaves other oxidative processes undisturbed. A significant decrease in [1-13C]alanine
and 13C bicarbonate were observed comparing both groups, attributed to a change in cellular
alanine concentration and pyruvate dehydrogenase (PDH) flux. It was shown that lactate can
be used to study carbohydrate oxidation in skeletal muscle at physiological levels and that the
downstream metabolite signals are sensitive markers to probe metabolic changes.
Since the detection of [5-13C]citrate and [5-13C]glutamate in the heart is hindered by the
close proximity of the [1-13C]acetate resonance, acetylcarnitine could be an interesting sub-
strate for hyperpolarized MR. Acetylcarnitine crosses the mitochondrial membrane easily,
while skipping a few metabolic steps needed for acetate to cross the membrane. More-
over, it does not interfere with the detection of [5-13C]glutamate and [5-13C]citrate. [1-
13C]Acetylcarnitine was successfully hyperpolarized and despite its short T1 it was possible
to detect the formation of [5-13C]glutamate in the heart in vivo. Due to the absence of the
[5-13C]citrate resonance, we hypothesized the existence of an intricate relationship between
reaction, transport and relaxation rates in the choice of hyperpolarized substrates.
Acetylcarnitine has relatively small poolsizes and has only been observed using hyperpo-
larized 13C MRS techniques. Therefore, it has not been possible to obtain reliable quantifi-
cation of the metabolic turnover of acetylcarnitine, which is an essential intermediate in the
metabolism of acetate. Methods were implemented to measure the oxidation of [2-13C]acetate
locally with increased sensitivity at high field (14.1T), using a 1H-13C polarization transfer
sequence. This allowed the observation of [2-13C]acetylcarnitine in vivo at 21.5 ppm, with a
metabolic turnover time τ of 0.34 µmol/g/hr. The acetylcarnitine resonance assignment was
confirmed by experiments infusing 13C labeled glucose. The measurement of the time courses
of Glu C4 and C3 were also clearly observed, without lipid contamination.
To conclude, this work presents novel metabolic information about skeletal and cardiac
energy metabolism using developed methods in hyperpolarized 13C MRS. The use of hyperpo-
larized 13C substrates to measure absolute flux through metabolic pathways in vivo would
not only revolutionize clinical diagnostic imaging but also serve as an important tool to better
understand diseased metabolism and the metabolic effects of new drugs aimed to combat
diseases.
KEYWORDS: Metabolism, nuclear magnetic resonance (NMR), 13C magnetic resonance spec-
troscopy (MRS), skeletal muscle, cardiac muscle, hyperpolarization, dissolution dynamic nu-
clear polarization (DNP), enzyme kinetics, mathematical modeling, substrate competition
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Résumé
La fonction musculaire cardiaque et squelettique repose sur la production constante d’énergie
par l’intermédiaire du métabolisme des acides gras et l’oxydation mitochondriale du pyruvate,
qui requièrent un équilibre subtil entre l’apport et l’utilisation du substrat. Les modifications
du métabolisme sont de plus en plus considérées comme jouant un rôle intrinsèque majeur
dans le cadre de nombreuses maladies telles que le diabète, le cancer et les défaillances car-
diaques. L’étude et l’identification des processus métaboliques sont cruciaux pour comprendre
avec précison et fiabilité ces pathologies.
Au delà des informations morphologiques et fonctionnelles, la résonance magnétique
nucléaire (RMN) fournit également un aperçu au niveau métabolique en employant des
techniques de spectroscopies telles que la RMN du 13C. La faible abondance naturelle et
sensibilité du noyau de 13C fait de la RMN du 13C un véritable défi. Afin de déjouer ces
limitations, les méthodes d’hyperpolarisation apparaissent comme des outils prometteurs
et procurent des augmentations de signal de l’ordre de 10 000. Les spectres provenant de
substrats hyperpolarisés marqués au 13C, ainsi que des produits métaboliques en découlant,
permetter l’étude in vivo des processus métaboliques dans les premières secondes après
l’injection du substrat.
Cette thèse porte sur le développement de méthodes RMN d’hyperpolarisation et d’applica-
tions permettant l’étude in vivo du métabolisme énergétique dans les muscles cardiaques et
squelettiques. Ces développements s’étendent de la mise en place du cadre expérimental aux
outils mathématiques pour la caractérisation des processus métaboliques observés.
Des méthodes ont été développées pour visualiser, in vivo, la cinétique du marquage en
13C de l’acétylcarnitine dans le muscle squelettique au repos après l’administration de [1-
13C]acétate hyperpolarisé. Deux nouveaux modèles mathématiques ont été développés afin
de quantifier les constantes des vitesses de réaction. Bien que séparée par deux réactions
enzymatiques, la conversion de l’acétate en acétylcarnitine a pu être exceptionnellement
mesurée via l’activité enzymatique de l’acétylCoA synthéase (ACS).
Un protocole de spectroscopie RMN du 13C a été développé et implémenté pour des études
hyperpolarisées dans le coeur, ce qui inclut un choix pertinent de déclencheurs cardiaques
qui font correspondre les mesures RMN avec la phase cardiaque. La propagation du marquage
en 13C vers l’acétylcarnitine et le citrate a pu être mesurée en temps réel dans le battement
de coeur suivant l’infusion du [1-13C]acétate hyperpolarisé. Pour réaliser cette étude, une
bobine RF a été ajustée à la fréquence du 13C et a été construite sur mesure afin d’améliorer la
sensibilité de la détection du signal RMN. La haute résolution spectrale à 9,4 T ainsi que le
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shimming synchronisé avec le battement cardiaque et le protocole d’acquisition RMN ont
permis la détection du citrate pour la première fois in vivo après injection de [1-13C]acétate
hyperpolarisé. Les modèles mathématiques ont été complétés afin d’inclure l’oxydation mito-
chondriale et les expressions analytiques ont été dérivées dans le but d’analyser la cinétique
de marquage du 13C du citrate.
Les défaillances cardiaques sont souvent associées à un changement de préférence du
substrat, alors que les méthodes diagnostiques telles que le PET fournissent uniquement des
informations sur la consommation du substrat. Le potentiel de la spectroscopie par RMN du
13C hyperpolarisé, qui mesure simultanément l’oxydation lipidique et des carbohydrate, a
été démontré in vivo, et la sensibilité de la méthode à des perturbations métaboliques a été
déterminée. Le [1-13C]butyrate et le [1-13C]pyruvate ont été utilisés comme des représentants
de l’oxydation des carbohydrates et lipides. Le jeûne a induit des changements significatifs de
préférence pour les substrats injectés. L’apparition d’une cohorte de métabolites secondaires
(bicarbonate, lactate, alanine, glutamate, citrate, acétylcarnitine, β-hydroxybutyrate et acé-
toacétate) a permis le suivi indépendant et simultané de l’oxydation au niveau du myocarde
à la fois des acides gras et des carbohydrates. Ce suivi in vivo est un indicateur sensible des
changements métaboliques.
Le lactate est un intermédiaire métabolique important pour l’oxydation mitochondriale.
Le métabolisme des carbohydrates dans le muscle squelettique du rat sain a été étudié dans
deux états nutritionnels (nourris et à jeun) en utilisant le [1-13C]lactate, qui peut être injecté à
des concentrations physiologiques n’influençant ainsi aucun autre processus oxydatif. Des
diminutions significatives en [1-13C]alanine et 13C bicarbonate ont été observées entre les deux
groupes. Ces diminutions sont attribuées à une modification de la concentration cellulaire
d’alanine et du flux de la déshydrogénase du pyruvate (PDH). Il a été montré que le lactate
peut être utilisé pour étudier l’oxydation des carbohydrate dans le muscle squelettique aux
niveaux physiologiques et que les signaux des métabolites secondaires sont des marqueurs
sensibles pour détecter les changements métaboliques.
La détection du [5-13C]citrate dans le coeur est difficile en raison de sa forte proximité
avec la résonance du [5-13C]acétate, ce qui limite également la détection du [5-13C]glutamate.
L’acétylcarnitine est un substrat intéressant pour la RMN hyperpolarisée compte tenu du fait
que, contrairement à l’acétate, elle traverse facilement la membrane mitochondriale sans
passer par certaines étapes métaboliques. De plus, elle n’interfère pas avec la détection du [5-
13C]glutamate et du [5-13C]citrate. La [1-13C]acétylcarnitine a été hyperpolarisée avec succcès
et malgré son court T1, il a été possible de détecter la formation in vivo de [5-
13C]glutamate
dans le coeur. En raison de l’absence de la résonance du [5-13C]citrate, nous avons supposé
qu’il existe une relation intriquée entre les taux de réaction, transport et relaxation dans le
choix des substrats hyperpolarisés.
L’acétylcarnitine a des tailles de pool relativement petites et n’a pu être observée qu’en
utilisant des techniques de spectroscopies RMN hyperpolarisées. Ainsi, il n’est pas possible
d’obtenir une quantification robuste du taux de renouvellement de l’acétylcarnitine, qui est
un intermédiaire essentiel du métabolisme de l’acétate. Des méthodes ont été implémen-
tées, permettant de mesurer localement l’oxydation du [2-13C]acétate avec une meilleure
x
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sensibilité à plus haut champ magnétique (14,1 T), en utilisant une séquence de transfert de
polarisation 1H-13C. Ceci a permis d’observer la [2-13C]acétylcarnitine in vivo à 21.5 ppm, avec
un temps de renouvellement métabolique de 0,34 µmol/g/h. L’attribution de la résonance
de l’acétylcarnitine a été confirmée en effectuant des expériences avec infusion de glucose
marqué au 13C. La mesure de la cinétique de Glu C4 et C3 a également été clairement observée,
sans contamination des lipides.
Pour conclure, ce travail présente de nouvelles informations sur le métabolisme é nergé-
tique du muscle squelettique et cardiaque en utilisant des méthodes en développement de
spectroscopie RMN hyperpolarisée du 13C. L’utilisation de substrats hyperpolarisés marqués
au 13C pour mesurer in vivo le flux absolu à travers les chemins métaboliques permet de
révolutionner l’imagerie diagnostique clinique. Elle fournit également un outil important pour
mieux comprendre le métabolisme de certaines pathologies ainsi que les effets métaboliques
de nouveaux traitements.
Mots-clés : Métabolisme, résonance magnétique nucléaire (RMN), spectroscopie par réso-
nance magnétique du 13C, muscle squelettique, muscle cardiaque, hyperpolarisation, pola-
risation dynamique nucléaire (DNP) par dissolution, cinétiques enzymatiques, modélisation
mathématique, compétition de substrat
xi

Contents
Acknowledgements / Dankwoord iii
Abstract (English/Français) vii
Table of contents xv
List of Figures xix
List of Tables xxi
List of Symbols and Abbreviations xxiii
List of Publications and Conference Proceedings xxv
Introduction and Outline of Thesis 1
1 An introduction to NMR spectroscopy 5
1.1 History of Magnetic Resonance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2 Basic Principles of MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2.1 Nuclei in a magnetic field . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2.2 Polarization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.2.3 Magnetization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2.4 Excitation and Bloch Equations . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.5 Relaxation of the magnetization . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.6 Detection of the MR signal - Fourier transform NMR . . . . . . . . . . . . 14
1.2.7 Measurement of relaxation time constants . . . . . . . . . . . . . . . . . . 16
1.2.8 Chemical Shift . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.2.9 Nuclear coupling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
1.2.10 Localized spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.3 Hyperpolarization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
1.3.1 Dynamic Nuclear Polarization . . . . . . . . . . . . . . . . . . . . . . . . . 25
1.3.2 Polarization mechanisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
1.3.3 Dissolution DNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
1.4 Radiofrequency Coils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
1.5 Dynamic 13C NMR Spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Contents
1.5.1 Modeling biochemical processes using 13C MRS . . . . . . . . . . . . . . 36
2 Enzymatic activity of acetylCoA synthetase revealed with hyperpolarized acetate 43
2.1 Introduction to acetate metabolism in skeletal muscle . . . . . . . . . . . . . . . 44
2.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.3 Kinetic model of hyperpolarized acetate metabolism in skeletal muscle . . . . . 50
2.4 Mathematical Derivation of the Signal Ratio . . . . . . . . . . . . . . . . . . . . . 54
2.5 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
2.7 Incorporation of a substrate build-up in the kinetic model . . . . . . . . . . . . . 62
2.8 Independence and sensitivity of fitting parameters kAC S and RA . . . . . . . . . 63
2.9 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3 In vivo real time cardiac metabolism using hyperpolarized acetate 71
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.2.1 Cardiac triggering for MR imaging and spectroscopy . . . . . . . . . . . . 73
3.2.2 In vivo magnetic resonance spectroscopy . . . . . . . . . . . . . . . . . . . 76
3.3 Kinetic model of hyperpolarized acetate metabolism in the heart . . . . . . . . 80
3.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4 Myocardial substrate competition using hyperpolarized 13C MR 91
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
4.3.1 Hyperpolarized [1-13C]pyruvate injection . . . . . . . . . . . . . . . . . . 96
4.3.2 Hyperpolarized [1-13C]butyrate injection . . . . . . . . . . . . . . . . . . . 97
4.3.3 Hyperpolarized [1-13C]pyruvate and [1-13C]butyrate co-injection . . . . 99
4.4 Butyrate and Pyruvate Flux Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.5.1 Pyruvate Injections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.5.2 Butyrate Injections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.5.3 Competition between pyruvate and butyrate . . . . . . . . . . . . . . . . . 105
5 Hyperpolarized lactate metabolism in resting skeletal muscle in vivo 113
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
5.2 Experimental Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.5 Metabolic flux analysis of alanine labeling . . . . . . . . . . . . . . . . . . . . . . 124
xiv
Contents
6 Hyperpolarized acetylcarnitine as a probe for myocardial metabolism in vivo 131
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
6.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
6.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
7 Acetylcarnitine turnover measurements in skeletal muscle in vivo using localized
sensitivity enhanced 13C MRS at 14.1 T 139
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
7.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
7.2.1 Animal preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
7.2.2 Saline and [2-13C]acetate infusion procedure . . . . . . . . . . . . . . . . 141
7.2.3 In vivo MR spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
7.2.4 In vitro MR spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
7.2.5 Fractional enrichments and turnover calculations . . . . . . . . . . . . . 143
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
8 Conclusion and Outlook 157
A Appendix 161
A.1 RF coil design for hyperpolarized 13C NMR studies . . . . . . . . . . . . . . . . . 161
A.1.1 Quadrature 13C coil for cardiac muscle applications . . . . . . . . . . . . 161
A.1.2 B1 mapping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
A.1.3 Sensitivity comparison with a conventional design . . . . . . . . . . . . . 163
A.2 Adiabatic RF pulse calibrations and simulations . . . . . . . . . . . . . . . . . . . 163
Curriculum Vitae 169
xv

List of Figures
1.1 Spin energy as function of the magnetic field . . . . . . . . . . . . . . . . . . . . . 7
1.2 Precession and macroscopic magnetization . . . . . . . . . . . . . . . . . . . . . 9
1.3 Excitation of the magnetization vector . . . . . . . . . . . . . . . . . . . . . . . . 11
1.4 Recovery of the magnetization after excitation . . . . . . . . . . . . . . . . . . . . 14
1.5 T1 measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.6 T2 measurement - A spin echo experiment . . . . . . . . . . . . . . . . . . . . . . 17
1.7 Chemical Shift . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
1.8 Uncoupled and coupled spin system . . . . . . . . . . . . . . . . . . . . . . . . . 21
1.9 Effect of 1H decoupling on the 13C spectrum of [1-13C]acetylcarnitine . . . . . . 22
1.10 Principle of slice selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.11 ISIS sequence diagram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
1.12 General mechanism of dynamic nuclear polarization . . . . . . . . . . . . . . . . 27
1.13 Energy levels and transitions of a two spin system consisting of a nucleus and an
electron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
1.14 Linearly and circularly polarized magnetic fields . . . . . . . . . . . . . . . . . . 32
1.15 Quadrature coil decoupling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.16 13C label flow through the TCA cycle following the metabolism of acetate, lactate
and pyruvate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
1.17 Glutamate multiplet patterns induced by 13C-13C coupling . . . . . . . . . . . . 36
2.1 Schematic of acetate metabolism in resting skeletal muscle in vivo . . . . . . . . 44
2.2 Graphical scheme and timing of in vivo DNP experiments . . . . . . . . . . . . . 46
2.3 Picture of experimental settings for performing hyperpolarized 13C experiments 47
2.4 Influence of repeated RF excitation on longitudinal and transverse magnetizations 47
2.5 Anatomical proton image of skeletal muscle and RF coil positioning . . . . . . . 49
2.6 Relaxivity of [1-13C]pyruvate and [1-13C]pyruvate in D2O at 400 MHz . . . . . . 50
2.7 Spectral time course of acetate and acetylcarnitine in skeletal muscle . . . . . . 56
2.8 T1 measurement of [1-13C]acetylcarnitine in plasma using a saturation recovery
sequence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2.9 Signal evolution and model fitting of hyperpolarized [1-13C]acetate metabolism 58
2.10 Relation between reaction rates and acetate dosage . . . . . . . . . . . . . . . . . 59
2.11 Derivation of the kinetic rate constant kAC S and initial reaction rate v0,AC S using
two different approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
List of Figures
2.12 Influence of the incorporation of an acetate build up on the estimation of kAC S 63
2.13 Sensitivity of fitting parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.1 Metabolism of hyperpolarized acetate in the heart . . . . . . . . . . . . . . . . . 74
3.2 A Wiggers diagram, showing the cardiac cycle events occuring in the left ventricle 75
3.3 Double gating for cardiac 13C MRS . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.4 Diagram of triggered gradient echo pulse sequence . . . . . . . . . . . . . . . . . 77
3.5 Cinematographic MR image series of the rat heart for trigger planning . . . . . 78
3.6 Cardiac positioning for hyperpolarized 13C MRS . . . . . . . . . . . . . . . . . . 79
3.7 Voxel location for cardiac triggered shimming . . . . . . . . . . . . . . . . . . . . 79
3.8 Spectral time course of [1-13C]acetate metabolism in the heart in vivo . . . . . . 84
3.9 Spectrum sum revealing the presence of [5-13C]citrate . . . . . . . . . . . . . . . 85
3.10 Integral time course of [1-13C]acetate and its metabolic producs . . . . . . . . . 86
3.11 Integral time course of [1-13C]acetylcarnitine and [5-13C]citrate . . . . . . . . . 86
4.1 Metabolic pathways of pyruvate and butyrate metabolism in healthy myocardium. 93
4.2 Hyperpolarized 13CMR spectra of the heart in vivo and and metabolite ratios
following the metabolism of [1-13C]pyruvate . . . . . . . . . . . . . . . . . . . . . 97
4.3 Hyperpolarized 13C MR spectra of the heart in vivo and and metabolite ratios
following the metabolism of [1-13C]butyrate . . . . . . . . . . . . . . . . . . . . . 98
4.4 Time course of hyperpolarized 13C MR spectra of the heart in vivo following the
metabolism of [1-13C]pyruvate and [1-13C]butryate simultaneously . . . . . . . 100
4.5 Metabolite ratios normalized to pyruvate intensities . . . . . . . . . . . . . . . . 101
4.6 pH measurement in cardiac tissue in vivo using the spectral evolution of hyper-
polarized 13C bicarbonate and 13CO2 . . . . . . . . . . . . . . . . . . . . . . . . . 104
5.1 Pathways of lactate metabolism in skeletal muscle . . . . . . . . . . . . . . . . . 115
5.2 13C spectra of lactate metabolism in skeletal muscle in vivo . . . . . . . . . . . . 118
5.3 Signal evolution of lactate and downstream metabolites. . . . . . . . . . . . . . . 119
5.4 Plasma lactate concentrations during a hyperpolarized experiments. . . . . . . 120
5.5 Signal ratios relative to alanine after lactate injection . . . . . . . . . . . . . . . . 120
5.6 Influence of repeated injections of lactate on muscle metabolism. . . . . . . . . 121
5.7 Pyruvate and bicarbonate ratios relative to alanine . . . . . . . . . . . . . . . . . 125
6.1 Scheme of myocardial acetylcarnitine metabolism . . . . . . . . . . . . . . . . . 132
6.2 Polarization buildup of [1-13C]acetylcarnitine and in vitro decay after dissolution135
6.3 Integrated time course of cardiac metabolism following the infusion of hyperpo-
larized [1-13C]acetylcarnitine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
6.4 In vivo cardiac 13C NMR spectrum following the injection of hyperpolarized
[1-13C]acetylcarnitine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
7.1 Effect of OVS and ISIS on signal localization . . . . . . . . . . . . . . . . . . . . . 142
7.2 Difference between unlocalized and localized 13C MR spectra in skeletal muscle 145
7.3 Fractional enrichment of 13C in acetate C2 in plasma . . . . . . . . . . . . . . . . 146
xviii
List of Figures
7.4 Time course of [2-13C]acetate metabolism in skeletal muscle in vivo at 14.1T . . 147
7.5 Evolution of the fractional enrichment of glutamate C2 C3 and C4 in skeletal
muscle in vivo after the infusion of [2-13C]acetate . . . . . . . . . . . . . . . . . . 148
7.6 Comparison of 13C spectra of a 13C labeled glucose and acetate infusion in brain
and muscle respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
7.7 Comparison of 13C spectra of a 13C labeled glucose and acetate infusion in
skeletal muscle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
7.8 Evolution of acetylcarnitine C2 concentration in skeletal muscle in vivo after the
infusion of [2-13C]acetate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
7.9 13C NMR of a skeletal muscle tissue extract . . . . . . . . . . . . . . . . . . . . . . 151
A.1 Electrical circuit and image of 13C coil in quadrature mode . . . . . . . . . . . . 161
A.2 23Na MRI of a NaCl phantom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
A.3 23Na MRS for the measurement of the quadrature property in an RF coil . . . . 162
A.4 Power calibration for adiabatic 90◦pulses . . . . . . . . . . . . . . . . . . . . . . . 163
A.5 13C MRI of a 13C labeled acetate phantom using a quadrature 13C surface coil . 164
A.6 B1 maps of the quadrature 13C surface coil . . . . . . . . . . . . . . . . . . . . . . 164
A.7 Bloch simulations of magnetization vector . . . . . . . . . . . . . . . . . . . . . . 165
A.8 NMR bandwidth calibrations for 10◦ pulses . . . . . . . . . . . . . . . . . . . . . 166
A.9 NMR bandwidth calibrations for 90◦pulses . . . . . . . . . . . . . . . . . . . . . . 167
xix

List of Tables
1.1 NMR properties of several nuclei . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2 Polarization levels of nuclear and electron spins . . . . . . . . . . . . . . . . . . . 26
1.3 T1 of
13C labeled metabolites of interest for in vivo DNP studies . . . . . . . . . 31
2.1 T1 of [1-13C]acetylcarnitine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.1 Body weight and glucose levels after an overnight fast. . . . . . . . . . . . . . . . 95
4.2 Chemical shifts of observed metabolites following the injection of hyperpolar-
ized sodium [1-13C]butyrate and sodium [1-13C]pyruvate. . . . . . . . . . . . . 96

List of Symbols andAbbreviations
δ Chemical shift
γ Gyromagnetic ratio
ħ Planck’s constant divided by 2pi
µ Magnetic moment
ω0 Larmor frequency
E Energy
k Kinetic rate constant
kB Boltzmann constant
KM Michaelis constant
v0 Initial reaction rate
Vmax Maximum reaction rate
B0 Main magnetic field strength or magnetic flux density
R1 Longitudinal relaxation rate equal to the reciprocal of T1
r1 Dipolar T1 relaxivity of a contrast agent
R2 Transverse relaxation rate equal to the reciprocal of T2
r2 Dipolar T2 relaxivity of a contrast agent
T 1 Spin-lattice or longitudinal relaxation time
T 2 Spin-spin or transverse relaxation time
T∗2 Transverse relaxation time including macroscopic inhomogeneities
T E Echo time, the time between excitation pulse and peak echo formation
T I Inversion time, the time between an 180◦ inversion pulse and acquisition
T R Repetition time, the time between consecutive RF excitation pulses
AAT acetoacetylCoA thiolase
Ace Acetate
ACS AcetylCoA synthetase
ALT Alanine transaminase
ATL Acetylcarnitine translocase
ATP Adenosine triphosphate
BIR-4 B1-insensitive rotation with 4 segments
CA Carbonic anhydrase
CAT Carnitine acetyltransferase
CoA Coenzyme A
Cre Creatine
List of Tables
CS Citrate synthase
DEPT Distortionless enhancement by polarization transfer
DNP Dynamic nuclear polarization
ECG Electrocardiogram
emf Electromotive force
FE Fractional enrichment
FFA Free fatty acid
FID Free induction decay.
FID Free induction decay
Glu Glutamate
IR Inversion recovery
ISIS Image selected in vivo spectroscopy
Lac Lactate
LCModel Linear combination of model spectra
LDH Lactate dehydrogenase
MCT monocarboxylate transporter
MRI Magnetic resonance imaging
MRS Magnetic resonance spectroscopy
NMR Nuclear magnetic resonance
NOE Nuclear Overhausser effect
OAA Oxaloacetate
OAT 3-oxoacid CoA transferase
OVS Outer volume suppression
PBS Phosphate buffered saline
PDH Pyruvate dehydrogenase
PET Positron emission tomography
ppm parts per million
PT Pyruvate transporter
RF Radio frequency
ROI Region of interest
SD Standard deviation
SEM Standard error of the mean
SNR Signal to noise ratio
SR Saturation recovery
STEAM Stimulated echo acquisition mode
Tau Taurine
TCA Tricarboxylic acid
TEMPO 2,2,6,6-Tetramethylpiperidine-1-oxyl
VOI Volume of interest
xxiv
Publications &ConferenceProceedings
Journal Articles
(1) J.A.M. Bastiaansen, T. Cheng, M. Mishkovsky, J.M.N. Duarte, A Comment, R. Gruetter. In
vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by 13C turnover
from hyperpolarized [1-13C]acetate to [1-13C]acetylcarnitine. Biochimica et Biophysica
Acta, vol. 1830, num. 8, p. 4171-4178 (2013)
(2) T. Cheng, M. Mishkovsky, J.A.M. Bastiaansen, O. Ouari, P. Hautle, P. Tordo, B.v.d. Brandt,
A. Comment, Method to minimize and monitor in situ the polarization losses in hyperpo-
larized biomolecules prior to in vivo MR experiments. NMR in Biomedicine, doi:10.1002/-
nbm.2993 (2013)
(3) J.A.M. Bastiaansen, M.E. Merritt, A Comment. In vivo myocardial substrate competition
using hyperpolarized 13C magnetic resonance. Submitted, (2013)
(4) J.A.M. Bastiaansen, H.A.I. Yoshihara, Y. Takado, R. Gruetter, A. Comment. Hyperpolarized
13C lactate as substrate for in vivo metabolic studies in skeletal muscle. Submitted (2013)
(5) J.A.M. Bastiaansen, T. Cheng, R. Gruetter, A. Comment. Mitochondrial cardiac metabolism
of hyperpolarized acetate. Manuscript in preparation (2013)
(6) J.A.M. Bastiaansen, T. Cheng, R. Gruetter, A. Comment. Hyperpolarized [1-13C]acetyl-
carnitine as a tracer for cardiac metabolism. Manuscript in preparation (2013)
(7) J.A.M. Bastiaansen, J.M.N. Duarte, A. Comment, R. Gruetter. Acetylcarnitine turnover in
rat skeletal muscle measured in vivo using localized 13C NMR at 14.1 T. Manuscript in
preparation (2013)
(8) Y. Takado, T. Cheng, B. Lanz, J.A.M. Bastiaansen, M. Mishkovsky, R. Gruetter, A. Comment,
Lactate brain metabolism in different mouse strains probed by hyperpolarized 13C MRS.
Manuscript in preparation (2013)
List of Tables
Conference Proceedings (Peer Reviewed)
(1) J.A.M. Bastiaansen, Y. Takado, H. Yoshihara, T. Cheng, A. capozzi, R. Gruetter, A. com-
ment, Hyperpolarized [1-13C]lactate metabolism in rat skeletal muscle in vivo. Fourth
International Symposium on Dynamic Nuclear Polarization (2013), oral presentation
(2) H. A. I. Yoshihara, J. A. M. Bastiaansen, C. Berthonneche, A. Comment, J. Schwitter, En-
ergy metabolism in the ischemic rat heart assessed using hyperpolarized 13C Fourth
International Symposium on Dynamic Nuclear Polarization (2013), poster
(3) Y. Takado, T. Cheng, B. Lanz, J.A.M. Bastiaansen, M. Mishkovsky, R. Gruetter, A. Comment,
Lactate brain metabolism in different mouse strains probed by hyperpolarized 13C MRS.
Fourth International Symposium on Dynamic Nuclear Polarization (2013), poster
(4) J.A.M. Bastiaansen, T. Cheng, R. Gruetter and A. Comment. Hyperpolarized [1-13C]acetyl-
carnitine as a tracer for cardiac metabolism. Proc. Intl. Soc. Mag. Reson. Med. 21, 1936
(2013) poster
(5) J.A.M. Bastiaansen, J.M.N. Duarte, A. Comment and R. Gruetter. Acetylcarnitine turnover
in rat skeletal muscle measured in vivo using localized 13C NMR at 14.1 T. Proc. Intl. Soc.
Mag. Reson. Med. 21, 0120 (2013) oral presentation
(6) T. Cheng, M. Mishkovsky, J.A.M. Bastiaansen, O. Ouari and P. Hautle et al. Method to min-
imize polarization losses in hyperpolarized biomolecules prior to in vivo MR experiments.
ESMRMB 29 (2012) poster
(7) J.A.M. Bastiaansen, T. Cheng, JMN Duarte, M. Mishkovsky, A. Comment, R. Gruetter,
Kinetic analysis of acetylCoA synthetase activity in skeletal muscle, ESMRMB 29 (2012)
oral presentation
(8) J.A.M. Bastiaansen, T. Cheng, R. Gruetter, A. Comment, In vivo real time cardiac metabolism
using hyperpolarized acetate, Proc. Intl. Soc. Mag. Reson. Med. 20, 5137 (2012) electronic
poster
(9) J.A.M. Bastiaansen, Tian Cheng, Mor Mishkovsky, Arnaud Comment, Rolf Gruetter, In
vivo enzymatic assay of carnitine acetyl transferase and acetylCoA synthetase using hy-
perpolarized acetate, Proc. Intl. Soc. Mag. Reson. Med. 20, 5117 (2012) electronic
poster
(10) E. Can, J.A.M. Bastiaansen, T. Cheng, N. Salameh, Y. Takado, M. Mishkovsky, R. Gruetter, A.
Comment, BDPA as a polarizing agent for in vivo hyperpolarized MR experiment, Metaflux
Meeting (2012) oral presentation
(11) Y. Takado, T. Cheng, J.A.M. Bastiaansen, M. Mishkovsky, R. Gruetter, A. Comment, In vivo
real-time metabolic studies of mice brain and skeletal muscle at 9.4T, Third International
Symposium on Dynamic Nuclear Polarization (2011) poster
(12) J.A.M. Bastiaansen, T. Cheng, M. Mishkovsky, A. Comment, R. Gruetter, The metabolic
effect of hyperpolarized [1-13C]acetate dosage in vivo, Third International Symposium on
Dynamic Nuclear Polarization (2011) poster
xxvi
List of Tables
(13) J.A.M. Bastiaansen, T. Cheng, R. Gruetter, A. Comment, Kinetics of hyperpolarized [1 -
13C]acetate metabolism in cardiac muscle, Third International Symposium on Dynamic
Nuclear Polarization (2011) poster
(14) J.A.M. Bastiaansen, T. Cheng, M. Mishkovsky, A. Comment, R. Gruetter, Study of acetyl-
carnitine kinetics in skeletal muscle in vivo using hyperpolarized [1-13C]acetate, Proc. Intl.
Soc. Mag. Reson. Med. 19, 6795 (2011), electronic poster
(15) J.A.M. Bastiaansen, T. Cheng, M. Mishkovsky, A. Comment, R. Gruetter, Hyperpolarized
acetate as a metabolic tracer for skeletal and cardiac muscle energetics, TOPIM 2011, oral
presentation
Previous work:
(16) J.A.M. Bastiaansen, X. Zhang, D. Janvelyan, S. Fraser and R.E. Jacobs, Spatiotemporal
connectivity in the mesolimbic system revealed by MEMRI, SSN (2010) poster
(17) J.A.M. Bastiaansen, X. Zhang, D. Janvelyan, S. E. Fraser, R.E. Jacobs, Dynamics of Mn
transport in the mesolimbic system reveal neural projections from the Nucleus Accumbens
in vivo, Proc. Intl. Soc. Mag. Reson. Med. 18, 311 (2010) oral presentation
(18) J.A.M. Bastiaansen, X. Zhang, R.E. Jacobs, Limits of Mn detection in vivo: Spatial segrega-
tion of relaxation behavior, Proc. Intl. Soc. Mag. Reson. Med. 18, 4502 (2010) electronic
poster
xxvii

Introduction andOutline of Thesis
Introduction
Beyond providing insight into tissue structure and functionality, nuclear magnetic resonance
(NMR) is a powerful, non-invasive tool to study metabolism in cell cultures, perfused organs,
animals and humans1. The most bio-relevant NMR active nuclei which posess a nuclear
magnetic moment are proton (1H), phosphorus (31P) and carbon (13C). 1H NMR allows the
detection of important neurotransmitters 2 but, in addition to its small chemical shift range, it
is hindered by the strong water signal. 31P provides information about energetically important
metabolites, intracellular pH and reaction fluxes, but its signal originates from a limited
number of low molecular weight compounds 3.
13C NMR has become a well established technique to investigate in vivo metabolic processes
and offers the possibility to study the fluxes through metabolic pathways 4, and can be coupled
with MR imaging techniques that give anatomical information. Since most metabolically
relevant compounds contain carbon, it is possible to detect many metabolites with excellent
spectral resolution. However, 13C NMR only detects the 13C isotope of carbon, which has
a natural abundance of 1.11% . This sensitivity limitation can be overcome by infusing 13C
labeled molecules to study their metabolism in vivo. Although powerful, 13C isotopomer
methods, used to analyze relative fluxes, mostly require metabolic steady state conditions
and sufficient sample to allow collection of 13C NMR spectra over reasonable scan times.
Contamination of the spectra by unwanted natural abundance 13C lipid resonances poses
additional challenges for applications in skeletal and cardiac muscle. Additionally, NMR suffers
from an intrinsically low sensitivity due to a low spin polarization at thermal equilibrium. The
most straightforward method to increase the sensitivity is to increase the external magnetic
field, or employ the use of polarization transfer sequences. Improved RF coil design, increases
the detection sensitivity and decreases the noise, but does not change the fundamental spin
polarization.
Hyperpolarized techniques, such as dynamic nuclear polarization (DNP), have emerged as
a means to enhance the sensitivity of MR tremendously, by increasing the nuclear spin polar-
ization. The process of DNP itself is carried out on frozen solids, but the advent of dissolution
DNP 5 has enabled the preservation of the sensitivity increase at room temperature. This allows
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for the measurement of low concentration metabolites as well as the observation of metabolic
processes in real-time in vivo after infusion of hyperpolarized 13C labeled biomolecules6.
Dissolution DNP is a relatively young technique which opens the way for many interesting in
vivo applications but the full scope of its potential remains to be investigated. Currently the
technique is being used in the first human trials in the investigation of prostate cancer 7;8.
Of particular interest in this thesis are skeletal and cardiac muscle, which function relies on
a continuous production of energy, mainly via the hydrolysis of adenosine triphosphate (ATP).
The synthesis of ATP occurs via two metabolic pathways; aerobic and anaerobic combustion.
Aerobic production of ATP is the predominant and most efficient pathway. It involves the
chemical conversion of carbohydrates, lipids and proteins into carbon dioxide and water
and requires a sufficent oxygen supply. Under normal physiological conditions, oxidative
metabolism of nonesterified fatty acids provides 40-60% of the ATP used by the heart. Glucose
is an important alternative fuel, and accounts for approximatly 20-40% of the energy needs of
the heart under fasting conditions9. The heart can use a variety of other substrates such as
lactate and ketone bodies for energy production, but the low plasma concentrations of these
substrates limit their usage. Skeletal muscle at rest oxidizes both carbohydrates and lipids,
and a shift to carbohydrate oxidation is observed with increasing exercise levels.
The use of the fatty acid acetate as a substrate was of particular interest. Acetate is an
important metabolic substrate which supplies 6-10% of the basal energy in humans 10. Until
recently, most studies were not able to obtain reliable quantification of the metabolic turnover
of hyperpolarized acetate to acetylcarnitine 11. Carnitine plays an essential role in transferring
long-chain fatty acids into the mitochondrial matrix for subsequent β-oxidation, and in the
regulation of the mitochondrial acetylCoA/CoA ratio. Thus, carnitine regulates the balance
between fatty acid and carbohydrate metabolism.
Since tissue metabolism is modified in many common disease states like cancer, diabetes,
and heart failure, the use of hyperpolarized 13C substrates to measure absolute flux through
important pathways in vivo would not only revolutionize clinical diagnostic imaging but also
serve as an important tool to better understand the metabolic effects of new drugs aimed to
combat these diseases12.
Aim
This work focused on the development of in vivo magnetic resonance techniques to investigate
metabolism in skeletal and cardiac muscle, both using DNP hyperpolarized 13C spectroscopy
as well as conventional room temperature MR methods at high field.
Since in vivo DNP experiments by itself are challenging, initial experiments were conducted
on skeletal muscle to establish a protocol for in vivo studies. Once these protocols were
established, methods were adapted and further developed to enable hyperpolarized 13C
experiments in the heart.
2
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Outline of thesis
Chapter 1 aims to provide a brief overview of the basics of NMR, 13C spectroscopy in vivo and
kinetic modeling which might be of aid in understanding the concepts used in this thesis.
Chapter 2 describes the experimental considerations and development of hyperpolarized
13C experiments in vivo in skeletal muscle. A particular interest is given to acetate and its
application for metabolic studies in resting skeletal muscle. Using hyperpolarized acetate, the
13C labeling of acetylcarnitine was measured in real-time. A mathematical model was intro-
duced to describe acetate metabolism in resting skeletal muscle, and two different analytical
approaches were discussed to calculate enzymatic activity. It was shown that the labeling rate
reflects the enzymatic activity of acetylCoA synthetase.
With the establishment of an in vivo protocol for hyperpolarized studies in skeletal muscle,
the scope of experiments was extended to that of the beating heart. Chapter 3 describes the
development of cardiac 13C MR experiments and appropriate cardiac triggering. Again, acetate
was chosen as substrate based on its applicability as shown in Chapter 2, and our knowledge
and experience in the past with its hyperpolarizable properties. Acetate metabolism was
studied in the beating healthy heart, and the mathematical models were extended to include
mitochondrial oxidation. Additionally, analytical expressions were derived to interpret the
dynamic 13C labeling in acetylcarnitine and citrate.
The heart is a highly metabolically active organ which uses a variety of substrates in a
well-balanced manner to support its mechanical function. Often, metabolic alterations lie at
the onset of diseases. Chapter 4 presents the heart with a substrate challenge in order to gain
insight into the preferred substrates for myocardial oxidation and the ability of hyperpolarized
MR to use substrate competition as a potential diagnostic tool. To this end, two different
metabolic compounds, the lipid butyrate and the carbohydrate pyruvate, were coinjected in
animals divided in two different nutritional groups. The metabolic changes as a result of this
competition, as well as the concept of cardiac pseudoketogenesis, are discussed.
Since pyruvate is commonly administered at supraphysiological concentrations, the use of
the carbohydrate lactate was investigated as a tracer for carbohydrate metabolism. Lactate is
not only a waste product, but also an oxidizable substrate in resting skeletal muscle, which does
not interfere with other metabolic processes. Chapter 5 investigated the use of hyperpolarized
lactate as a substrate for skeletal muscle metabolism in fed and fasted rats. Furthermore, the
implications of endogenous substrate concentration changes on observed metabolism are
discussed.
The detection of citrate in chapter 3 was hindered by the close proximity of the acetate
resonance, which also obscures the detection of glutamate. Acetylcarnitine could be an
interesting substrate since it crosses the mitochondria easily, skipping a few metabolic steps,
and does not interfere with the detection of glutamate and citrate. Chapter 6 investigates the
feasibility of hyperpolarized acetylcarnitine as a tracer for myocardial substrate oxidation.
3
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The intrinsic insensitivity of the 13C carbon nucleus can also be overcome by increasing the
field and using polarization transfer sequences. Chapter 7 presents acetate studies conducted
in skeletal muscle at 14.1 T using a localized polarization transfer sequence. The influence of
localization methods on lipid resonances is shown, as well as the quantification of 13C labeled
muscle metabolites. Furthermore, the applicability of this method to measure the turnover of
acetylcarnitine is demonstrated.
Finally, in Chapter 8, the main achievements of this thesis are presented with an outlook to
possible applications, and future directions based on the presented research are discussed.
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1An introduction toNMRspectroscopy
Abstract
Nuclear magnetic resonance is a versatile and widely used technique, most commonly known
for its applications in imaging (MRI). This thesis uses the phenomenon of NMR for its spec-
troscopic applications. Since nuclei with magnetic moments are detectable using MR spec-
troscopy, biomolecules containing these nuclei can be measured, each with their own fre-
quency signature. The non-invasive nature of NMR spectroscopy allows for the measurement
of biochemical reactions in living organisms to study metabolism. This chapter gives a brief
overview of the principles of magnetic resonance spectroscopy in vivo and serves as back-
ground information for the remaining chapters.
Chapter 1. An introduction to NMR spectroscopy
1.1 History of Magnetic Resonance
The phenomenon that specific atomic nuclei are able to absorb and transmit electromagnetic
energy was first observed in 1946 by E. Purcell1 and F. Bloch2, for which they were awarded
the Nobel Prize in Physics. These so-called nuclear magnetic resonanc (NMR) experiments
were initially performed by physicists to determine the magnetic moments of nuclei. NMR
typically uses radiofrequencies in the range of 10 - 800 MHz. Later it was discovered that
nuclei within the same molecule absorb energy at different resonance frequencies and that
these are influenced by the chemical environment of the nucleus, in addition to the applied
magnetic field. This discovery, made by Proctor 3 and Dickinson 4 in 1950 lead to an extension
of the applicability of MR to study the structure and environment of different molecules. In
the next decades after its discovery NMR was used to study living objects. A growing interest in
defining and explaining the properties of water in biological tissues resulted in the observation
that NMR properties of healthy tissue is significantly different from that of cancerous tissue 5.
In the mid 70’s Lauterbur 6, Mansfield7 and coworkers were able to reconstruct images from
the NMR resonances using position dependent magnetic fields. This led to the establishment
of one of the major applications of NMR as we know today, magnetic resonance imaging
(MRI), and was awarded the Nobel price in Medicine in 2003. Over the last decades, NMR
spectroscopy and imaging has evolved tremendously and became a widely used tool to study
and analyze tissue structure, function, composition and dynamic metabolic processes in live
subjects.
1.2 Basic Principles of MR
1.2.1 Nuclei in a magnetic field
Nuclei with a net spin angular momentum~L interact with a magnetic field 8;9. This interaction,
known as nuclear magnetic resonance (NMR), is described by the linear relationship between
the static magnetic field B0 experienced by a nucleus and the resulting angular frequency of
rotation ω0 of the nuclear spin,
ω0 = γB0 (1.1)
where γ is the gyromagnetic ratio, which is a unique constant for each nuclear isotope pos-
sessing a spin. The gyromagnetic ratio of several nuclei of interests are given in Table 1.1.
The angular frequency ω0 is also referred to as the Larmor frequency, and is identical to the
frequency of the electromagnetic radiation associated with the possible spin energy transitions
induced by the magnetic field B0.
Nuclei in a magnetic field have (2I +1) energy levels where I is the spin quantum number
which is an integer or half-integer and determined by the combined spin of the protons and
the neutrons inside the nucleus (Table 1.1). This energy splitting is called the Zeeman effect.
Each nuclear spin is associated with a quantized magnetic dipole moment~µ which is related
6
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Figure 1.1: (A) The nuclear spin energy for a spin 12 particle as funcion of the magnetic field
strength B0. (B) The low energy levelα corresponds to magnetic moments parallel with B0, while
spins in the higher energy level β have an antiparallel alignment with B0.
to the angular momentum~L and given by:
~µ= γ~L (1.2)
The angular momentum of nuclei in the absence of a magnetic field are oriented randomly.
When these spins are placed in a strong external magnetic field, their magnetic dipole mo-
ments tend to align with the field in either of the two states. For spin I = 12 nuclei there are two
possible energy levels in a magnetic field B0:
E =±µB0 =±1
2
γħB0 (1.3)
These two spin states are referred to as “up” and “down”, referring to a low (α) and a high
(β)energy state (Figure 1.1). The energy difference∆E between the two spin states is described
as follows (Figure 1.1):
∆E = γħB0 =ħω0 (1.4)
The energy needed to make transitions between energy levels increases with increasing
magnetic field.
1.2.2 Polarization
The distribution of the spin states in a magnetic field is in thermal equilibrium and can be
calculated using the Boltzmann equation:
nα
nβ
= e∆E/kB T (1.5)
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Table 1.1: List of NMR properties of nuclei of interest in biomolecular applications
Nucleus Spin Gyromagnetic ratio Natural abundance
γ [MHz/T] [%]
1H 1/2 42.58 99.985
2H 1 6.54 0.015
12C 0 - 98.9
13C 1/2 10.71 1.1
31P 1/2 17.25 100
23Na 3/2 11.27 100
19F 1/2 40.08 100
where nα and nβ denote the population in both the low and high energy state, kB is the
Boltzmann constant and T is the absolute temperature. The number of spins parallel to the
magnetic field exceeds the number anti-parallel to that field, but this excess is very small. The
polarization P is defined as the fraction of spins that are net aligned with the field and can be
simplified to:
P = nα−nβ
N
' ħω0
2kB T
(1.6)
where N = nα+nβ is the total number of spins. This means that at room temperature at low
field the fraction of spins that are "up" is only one in a million. Considering the Avogadro
number the amount of molecules in a small volume of sample that is in excess is such that it
leads to measurable NMR effects.
For a sample at 37◦C (310.15 K) and in a magnetic field of B0 = 9.4 T, the 13C (γ=10.71 MHz/T)
spin polarization is only 8 ppm, 0.0008%
For a given amount of spins n the longitudinal equilibrium magnetization M0 is determined
by the magnetic moment component of each spin multiplied by the net amount of spins that
are aligned and is described as follows:
M0 = nγ
2ħ2
4kB T
B0 (1.7)
1.2.3 Magnetization
Although the NMR phenomenon is purely a quantum mechanical process, its macroscopic
manifestation and interaction with external magnetic fields is, under most circumstances, well
described by classical physics. In a classical description, the magnetic moment will experience
a torque and starts to precess around an axis along the direction of the magnetic field with
frequency ω0 as illustrated in Figure 1.2A and this precession motion is described with the
8
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Figure 1.2: (A) The precession of a spin 12 magnetic moment µ about a magnetic field B0
according to a classical description. (B) The sum of all individual magnetic moments µ within
a sample result in the net magnetization vector M0.
following equation:
d~µ
d t
= γ~µ×~B (1.8)
In NMR, samples are studied which contain many individual spins. The spin angular
momentum of all these spins are distributed on a cone (Figure 1.2B). Consider a volume V
which is small enough that the external fields are constant but which contain a large number of
nuclei. The total magnetization M in that voxel is the sum of the individual magnetic moments
µof the nuclei contained in that voxel (Figure 1.2B). This net magnetization vector is finite,
observable and when the spin system is in a state of equilibrium this vector is parallel to the
field,
~M0 = 1
V
∑
pr otons
~µi (1.9)
A sum over the equation of motion for the individual spins yields the following description
of the magnetization vector M :
d ~M
d t
= γ~M ×~B (1.10)
This type of equation is known as the Bloch Equation 2;10;11 and illustrates the interaction of
spins with external magnetic fields.
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1.2.4 Excitation and Bloch Equations
Magnetic resonance is based on the detection of the precessional motion of the magnetization
vector. At thermal equilibrium the spins have no phase coherence in the transverse plane and
the net longitudinal magnetization M0 is a static vector (Figure 1.2B):
dMz (t )
d t
= 0 (1.11)
No transversal components of ~M exist at thermal equilibrium. To be able to measure the
nuclear magnetization, M0 needs to be moved away from its equilibrium. To be more specific,
the M0 needs to be rotated to the transverse plane. This is achieved by a second magnetic field,
B1, which is a circularly polarized radio frequency (RF) field:
~B1(t )=B1 cosωt +B1 sinωt (1.12)
This second magnetic field B1 is perpendicular to B0 and oscillates in the x y-plane with
the Larmor frequency ω0 of the system. The longitudinal magnetization M0 will experience a
torque from the B1 field, M0 will then be tipped away from the z-axis towards the transversal
plane. The magnetization vector will start to precess around the B0 axis with ω0 and around
the B1 axis with ω1= γB1 (Figure 1.3A). The behavior of the macroscopic magnetization vector
as a result of the magnetic interactions with B1 and B0 is described classically by the Bloch
equation2;10;11, which is given by,
d ~M
d t
= γ~M × (~B0+ ~B1) (1.13)
Seen from a rotating frame of reference (1.3B), the magnetization vector experiences B1
as a static field when B1 is “on resonance”. oscillating with ω0. The angle of rotation α is
determined by the duration t of the application of B1,
α= γB1t (1.14)
Typically, this angle α is referred to as the flip angle. Since the duration t needed to flip the
magnetization by the required amount is typically very short, typically ranging from 100 µs
to a few ms, the applied B1-field is referred to as an RF pulse. The term excitation pulse is
also used, reflecting the fact that the spin system will be in a higher energy state when the net
magnetization of the system is moved away from its equilibrium orientation.
10
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Figure 1.3: (A) The on-resonance trajectory of M0 when an oscillating magnetic field B1 is added
to the static magnetic field B0 in a laboratory frame xyz. The longitudinal magnetization M0
will precess about the static magnetic field B0 and the irradiating RF field B1 in the transverse
plane. (B) An identical situation is sketched in a rotating frame of reference where the x’ and
y’-axis are rotating about z with ω0.
1.2.5 Relaxation of the magnetization
During and after the application of the RF pulse, the magnetization vector consists of two
components. The transversal magnetization Mx y which rotates about the z-axis and the
longitudinal magnetization Mz . The oscillating nature of Mx y allows detecting induction of
a current in a coil placed within this oscillating field. After application of the RF pulse, the
measured NMR signal rapidly decays to zero. This process is generally referred to as relaxation,
which describes the process of the magnetization returning to its thermal equilibrium. It is the
result of several interactions and exchange and loss of the excitation energy. The Bloemberg
Purcell Pound theory explains the relaxation mechanism by condering the motion and rotation
of the spins influenced by its environment12.
Two different relaxation processes occur with their own time constant, one is related to the
decaying transversal magnetization Mx y , and one to the longitudinal magnetization Mz , and
can be described by:
dMx y (t )
d t
= −Mx y (t )
T2
(1.15)
dMz (t )
d t
= −Mz (t )−M0
T1
(1.16)
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with T1 the longitudinal relaxation time constant and T2 is called the transversal relaxation
time constant. The Bloch equations can be extended to incorporate relaxation as follows:
d ~M
d t
= γ~M ×~Bext + 1
T1
(~M0− ~Mz )− 1
T2
~Mx y (1.17)
Spin longitudinal relaxation is also referred to as spin-lattice relaxation. This is caused
by energy transfer from the spins to the surrounding ’lattice’, which can be either solid or
liquid. The rate of recovery of Mz (0) to the thermal equilibrium value M0 is described by a
time constant T1 as follows:
Mz (t )=Mz (0)e−t/T1 +M0(1−e−t/T1 ) (1.18)
where Mz (0)= 0 for a saturation recovery experiment using a 90◦ flip angle and Mz (0)=−M0
for an inversion recovery experiment which rotates M0 by 180◦ . The inverse of the longitudinal
relaxation time, 1/T1, is referred to as the longitudinal relaxation rate, R1. The differences in
T1 in for example tissues, give rise to image contrast when using pulse sequences which are
sensitive to variations in T1, referred to as T1-weighted sequences. In T1-weighted sequences,
the repetition time TR is short (compared to the longest T1 observed) and tissues with short T1
give more signal than tissues with a long T1 since more magnetization is recovered.
The term transversal relaxation, also called spin-spin relaxation, is used to describe the
decay of the transversal component Mx y . This is a result of local field inhomogeneities on
a microscopic scale. The field variations are introduced by various shielding effects at the
molecular level as well as macroscopic field inhomogeneities due to variations in the local
susceptibility. This leads to different local precessional frequencies and dephasing of Mx y .
The decay time of Mx y is described by T2 as follows:
Mx y (t )=Mx y (0)e−t/T2 (1.19)
In practice, there is an additional dephasing of the magnetization. B0 inhomogeneities will
create a distribution of locally different B0 magnetic fields across the sample which leads to
a distribution of Larmor frequencies. This introduces an acceleration of loss of transverse
magnetization after excitation. This additional loss can be described with the relaxation time
constant T∗2 :
1
T ∗2
= 1
T2
+γ∆B0 (1.20)
where γ∆B0 indicate the effect of static external field inhomogeneities. The loss of transverse
magnetization due to T∗2 is recoverable. T
∗
2 dominates the dephasing of Mx y after excitation,
but another pulse can be applied which rephases the spins.
Immediately following an excitation pulse all the protons in a voxel precess in phase and
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their individual magnetic moments will collectively contribute to the transversal magneti-
zation vector. However, the presence of field variations on a molecular level will introduce
variations in the Larmor frequency with consequent loss of phase coherence among the spins
in a voxel. The loss of phase coherence therefore causes Mx y to decay faster than Mz is re-
covering so that T2 is always shorter than T1 in vivo. transversal relaxation times can vary
significantly depending on tissue composition and local field homogeneity. T2 is generally
longer in fluids than in solids. In order to make a pulse sequence sensitive to T2 differences,
the repetition time TR needs to be long and the echo time TE should be sufficiently long to
ensure that a large enough difference in the transversal magnetization has been established
before the MR signal is acquired.
Fundamental understanding of both relaxation processes and their relation to molecular
motion can be achieved by introducing a spectral density function J (ω), which gives a measure
of the amount of motion at a frequency ω, and is described as follows:
J (ω)= τc
1+ω2τ2c
(1.21)
where τc is the correlation time, which describes random motions. τc represents the average
time it takes for a molecule to rotate by one radian. For example, small molecules have short
τc relative to large molecules.
The relationship between the relaxation time and the spectral density was established by
time-dependent perturbation theory 12. For a homonuclear spin 1/2 system, the two relaxation
times can be described as:
1
T1
= K [J (ω0)+4J (2ω0)] (1.22)
1
T2
= K
2
[3J (0)+5J (ω0)+2J (2ω0)] (1.23)
where K represents the constant
K = (µ0
4pi
)2 · 3
10
· ħ
2γ4
r 6
(1.24)
where µ0 is the magnetic constant and r the distance between the two spins. It can clearly be
seen that T2 relaxation contains the contribution from an additional low frequency component
relative to T1 relaxation. Therefore T2≤ T1. When the molecule has a fast rotation andω2τ2c <<
1, T1 and T2 tend to be similar. When the correlation time is long enough ω
2τ2c >> 1, T2 will
be shorter than T1. Between these two conditions, there is a range of correlation time values
for which T1 reaches a minimum but T2 will keep decreasing continuously. In the case of
macromolecules, which have a slow rotational motion, the low frequency component is more
expressed, resulting in a short T2 and long T1. When τc increases T1 values are changing,
13
Chapter 1. An introduction to NMR spectroscopy
z
y
x
A B
time
M
x 
(t)
M
B0
M
y 
(t)
M
z 
(t)
‘Real’ FID
‘Imaginary’ FID
T
2*
T
1
T
2*
Figure 1.4: (A) The on-resonance trajectory of the magnetization ~M after a 90◦ excitation in the
laboratory frame. The magnetization undergoes precession and relaxation while it returns to
its thermal equilibrium. (B) The magnetization components of ~M are given in the x y and z
direction. Mx and My both decay with T
∗
2 and Mz with T1.
indicated that T1 is likely to be field dependent.
1.2.6 Detection of the MR signal - Fourier transform NMR
After the magnetization is perturbed by an RF pulse and rotated in the transverse plane, RF
coils detect the oscillating magnetization as an induced emf. This oscillating NMR signal
decreases as a function of time because of relaxation processes described in section 1.2.5
and is called a Free Induction Decay (FID). The FID is the sum of many oscillating waves of
different frequencies, amplitudes and phases. It is usually detected using two orthogonal
detection channels along the x and y axis, and known as quadrature detection (see Section
1.4). This allows for the simultaneous measurement of the x and y components of the FID. For
each resonance, the two signals acquired are cosine and sine functions of the offset frequency
Ω=ω0−ω, decaying with T∗2 .
Consider the application of a short RF pulse with a 90◦ excitation, the magnetization com-
ponents just after the pulse are obtained using the Bloch equation (Eq. 1.17) and given by:
Mx (0) = 0 (1.25)
My (0) = M0 sinθ
Mz (0) = M0 cosθ
14
1.2. Basic Principles of MR
Right after the magnetization is precessing around B0 and undergoes relaxation, therefore the
magnetization components after an excitation can be described by (Figure 1.4):
Mx (t ) = M0 sinθcosΩte−t/T
∗
2 (1.26)
My (t ) = M0 sinθ sinΩte−t/T
∗
2
Mz (t ) = M0 cosθe−t/T1 +M0(1−e−t/T1 )
Mx (t ) and My (t ) can be regarded as a real and imaginary part of the signal s(t ) which, after
a 90◦excitation obtains the general form of:
s(t )∝Mx y (t )=Mx (t )+ i My (t )=M0 [cosΩt + i sinΩt ]e−t/T
∗
2 (1.27)
These can be converted into the frequency domain function S(ω) by Fourier transformation
and is also called the spectrum
S(ω)=
∫
s(t )e−iωt d t (1.28)
Fourier transformation of the time domain signal yields the real and imaginary frequency
domain signals given by
R(ω) = A(ω)cosφ− i D(ω)sinφ (1.29)
I (ω) = A(ω)sinφ+ i D(ω)cosφ (1.30)
where
A(ω) = = M0T
∗
2
1+Ω2T ∗22
(1.31)
D(ω) = = M0ΩT
∗2
2
1+Ω2T ∗22
(1.32)
The real part A(Ω) is an absorptive Lorentzian curve, centered on frequencyΩwith a full
width at half height of 1/piT ∗2 while the imaginary part, D(Ω), is the corresponding dispersive
Lorentzian.
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Figure 1.5: (A) T1 relaxation can be measured using an inversion recovery (180
◦/ 90◦, α=2) or
saturation recovery (90◦/ 90◦, α=1) method. After the inversion of the magnetization it relaxes
back to its thermal equilibrium value M0 with time constant T1. (B) Using a variety of inversion
times TI the recovery of M0 can be sampled and fitted to the expression for M0 recovery (Eq.
1.33).
1.2.7 Measurement of relaxation time constants
In section 1.2.5 the return of the magnetization to its equilibrium state was introduced. The
time constants T1 and T2 or T
∗
2 describe these relaxation phenomena and knowledge about
them is essential, since they affect any magnetic resonance experiment. Knowledge about
these time constants is important for signal quantification, chemical exchange and the design
of timings for data acquisition.
In the case of hyperpolarized 13C experiments, the T1 value is on of the important factors
determining the time during which data can be acquired, i.e. the measurement window.
T1 measurements
To estimate T1 one can consider a sequence with an initial excitation angle α and an inversion
time TI . Conventional methods to measure T1 are the inversion recovery experiment with
an initial 180◦ excitation and the saturation recovery experiment with a 90◦ excitation pulse
(Figure 1.5). The inverison recovery sequence is the gold standard for the determination of T1
relaxation times. The recovery of the longitudinal magnetization is given by:
Mz (t )=M0(1−αe−t/T1 ) (1.33)
where α = 2 for an inversion recovery measurement or α=1 for a saturation recovery measure-
ment. By varying the parameter TI several FIDs can be acquired and their signal intensities
can be fitted using Eq. 1.33. The inversion recovery method is not optimal in terms of signal
per unit of time since the majority of scan time is used to wait untill Mz is fully recovered
to M0 before another excitation can be performed. In general the delay time between two
consecutive excitations is T R = 5T1.
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Figure 1.6: (A) A typical spin-echo experiment is sketched with the application of a 90◦ and
180◦ excitation pulse. (B) Measurement of T2 relaxation is perfomed by obtaining the FIDs at
different echo times and fitting the data to the expression for the decaying magnetization (Eq.
1.34). (C) First a 90◦ pulse excites the spins after which they dephase in the transverse plane
during the first half of the echo time with a time constant T∗2 . As described in section 1.2.5 this is
due to static and dynamic field inhomogeneities and frequency offsets. A 180◦ refocusing pulse
mirrors all the magnetization vectors after which the spins rephase during the second half of
the echo time due to the static magnetic field inhomogenieties and frequency offsets. At the echo
time TE , all spins have rephased and an echo is formed.
Since the saturation recovery experiment reduces the Mz to zero at time t = 0, it does not
require a long repetition time. This significantly reduces the temporal resolution.
T2 measurements
After RF excitation, spins in different positions will precess at slightly different Larmor frequen-
cies due to the field inhomogenieties. This results in a loss of phase coherence and both effects
are characterized by the time constant T∗2 , like described in Eq. 1.20. After a 90
◦ pulse the T∗2
effect will obscure any information regarding T2, but during the generation of spin-echoes
it is possible to separate the contribution of T2 and magnetic field inhomogeneity
13. In a
spin echo sequence (Figure 1.6) the magnetization is tipped to the transverse plane by a 90◦
pulse. During the subsequent delay the magnetization starts to lose coherence because of
the intrinsic T2 relaxation and a range of B0 magnetic fields, and precesses about z with a
17
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veriety of Larmor frequencies. After a delay of TE /2 a 180◦ pulse is applied which causes a 180◦
rotation about y . During a second delay TE /2 the spins precess again at their local Larmor
frequencies and will be refocused at the end of the second delay to form a spin echo. The time
between the 90◦ pulse and the time of the echo is called the echo time TE . By varying the echo
time in several experiments and measuring the signal, the T2 relaxation time constant can be
calculated by fitting the signal intensities as function of TE to the following equation:
Mx y (t )=Mx y (0)e−TE /T2 (1.34)
There are two additional dynamic dephasing terms which cannot be refocused during an
180◦ pulse and these are related to diffusion and exchange of the spins in the presence of local
field inhomogeneities. By applying a train of 180◦ pulses instead of a single one, the measured
T2 relaxation time constant is closer to the intrinsic T2 relaxation time constant
14;15.
1.2.8 Chemical Shift
The frequency of nuclei is not solely determined by the resonance condition ω0 = γ B0. Nuclei
of the same element in diferent molecules resonate at different frequencies. The frequency
ω not only depends on the gyromagnetic ratio γ and the external field B0, but also to the
chemical environment of the nucleus of interest3. This is referred to as chemical shift and
is caused by shielding of nuclei from external magnetic field by electrons surrounding them
(Figure 1.7).
The electrons will rotate about B0 in an opposite sense to the proton spin recession. The
static field B0 induces currents in the orbital electrons, which in turn generate a local magnetic
field that is several orders of magnitude times smaller than the main magnetic field. The
electron magnetic moment opposes the primary applied magnetic field B0. This reduces the
magnetic field that is sensed by the nucleus to
~B = ~B0(1−σ) (1.35)
where σ is the shielding constant, which is a dimensionless number expressed in parts per
million (ppm). It depends on the chemical environment of the nucleus. The resonance
condition for nuclei can be modified to
v0 = ( γ
2pi
)B0(1−σ) (1.36)
with v0 =ω0/2pi. To make chemical shifts independent of magnetic field strength, they are not
expressed in units of Hertz, but in terms of ppm. By convention this is defined as:
δ= v − vr e f
vr e f
×106 (1.37)
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Figure 1.7: (A) Reorientation of the electron cloud in a magnetic field generates a magnetic
moment µe at the nucleus. This magnetic moment opposes the external magnetic field B0,
thereby reducing the effective magnetic field felt by the nucleus. This leads to a change in
Larmor frequency and thus in chemical shift. This is called electronic shielding. (B) Nearby
electronegative atoms attract electrons which lead to lower electron density and deshielding of
nearby protons. Therefore the resonance frequency is higher in OH than in CH groups. (C) The
electronegative oxygen atoms in lactate shift the electron density away from protons, leading to
reduced electronic shielding and to a higher Larmor frequency. The proton NMR spectrum of
lactate shows these shielding effects, the methine proton is closer to electronegative oxygen atoms
than the three methyl protons. The resonance splitting is due to nuclear coupling (Section 1.2.9).
The methine resonance splits into a quartet due to the neighbouring protons in the methyl group
which induces 4 different energy level transitions in the methine proton. Conversely, the CH3
resonance splits into a doublet due to the neighbouring methine proton.
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where v and vr e f are the frequencies of the compound under investigation and of a reference
compound. For in vivo NMR spectroscopy the reference compounds are usually biomolecules
present in the issue such as N-acetyl aspartate (2.01 ppm) for 1H MRS. Typically, chemical
shifts are spread over 10 ppm for proton spectroscopy and about 200 ppm for 13C NMR
spectroscopy.
1.2.9 Nuclear coupling
Besides the chemical environment of the nucleus which gives it a characteristic frequency
known as chemical shift, nuclear spins are also affected by surrounding nuclear spins. This
phenomenon results in the splitting of resonances into several smaller lines, and is called spin
spin coupling. It originates from spins interacting through space (dipolar coupling) or through
chemical bonds (scalar coupling). In a liquid the dipolar interactions normally average out
due to rapid tumbling. However, interactions through the electrons of the chemical bonds
do not average to zero and produce multiplets in spectra, as can be seen in the 1H spectrum
of lactate in Figure 1.7C. The frequency difference of the splitting is given by the J-coupling
constant indicated in Hz.
Consider the spin-spin coupling between two spin 1/2 nuclei I (for example a proton) and
S (a carbon-13). Spin I has two possible energy levels, related to the magnetic moment being
parallel or anti-parralel to the main magnetic field B0. The S nucleus senses these two different
states through the spin of electrons in the covalent S− I chemical bond, which causes the
energy levels to split in four (Figure 1.8). The energy of the levels depends on the J coupling
constant relative to the absolute frequency difference between the two nuclei |v I −vS |. The J
coupling constant is independent of the external magnetic field.
Typical J coupling constants are in the range of 1-15 Hz for 1H-1H couplings, 100 - 200 Hz
for 1H-13C couplings and 30-80 Hz for 13C-13C couplings. These J coupling constants are for
one chemical bond, except for 1H-1H interactions.
The J coupling property provides information about the structure of molecules. When more
nuclei are coupled, spectral patterns can become complex, containing triplets, quadruplets or
even doublet of quartets in the case of [1-13C]acetylcarnitine (Figure 1.9). The total area of a
certain resonance is proportional to its magnetization and thus nuclear coupling will in fact
reduce the SNR of each peak.
The appearance of 13C NMR spectra is in general dominated by heteronuclear 1H-13C cou-
pling since most carbon nuclei are directly bonded to one, two or three protons. Crowded
spectra also complicate the quantification of resonances. To increase the sensitivity and sim-
plfiy the spectral appearance, the multiplets, originating from heteronuclear 1H-13C coupling,
are collapsed into singlets by applying 1H decoupling during the 13C MRS acquisition. To this
end, a continuous RF field is applied at the larmor frequency of the 1H nucleus. This causes
a continuous exchange between the energy levels of 1H, which averages out the coupling
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Figure 1.8: Energy diagrams and NMR spectra for an isolated (left) and a weakly coupled (right)
two spin system of nuclei I and S. When the two nuclei are uncoupled the NMR spectrum show
individual resonances for nucleus I and S with their frequencies v1 and v2 respectively. The
coupling between the two nuclei result in a splitting of the resonances of I and S, since the
energy level transition of each nucleus has two different frequencies.
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Figure 1.9: Effect of 1H decoupling on the 13C MRS spectrum of [1-13C]acetylcarnitine, an
intermediate metabolite detected after injecting hyperpolarized [1-13C]acetate 2. (A) 13C spec-
trum of [1-13C]acetylcarnitine is a doublet of quartets as a result of 1H-13C coupling with a
neigbouring methyl (CH3) and methine group (CH). (B) 1H decoupled 13C spectrum of [1-13C]
acetylcarnitine.
between the 1H and 13C nuclei, resulting in a singlet (Figure 1.9). In the case of heteronuclear
decoupling of an entire 13C spectrum, which contains a wide range of chemical shifts, broad-
band decoupling is usually applied. Broadband decoupling is performed by applying a series
of composite pulses such as WALTZ-16 16.
Because of the low probability of two adjacent 13C isotopes, homonuclear 13C-13C scalar
couplings are usually not observed. However, in 13C experiments where labeled 13C com-
pounds are infused multiple carbon positions will carry the 13C label eventually and metabolite
resonances will appear as multiplet structures due to the 13C-13C homonuclear couplings. The
appearance of such isotopomers allows isotopomer analysis and can provide information on
the underlying metabolic pathways as discussed in Section 1.5.
1.2.10 Localized spectroscopy
So far we have considered macroscopic magnetizations which are excited to the transverse
plane for MR detection. This restricts the data acquisition to a very large volume. The principle
of localization is to obtain information from a particular location inside a tissue. Spatial
localization of a volume of interest (VOI) is achieved by using a spatially varying magnetic
field so that the Larmor frequencies become spatially-dependent. This additional field is also
called a gradient which intensity is linearly varying in three orthogonal directions.
RF excitation can be performed for a particular range of frequencies, and thus the gradients
can be adjusted so that the RF excitation affect a particular location in the sample. The position
is then determined by the magnetic field gradient strength and the RF pulse frequency. A
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Figure 1.10: The principle of slice selection is illustrated. An RF pulse with carrier frequency
ωRF is applied in the presence of a gradient along the x direction. When the gradient strength is
changed, slices are excited with different thickness ∆x
proportional relationship exists between the spatial position x and the spin frequency when
using simultaneously a frequency selective RF pulse with a linear gradient.The spin frequency
ω of a given nucleus is depending on its position x in the sample as follows:
ω(x)= γ(B0+Gx x) (1.38)
where γB0 is the Larmor frequency ω0. When a gradient is applied of amplitude G in a certain
direction during an RF pulse, a slice perpendicular to the gradient direction will be selected.
The width of the slice is determined by the magnetic field gradient strenght and by the RF
pulse bandwidth, and its position is given by the center frequency of the RF pulse (Figure
1.10). Now consider a certain bandwidth of frequencies ∆ω, the spatial displacement ∆x of
the acquired signal can be given by:
∆x = ∆ω
γGx
(1.39)
where Gx is a gradient along x. The application of gradients are used in many applications of
MR spectroscopy and are the principal components in MR imaging.
Outer volume suppression
Outer volume suppression (OVS) leaves the magnetization in the VOI unperturbed during
the localization and suppresses the external signals 17. The application of a slice-selective 90◦
pulse is followed by crusher gradients that excite spins outside of the VOI and dephases them
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Figure 1.11: The ISIS sequence used for localization in NMR spectroscopy consists of three
orthogonal slice selective 180◦ excitations followed by a 90◦ pulse for MR signal acquisition. 3D
localization is achieved with the add and subtract scheme of 8 acquisitions, isolating signal
from the VOI.
immediately after excitation in the transverse plane. The result of the dephasing is a zero net
magnetization in the corresponding slices surrounding the VOI, while the signal from the
VOI remains untouched. Thus, the OVS pulses selectively remove unwanted signal although
it is limited by the T1 recovery of the magnetization in the different slices before the actual
acquisition starts.
ISIS
Image selected in vivo spectroscopy (ISIS) enables the excitation of magnetization in a VOI. In
the MR sequence, the magnetization in the VOI is measured by successive excitations of three
orthogonal slices which intersection corresponds to the VOI. ISIS relies on a set of longitudi-
nal magnetization preparation 180◦ slice-selective inversion pulses in orthogonal directions
followed by a 90◦ pulse for signal acquisition (Figure 1.11). Acquisitions are performed with
the inversion pulses turned on and off in different combinations during successive scans. The
acquired signals are added and subtracted following a specific procedure. The 1D ISIS requires
two consecutive signal acquisitions. The first acquisition is a standard 90◦ excitation followed
by the detection of the transverse magnetization. The second acquisition is identical, except
that a slice selective 180◦ pulse inverts the magnetization prior to 90◦ pulse. The subtraction
of the two acquisitions removes the signal from outside the slice. For the 3D ISIS sequence, a
total of 8 scans acquisitions are combined to isolate the signal from the magnetization located
in the VOI with a specific encoding scheme (Figure 1.11). As a consequence of this acquisition
scheme with adding and subtracting, the final signal is particularly sensitive to physiological
motion. An advantage of ISIS localization is that it can be used as a preparation module to any
spectroscopic sequence.
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1.3 Hyperpolarization
As seen in Section 1.2.2 Equation 1.6 the thermal equilibrium polarization depends on three
factors, the gyromagnetic ratio γ, external magnetic field B0 and the sample temperature T .
Various methods have been proposed which enhance the nuclear spin polarization to a signif-
icant fraction. They create a polarization level which is far beyond the thermal equilibrium
polarization and are collectively referred to as hyperpolarization techniques. These techniques
have recently begun to show potential for in vivo applications. They include a "brute force"
approach18, optical pumping of noble gases19, para-hydrogen induced polarization20 and
dynamic nuclear polarization (DNP)21. This studies conducted in this thesis employed dy-
namic nuclear polarization to obtain highly polarized biomolecules for subsequent metabolic
studies.
1.3.1 Dynamic Nuclear Polarization
DNP hyperpolarization is achieved by transferring the electron spin polarization into a nuclear
one. The process is usually carried out at temperatures below liquid helium temperature (1
± 0.05 K), moderately high magnetic field (5 T) and on frozen glassy mixtures containing
the target molecules and a small amount of radical. At these temperatures the electron spin
polarization increases dramatically (95%) (Table 1.2). Continuous microwave irradiation at
a frequency ω, which is close to the Larmor frequency of the electron spins ωe , saturates
the ESR line of the unpaired electrons of stable radicals which are added to the sample
containing the nuclear spins of interest (Figure 1.12). Due to the out-of-resonance irradiation,
the electrons start to interact with nuclei, trough electron-nuclear spin flip-flop transitions, to
compensate the energy offset. Now the electron spin polarization will be transferred via the
dipolar-dipolar hyperfine coupling to its neighboring nucleiar spins. The exchange of energy
between the electron and the nuclear spins through electron-nuclear interactions typically
involves one nuclear spin and one or more electron spins. Then, resonant mutual flips or
transitions between two neighboring nuclear spins, also referred to as spin-diffusion, induce
a polarization transfer to the nuclear spins in the bulk and the polarization will be build up
as long as the nuclear T1 permits. The spin diffusion mechanism involves both dipolar spin
diffusion and, a faster, Zeeman spin diffusion22;23
In DNP, the electron spins polarize the nuclear spins, but in the same fashion these param-
agnetic centers also introduce a faster relaxation (Section 1.2.5). It is thus necessary for the
polarized nuclear spins to be isolated from the electron spins, at least for a large part of the DNP
experiment, and to carefully choose the ratio between nuclear and electron spin density. Typi-
cally the electron concentration is low (0˜.001 electron spins per nuclear spin). on average Ne
electron spins must polarize NN /Ne nuclear spins and after each forced microwave-induced
transition the electron spin must relax back into its thermal equilibrium before any of the
NN /Ne nuclear spins in its sphere or influence relax through a nuclear relaxation mechanism.
The efficiency also depend on the ratio between the nuclear and electron spin longitudinal
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Table 1.2: Polarization levels at several temperatures for electron spins and the nuclear spins of
carbon-C13 and proton
Nucleus Temperature Magnetic Field Polarization
[K] [Tesla] [%]
1H 300 9.4 0.003
13C 300 9.4 0.0008
1H 1.2 3.35 0.3
13C 1.2 3.35 0.08
e 1.2 3.35 95
relaxation, which is highly influenced by the intensity of the applied magnetic field B0 and the
temperature of the sample. In order to effectively enhance the nuclear polarization of solid
dielectric samples via DNP the following condition should be fullfilled21:
NN
Ne
T1e
T1N
<< 1 (1.40)
where NN and Ne are respectively the number of nuclear and electron spins in the sample.
In other words, the total rate of spontaneous electron spin flips Ne /T1e should considerably
excdeed the rate of spontaneous nuclear spin flips NN /T1N . If the nuclear relaxation is domi-
nated by the hyperfine interaction with the electrons, then the condition will automatically
hold.
There are three DNP mechanisms, the nuclear Overhauser effect (NOE) thermal mixing and
the solid effect.
1.3.2 Polarization mechanisms
Overhauser Effect
In 1953 it was predicted that electron spins can polarize nuclear spins24. Experimentally it
was shown that not only metals25, but also insulators in combination with paramagnetic
impurities 26 are polarizable using DNP.
This Overhauser effect can be described by flip-flop transitions in two-spin systems con-
sisting of an electron and a nuclear spin. The application of microwave irradiation, at the
frequency of the electron spin resonance, saturates the ESR transitions (Figure 1.13). The
electron spins are subject to relaxation, during which the nuclear spins will be polarized via
an interaction referred to as hyperfine coupling.
By solving the rate equations established by Solomon27, the NOE enhancement can be
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Figure 1.12: The transition of the electron spin resonance is saturated by a microwave source.
The frequency of the source is close to ωe . Through flip-flop electron-nuclear spin interactions
the polarization is transferred from electron spin to nuclear spin. Due to the much faster electron
spin relaxation processes, compared to that of the nuclei, the electron spins return to thermal
equilibrium while the nuclear spin polarization builds up.
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Figure 1.13: Energy levels and transitions of a coupled spin system consisting of a nuclear and an
electron spin. The energy transitions of the electron spins are much larger than the transitions
of the nuclear spins. W0 and W2 represent the zero quantum and double quantum transitions.
The zero quantum transition, W0, is pumped by the microwave irradiation, with subsequent
nuclear spin W1,n and electron spin relaxation, W1,e
27
Chapter 1. An introduction to NMR spectroscopy
written as follows:
²= 1− sξ f
∣∣γS∣∣
γI
(1.41)
where s represents the electron spin saturation level, ξ, a coupling factor which affects the
efficiency of the microwave power saturation and f represents the leakage factor which is
related to the paramagnetic relaxation time. ξ, the coupling factor, can be described expressed
as follows:
ξ= W2−W0
W0+W2−2W1,n
(1.42)
This coupling factor has a value depending on the interaction. The value can range from -1
in the case of pure scalar interactions, while it can be up to 0.5 in the case of pure dipolar
interactions.The degree of electron spin saturation can be represented by the saturation
parameter s, which can be described in terms of the component of the magnetization along
the z axis as follows:
s = M0−〈Mz〉
M0
(1.43)
In case of a high power for the microwave irradiation, a full saturation can be achieved, s = 1.
It is clear that in the case of microwave absence, the saturation becomes s = 0. The fraction of
the nuclear polarization which is lost due to the presence of electron spins, the leakage factor
f , can be expressed as follows:
f = W2+W0+2W1n
W0+W2+2W1,n +W1,e
= 1− T
+S
1n
T−S1n
(1.44)
where T−S1n is the relaxation time of the nucleus without the presence of electron spins, and T
+S
1n
is the relaxation time of the nucleus in the presence of electron spins. When both s and f are
equal to unity and ξ=−1, the enhancement factor from the Overhauser effect is proportional
to the gyromagnetic ratio between the electron spin and nuclear spin. Resulting in a maximal
theoretical enhancement factor of ²H ≈ 660 for 1H and ²C ≈ 2630 for 13C .
Solid Effect
Like the Overhauser effect, the solid effect is also based on the interactions and transitions
between an electron spin and a nuclear spin. However, unlike the Overhauser effect, the
energy transitions of the spins take place at the same time as the microwave irradiation.
The frequency of the microwaves should equal the relative difference between the frequency
of the electron resonance and the nuclear resonance frequency ωmw =ωe ±ωn . This slight
offset from the electron spin resonance frequency leads to a zero quantum transition, since it
forces the simultaneous transition of the electron spin and the nuclear spin (Figure 1.13). This
is referred to as a flip-flop transition if ωmw =ωe −ωn or a flip-flip transition if ωmw =ωe +ωn .
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The latter is a double quantum transition.
The polarization process at a frequency of ωmw =ωe +ωn is referred to as negative DNP, since
it forces the nuclear spins to populate the higher energy level, which leads to P < 0. On the
other hand, when the polarization is carried out at a frequency ωmw =ωe −ωn the process is
referred to as positive DNP.
Thermal mixing
When the electron spin concentration is relatively large, the dipolar interaction between
electron spins are non-negligible compared with the solid effect, and thermal mixing is the
dominant DNP mechanism. The local magnetic field Bl which is induced by the dipolar field
of the electron spins, causes that the width of the electron Zeeman energy levels becomes
non-negligible as well. The probability of the existence of two electron spin ensembles, with a
difference in Zeeman energy that matches the Zeeman energy of surrounding nuclear spins,
becomes high.
Using a spin temperature formalism is necessary to understand the concept of thermal
mixing. To this end, several thermal reservoirs are defined: The Electron Zeeman Reservoir
(EZR), the Electron Dipolar Reservoir (EDR) and the Nuclear Zeeman reservoir (NZR).
EZR defines the Zeeman energy of the ensemble of electron spins and NZR that of nuclear
spins. EDR includes the dipolar energy of the electron spins ensemble. Each reservoir can
be defined by a spin temperature, which is TZ for EZR, TSS for EDR and TI for NZR. At a
thermal equilibrium TZ = TSS = TI = TL , resulting in all spin temperatures being equal to the
temperature of the lattice.
The concept of thermal mixing can be understood as a two-step process. The first step
consists of dynamic cooling and the second of thermal mixing proper 21;28. Dynamic cooling
constitutes the lowering of the spin temperature of EDR, TSS . The ultimate spin temperature
can be estimated based on the intensity of the local magnetic field Bl as follows:
T f ∼=
Bl
Bi
Ti (1.45)
where Bi is the initial magnetic field and, Ti defines the initial temperature of the system.
Using continuous RF irradiation at an off-resonance frequency ω, the effective local magnetic
field Be f f can be reduced by a factor:
Be f f
B0
= ∆
ω0
(1.46)
The spin temperature can be positive or negative, depending on the resonance offset, ∆ =
29
Chapter 1. An introduction to NMR spectroscopy
ω0−ω. The Zeeman spin temperature, T ′Z , is reduced by the same factor, under microwave
irradiation, and is given by:
T ′Z =
∆
ω0
TL (1.47)
In this scenario, the electron Zeeman energy at a local magnetic field is decreased and compa-
rable to the transition energy which is required for dipolar interaction. The energy exchange
between EZR and EDR becomes possible and the EDR temperature is decreased.
The process of thermal mixing, through the thermal contact with the EDR, decreases the
NZR spin temperature, thus increasing the nuclear spin polarization. This happens when
the Larmor frequencies of electron spins are so dispersed that their difference is equal to the
Larmor frequency of the nuclear spins. This thermal contact is inherent to the spin system
and is depending on the radical concentration.
1.3.3 Dissolution DNP
The DNP process itself is carried out on a frozen sample. The invention of dissolution DNP 29
offered the possibilities to benefit from the the DNP signal enhancement for in vivo appli-
cations. The polarized solid material is brought into the liquid state by dissolution in an
appropriate solvent while the nuclear polarization is preserved. Using this technique one can
achieve signal to noise (SNR) enhancements of 10,000-fold for detection of 13C metabolites
in vitro29. Because of the enormous sensitivity increase, it allows for detecting metabolites
present at such low concentrations, that conventional MR is unable to detect 30. Additionally
it enables the observation of fast metabolic processes in real-time in vivo after infusion of
hyperpolarized 13C labeled biomolecules 31.
However, the hyperpolarized spin state has a short lifetime and the hyperpolarized 13C
substrates return to normal Boltzmann polarization levels with a time constant T1 (Section
1.2.5).This T1 limits the measurement time window and the amount of experiments which can
be performed. It is favourable to use 13C labeled carbonyl positions in biomolecules since the
T1 is about 30-50 seconds. Several T1 times of biomolecules of interest are shown in Table 1.3.
Once a part of the hyperpolarized magnetization is brought to the transversal plane for
detection, it will return to its thermal equilibrium, and not its initial hyperpolarized level.
Therefore one can consider the amount of excited hyperpolarized magnetization as a loss of
polarization. For this reason only a single 90◦ acquisition or multiple acquisitions with a low
flip angle can be performed during one experiment following the DNP sample dissolution and
subsequent infusion.
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Table 1.3: Longitudinal relaxation times T1 of
13C labeled metabolites of interest for in vivo
DNP studies. Adapted from 32
Metabolite T1[s]
[1-13C]acetate 50
[1-13C]alanine 30
[1-13C]aspartate 29
[1-13C]bicarbonate 32
[1-13C]pyruvic acid 60
[1-13C]butyric acid 44
[1,5-13C]citric acid 25
[1-13C]lactate 46
[1,3-13C2]β-hydroxybutyrate 31
[1-13C]octanoate 35
[1,4-13C]fumarate 35
[1-13C]glutamate 25
[5-13C]glutamine 26
1.4 Radiofrequency Coils
Radiofrequency coils are used for the excitation and detection of the MR signal and can be
seen as an LCR circuit. The RF transmitter coil generates a transverse magnetic field which
oscillates in the RF range and rotates the longitudinal magnetization into the transverse plane.
The precessing transverse magnetization induces a voltage, or electromotive force (em f ), in a
nearby receiver coil according to Faradays law:
ξ=
∮
C
E ·dl =−
∫
S
dB
d t
·dS (1.48)
where ξ is the electromotive force induced across the loop C, E is the electric field across a loop
section dl , B is the magnetic field and S is the loop area. The signal S from an MR experiment
will depend on the square of the static magnetic field B0:
S ∝ γ
3B02ρ0
T
(1.49)
where ρ0 defines the number of spins per unit volume or "spin density".
There are many different types of RF coil designs that are being utilized for NMR spec-
troscopy in vivo.
A volume coil, for example a Helmholtz coil 33, provides a homogeneous B1 field which
can excite the spins uniformly in a large volume, but the large size and poor filling factor
compromises their sensitivity for the acquisition. In situations where the total subject under
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Figure 1.14: (A) A linearly polarized magnetic field generated by a single coil which can be
decomposed into two counter rotating parts, from which only one interacts with the spins. (B)
Two coils in quadrature mode generate a rotating magnetic field . (C) A typical coil set-up for
1H decoupled 13C NMR for in vivo applications.
investigation is much larger than the region of interest, an extensive amount of signals coming
from surrounding tissue needs to be suppressed in order to achieve adequate localization.
Surface coils have a very good filling factor and a high sensitivity, since a surface coil can be
placed adjacent to the region of interest and can often be reshaped to exactly fit the object
under investigation34. The downside of surface coils is that the B1 field generated is far from
homogeneous meaning that the excitation of the spins is dependent on the distance from
the coil when using conventional RF pulses. However, this inhomogeneous excitation can be
overcome using socalled adiabatic RF pulses, which can excite spins uniformly untill a certain
distance. The sensitive volume of a single loop coil approximately equals one coil radius and
this sensitivity decreases with increasing distance form the coil. Roughly, the B1 field along
the coil axis can be described by:
B1,ax ∝ r
2
(r 2+ y2)3/2 (1.50)
The main advantage for surface coil reception is the high sensitivity that can be obtained
immediately adjacent to the coil. This has made surface coils the primary choice for applica-
tions that are inherently sensitivity limited, like MRS. For almost all in vivo metabolic studies a
double RF surface coil set-up is required. Besides the metabolic measurements which require
MR probe to measure resonances from 31P or 13C nuclei, it is necessary to have an additional
1H probe to obtain information about localization, perform shimming, decoupling and polar-
ization transfer. The coil loops have typically a relatively small surface area, around 12-15 mm
diameter for small animal applications, and often the same coil is used for both excitation and
detection. Due to significant coil interactions and large RF power depositions during proton
decoupling when both of the coils are placed in a co-planar arrangement, the 1H RF coil is
split into two surface coils driven in quadrature. Currently this is the most commonly used
design and was described by 35 and shown in figure 1.14C.
A hybrid decoupler splits the incoming RF power evenly over the two 1H coils, while simul-
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Figure 1.15: (A)Response of two adjacent surface coils tuned to the same frequency. The original
resonances plit into two resonances and the sensitivity of the coils at frequency ω0 is reduced.
(B) By separating the adjacent circular coils by 0.75 their diameter their mutual inductance is
set to zero and splitting resonances are eliminated.The exact overlap is determined empirically.
taneously phase shifting the current by 90◦ for one of the 1H coils. During reception the hybrid
splitter combines the two out-of-phase NMR signals, such that one in-phase signal arrives
at the pre-amplifier. This gives the quadrature design advantages in terms of RF power but
also in the form of a more homogeneous excitation in the sensitive volume36. The circularly
polarized magnetic field that is produced is more efficient in exciting the spins compared
to a linearly polarized field since one of its rotating components does not interact with the
precessing spins (see Figure 1.14 A and B). Theoretically, an SNR enhancement of a factor
of
p
2 is expected and only half of the transmitter RF power is required to rotate the nuclear
magnetization as compared to the single loop arrangement37.
When two identical resonance loops are in close proximity the oscillating current in one loop
generates an oscillating magnetic field which induces a voltage across the second loop. This
causes the resonance frequency to shift, for both coils in opposite directions and manifests
itself as a splitting (see Figure 1.15 A). To reduce this coupling adjacent coils need to be
overlapped to eliminate the mutual inductance(see Figure 1.15 B)38.
For the studies conducted in this thesis two different kinds of surface coils were constructed
which are described in Appendix A.1.
1.5 Dynamic 13C NMR Spectroscopy
Almost all biologically relevant compounds contain carbon, making 13C NMR spectroscopy
capable of detecting many metabolites. 13C NMR spectra are characterized by a large spectral
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range, narrow line widths and low sensitivity because of the natural abundance of 13C (1.1%).
This can be overcome using averaging, polarization transfer, larger volumes and decoupling
(Section 1.2.9). The spectrum can be divided into spectral ranges indicative of certain chemical
groups. Chemical shift ranges above 150 ppm characterize carbonyl groups and is the region of
interest in most hyperpolarized 13C experiments. In conventional 13C spectroscopy this region
lies between 15-100 ppm, which contain carbons close to hydroxyl groups, such as glucose,
resonating around 60-100 ppm. The CH, CH2 and CH3 groups, resonating around 45-60 ppm,
25-45 ppm and <25 ppm respectively. Lipid resonances dominate the spectrum around 20-50
ppm and are so abundant that natural abundance detection is possible in for example skeletal
muscle. Two areas make 13C NMR spectroscopy unique for in vivo applications: the detection
of metabolic fluxes from 13C labeled precursors and the detection of glycogen.
Most metabolites must become sufficiently enriched in 13C for detection by NMR. This is
accomplished by using 13C labeled precursors. In general, resonances can only be observed
in 13C NMR spectra of intact tissues if their concentration exceeds a limit of 1 mM.Most
intermediates are normally present in tissues below this concentration, and hence cannot
be observed directly by NMR, even with a 13C enrichment of unity, without excessively long
periods of data accumulation.
As metabolism proceeds through particular pathways, the 13C label transfers from one
biomolecule to the other through many enzymatic transformations. Eventually, several carbon
positions of TCA cycle intermediates will become 13C labeled and neighboring 13C nuclei
will give rise to multiplet structures due to 13C-13C scalar coupling (Section 1.2.9). Figure
1.16 shows an illustration of the 13C label transfer from several 13C labeled precursors after 4
turns of the TCA cycle. The resulting labeling patterns are dependent on the chemistry of the
enzymatic reactions, the reaction rate and the pool sizes of the intermediates. The multiplet
structure of the resonance of a certain carbon position, consisting of so called isotopomers
(Figure 1.17), informs about the relative 13C concentration of the neighbors of that carbon
position. The fraction of a carbon position that is 13C versus 13C labeled is called the fractional
enrichment:
F E =
13C
13C +12 C (1.51)
The fractional enrichment of a neighbouring 13C labeled carbon position can be deter-
mined by taking the ratio of the multiplet, induced by the 13C-13C coupling of its neighbour,
to the total carbon resonance area. Chapter 7 uses isotopomer analysis to determine the
fractional enrichment of 13C labeling in glutamate position C2, C3 and C4 after the infusion
and metabolism of [2-13C]acetate in skeletal muscle. Consider the glutamate C4 resonance
position. When glutamate is labeled at both C4 and C3, a doublet pattern will appear, when
glutamate is only labeled at the C4 position, a singlet appears in the spectrum (Figure 1.17).
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Figure 1.16: Illustration of the 13C label transfer from the carbon positions C1, C2 and C3 of
pyruvate, lactate and alanine and the C1 and C2 of acetate. The illustration shows the possible
labeling patterns of several TCA cycle intermediates up to 4 cycles. In this scheme, pyruvate
carboxylation (PC) and dilution of non-labeled acetylCoA are not taken into account. In the first
cycle, the C1 and C2 of acetylCoA condenses with unlabeled oxaloacetate (OAA). The symmetry
of the succinate molecule scrambles the labeling in oxaloacetate.
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1 2 3 4 5
Glutamate C2
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Glutamate C3 Glutamate C4
Figure 1.17: Illustration of 13C spectra of glutamate C2, C3 and C4 labeled at several carbon po-
sitions. Neighbouring 13C nuclei split the resonances in multiplets due to the 13C-13C coupling.
Grey spheres indicate 13C nuclei, black spheres 12C nuclei and white spheres could be 12C or 13C.
Therefore, the ratio of the doublet area to the total area of the C4 resonance,
C 4D34
C 4
= F EGl u,C 3, (1.52)
is the fraction of glutamate molecules labeled at C4, which are also labeled at C3. This fraction
represents in fact the fraction of glutamate labeled in C3, and thus, analyzing the multiplet
pattern of glutamate C4 allows the calculation of the fractional enrichment of glutamate C3.
During dynamic 13C experiments that typically run for several hours, a large set of metabo-
lites will be labeled in this manner and give rise to so-called spectral time courses. These
time courses can be modeled using differential equations that take into account current
physiological and biochemical knowledge of the system.
1.5.1 Modeling biochemical processes using 13C MRS
13C spectroscopy has the potential to measure dynamic processes, which for a comprehensive
interpretation require mathematical treatment. Individual carbon resonances relative to
the total intermediate present in tissues allows to determine the fractional enrichment of
separate carbon atoms. The labeling pattern of carbon positions in different metabolites
provides information on the pathway through which the metabolism proceeds. Also, changes
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in the fractional 13C enrichment of specific carbon atoms with time contain flux information
concerning the state of activity of specific metabolic pathways. Flux information from the
data can be obtained by using nonlinear least squares analysis of the differential equations
describing the enzymatic pathways with the kinetic rate constants of fluxes as the unknown
parameters. These parameters can be used to study differences in metabolism in pathological
situations.
Irreversible Reactions
In living organisms there is a plethora of biochemical reactions happening to provide energy to
maintain healthy functionality. Biochemical transformations are catalyzed by enzymes, which
convert one molecule to the other. In a simple schematic of metabolism one can consider a
simple three step biochemical reaction which starts with a substrate S and is converted to
products P which is in turn converted to another downstream product D :
S
kSP−−→ P kPD−−→D (1.53)
The conversion of substrate S to product P is characterized by a reaction rate kSP which
describes how fast one set of molecules is converted to the other and is expressed in s−1. The
amount of product P depends on the conversion rate of S to P and on the conversion rate of
P to D. These three reactions can be described mathematically by the following differential
equations:
dS(t )
d t
=−kSP S(t ) (1.54)
dP (t )
d t
= kSP S(t )−kPD P (t ) (1.55)
dD(t )
d t
= kPD P (t ) (1.56)
This is an example of a non-reversible chemical reaction, i.e., the reaction goes in one
direction only. The reaction rates k reflects the enzymatic conversion per unit of time and
does not give information about chemical reactions quantitatively in terms of how much of a
specific substrate is converted over time. Metabolic fluxes combine the kinetic rate constant
with the amount of substrate available and are expressed in mM/s and can be described as
follows:
VSP = kSP S (1.57)
One can describe the concentration change of product P by the inflow from S and the
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outflow towards D with the following mass-balance equation:
dP (t )
d t
=VSP −VPD (1.58)
In the case of a so-called metabolic steady state the concentration of metabolites does not
change over time, making dP/dt = 0 and thus VSP = VPD . As long as the inflow is the same as
the outflow, the concentration of P will not change. These types of equations are also known as
mass-balance equations. Measuring the concentration of P over time will not give information
about the kinetics which is involved in the formation and removal of P , i.e., will not give insight
into the metabolic fluxes into and out of the poolsize of P . To be able to measure the rate of
formation and degradation of P it is necessary to introduce some sort of label in the initial
substrate P which can be followed over time while that label is being transferred into product
P and further into downstream metabolite D . Since most reactions in vivo involve molecules
with carbon backbones it is useful to label specific carbon atoms. One feature of carbon is that
it naturally occurs in the 12C isotope form which does not have a nuclear magnetic moment.
The isotope 13C does have a nuclear magnetic moment; it has a spin 1/2, which allows it to be
detected by NMR. The introduction of a 13C labeled carbon in biomolecules does not have an
effect on its metabolism. When incorporating 13C labeled (?) biomolecules into the chemical
reactions described before Equation 1.55 and 1.58 can be rewritten as follows:
dP?(t )
d t
= kSP S?(t )−kPD P?(t ) (1.59)
dP?(t )
d t
=VSP S
?(t )
S(t )
− P
?(t )
P (t )
VPD (1.60)
The asterisk indicates a 13C labeled compound which can be tracked using 13C NMR spec-
troscopy. These type of equations are referred to as isotope-balance equations and the ratio
of labeled versus unlabeled substrate is also referred to as the fractional enrichment of the
metabolite pool. In conventional 13C NMR studies performed under steady-state conditions,
VSP equals VPD and the fractional enrichment of substrate S and the enrichment itself is
constant over time. Therefore the time dependence of the 13C labeling of P can be solved
analytically:
P?(t )= kSP S
?
kPD
(1−e−tkPD ) (1.61)
P?(t )= PS
?
S
(1−e−t VPDP ) (1.62)
In hyperpolarized studies a rapid injection is employed and the 13C labeled substrate is not
constant over time, resulting in a time-dependent fractional enrichment of the substrate S.
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However, in these type of experiments the 13C labeled molecule which is injected often exceeds
the level of the non-labeled molecule making the fractional enrichment approaching unity,
S?/S = 1. When it is assumed that the labeled substrate is introduced at t=0. The analytical
solution can be described as follows:
P?(t )= kSP S
?
0 (e
−tkSP −e−tkPD )
kSP −kPD
(1.63)
P?(t )=
VSP
S S
?
0 (e
−t VSPS −e−t VPDP )
VSP
S − VPDP
(1.64)
Reversible Reactions
Reactions can also be catalyzed by reversible enzymes, meaning that the reactions are going
both in the forward and backward direction:
S
kSP−−*)−−
kPS
P (1.65)
The differential equations describing enrichment in P are as follows:
dP?(t )
d t
= kSP S?(t )−kPSP?(t ) (1.66)
dP?(t )
d t
= S
?(t )
S(t )
VSP − P
?(t )
P (t )
VPS (1.67)
Mass-balance and isotope-balance equations can be constructed for all metabolic pools,
making up the metabolic model. For a full description of a set of metabolic pathways in vivo,
such as after a [2-13C]acetate infusion in skeletal muscle (as described in Chapter 7), including
multiple flows into a single pool and multiple metabolites, numerical approaches are used to
solve the equations to obtain the metabolic flux parameters 39.
Bloch McConnel Equations
So far reactions kinetics were described which concern the 13C label changes, concentration
changes and pool sizes. In hyperpolarized NMR experiments the measured signal depends
not only on the concentration of the 13C labeled molecules but mainly on the polarization
and the RF excitations:
In hyperpolarized NMR experiments concentrations changes of 13C labeled metabolites
are large and the measured signal is directly related to the polarization level. This is affected
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by the initial polarization level of the injected substrate which decays with the longitudinal
relaxation time T1. Additionally, the measured signal is affected by MR acquisitions since each
acquisition results in additional signal losses 40.
The 13C concentrations changes of the metabolites since this provides information about
the reaction kinetics. To be able to do this one has to filter out the polarization effect and
this can be done by taking into account the relaxation times of the observed metabolites.
The magnetization of metabolites, which is the combination of the polarization levels and
the concentration of the substance, can be described by the Bloch-McConnel equations41.
Describing the magnetization levels of an injected substrate S and its product P in a reversible
reaction process leads to the following expression:
d MP?(t )
d t
=RP
[
MP?(t )−MP?,eq
]+kSP MS?(t )−kPS MP?(t ) (1.68)
where Rp is the longitudinal relaxation rate, RP = 1/T1,P , of the product P , MP,eq is the thermal
equilibrium magnetization. In hyperpolarized experiments the 13C signal is boosted over
10,000 fold and one can assume that the thermal equilibrium magnetization of product P
approaches zero, MP,eq = 0.
This description given here relies on several assumptions. The first is that the hyperpolarized
substance is injected in the same compartment where it is also metabolized and does not
take into account the transport from the plasma to the tissue compartment, whether this
is concentration gradient mediated or enzymatic transport. In many situations, such as
in cell cultures, it is fair to neglect this contribution since enzymatic transport is relatively
fast compared to the reaction kinetics42. The second assumption is that the hyperpolarized
product is quickly distributed to a homogeneous concentration in the plasma pool, "the
well-mixed chamber" assumption. Often this is an acceptable assumption to make for organs,
which are further downstream from the intravenous injection site.
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2Enzymatic activity of acetylCoAsynthetase revealedwith hyperpolarizedacetate
Abstract
Acetate metabolism in skeletal muscle is regulated by acetylCoA synthetase (ACS). The main
function of ACS is to provide cells with acetylCoA, a key molecule for numerous metabolic
pathways including fatty acid and cholesterol synthesis and the Krebs cycle. Hyperpolarized [1-
13C]acetate prepared via dissolution dynamic nuclear polarization was injected intravenously
at different concentrations into rats. The 13C magnetic resonance signals of [1-13C]acetate
and [1-13C]acetylcarnitine were recorded in vivo for one minute.
The kinetic rate constants of the observed reactions were deduced from the 3s time res-
olution measurements using two analytical approaches, either mathematical modelling or
relative metabolite ratios, both methods yielding similar results. The in vivo conversion rates
from hyperpolarized acetate into acetylcarnitine were quantified, and, although separated
by two enzymatic reactions, a kinetic analysis of the 13C label flow from [1-13C]acetate to [1-
13C]acetylcarnitine led to a unique determination of the activity of ACS. The in vivo Michaelis
constants for ACS were KM = 0.35 ± 0.13 mM and Vmax = 0.199 ± 0.031 µmol/g/min.
This study demonstrates the feasibility of directly measuring ACS activity in vivo and, since
the activity of ACS can be affected by various pathological states such as cancer or diabetes,
the proposed method could be used to non-invasively probe metabolic signatures of ACS in
diseased tissue.
Adapted and extended fromIn vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by 13C turnover from hyperpo-larized [1-13C]acetate to [1-13C]acetylcarnitineJessica AM Bastiaansen, Tian Cheng, Mor Mishkovsky, João MN Duarte, Arnaud Comment and Rolf GruetterBiochimica et Biophysica Acta 1830 Issue 8 August 2013 Pages 4171-4178
Chapter 2. Enzymatic activity of acetylCoA synthetase revealed with hyperpolarized acetate
2.1 Introduction to acetate metabolism in skeletal muscle
Acetate plays an important role in human and rodent energy metabolism and it is readily taken
up by skeletal muscle1–3 (see 2.1). Acetate is a pyruvate dehydrogenase (PDH) independent
acetylator of tissue carnitine and free coenzyme A (CoA) 1 and is converted into acetylCoA via
a reaction catalysed by the enzyme acetylCoA synthetase (ACS):
Acet ate+Co A+ AT P AC S−−−→ Acet ylCo A+ AMP +PPi (2.1)
The main function of ACS is to provide the cell with acetylCoA, a key molecule for numerous
metabolic pathways including fatty acid and cholesterol synthesis and the tricarboxylic acid
(TCA) cycle. ACS has been previously shown to be the rate limiting enzyme in the metabolism
of acetate 4 5. Pathological and substrate changes have an effect on the activity of ACS, which
has been reported to be turned off faster than other CoA dependent enzymes during free CoA
decrease 6. Its activity increases together with insulin in response to a carbohydrate-rich diet
to induce fatty acid synthesis 7.
Carnitine acetyltransferase (CAT) converts acetylCoA to acetylcarnitine:
Acet ylCo A+C ar ni ti ne C AT←−−→ Acet yl car ni t i ne+Co A (2.2)
In skeletal muscle, carnitine plays two metabolic roles: on one hand it serves as a shuttle of
acetyl groups and long chain fatty acids from the cytosol into mitochondria and thus enabling
acetate
MUSCLE
ACS
acetylCoA
CAT
acetylcarnitine
carnitine CoA
ATP + CoA
AMP + diphosphate
PLASMA
VCAT
f
VCAT
b
VACS VOUT
Figure 2.1: Schematic representation of the uptake and metabolism of acetate in rat skeletal
muscle in vivo. Acetate diffusion into the muscle cell is facilitated by a concentration gradi-
ent. Via acetylCoA synthetase (ACS) it is transformed to acetylCoA in the cytosol. Carnitine
acetyltransferase (CAT) converts acetylCoA to acetylcarnitine. Acetylcarnitine translocase (ATL)
transports the acetylcarnitine to the mitochondrion where CAT converts acetylcarnitine back to
acetylCoA for further utilization by the TCA cycle. In this study we measured cytosolic processes.
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beta oxidation 8–12. On the other hand it can act as a buffer for excess acetylCoA when the rate
of acetylCoA generation is greater than its entry into the TCA cycle. The reaction catalyzed by
CAT has a well maintained equilibrium 13 and despite different steady state concentrations of
the reactants, the equilibrium constant is given by 14:
Keq = [Acet ylCo A][C ar ni ti ne]
[Co A][Acet yl car ni t i ne]
= 0.6±0.06 (2.3)
The general function of CAT is to balance rapid changes in the acetylCoA/CoA ratio in both
the cytoplasmic and mitochondrial compartments10. In rat skeletal muscle, 98% to 99% of
extra acetylCoA produced is buffered by acetylcarnitine15. Since the mitochondrial inner
membrane is impermeable to acetylCoA, CAT is essential in the metabolism of acetate, as was
shown in canine skeletal muscle16. After transformation to acetylcarnitine it traverses the
inner mitochondrial membrane via acetylcarnitine translocase (ATL) where a mitochondrial
CAT transfers the acetyl group back to CoA upon which acetylCoA can enter the TCA cycle.
Acetate, being a short chain fatty acid has a typical plasma concentration of 0.2 mM in
rats which decreases during fasting and increases in a diabetic state 5. Its oxidation has been
deemed significant since it is rapidly cleared from the blood if injected in vivo or generated
from precursors such as ethanol in the liver17. Acetate uptake by resting skeletal muscle is
driven by a concentration gradient and is proportional to the plasma concentration18;19. In a
single passage of blood, half of the acetate presented to the tissue was removed by the muscle
tissue indicating a high affinity for acetate 5. In contracting skeletal muscle however, acetate
oxidation decreased, indicating a shift of substrate preference compared to resting skeletal
muscle 20.
To date, most of the information concerning these enzyme activities in rat has however been
collected from cell cultures and tissue preparations 5;21 . The ability to measure ACS and CAT
activities in vivo is expected to provide valuable insight in normal and pathological conditions.
13C magnetic resonance spectroscopy (MRS) is a well-established technique to investigate
in vivo metabolic processes22 and it can be coupled with standard MR imaging techniques
that gives anatomical information. The advent of dissolution dynamic nuclear polarization
(DNP) allows for the measurement of specific metabolic reactions in real-time, thanks to a
sensitivity enhancement of several orders of magnitude23;24 , which is now being used in
human trials in the investigation of prostate cancer 25 .
The incorporation of 13C into acetylcarnitine has been reported after the infusion of hyper-
polarized 13C acetate 26 and after the injection of [2-13C]pyruvate 27;28. The aim of the present
study was to elucidate the enzyme kinetics involved in the in vivo transformation of acetate to
acetylcarnitine in rat skeletal muscle in vivo, by extracting quantitative kinetic rate constants
from the observed [1-13C]acetylcarnitine labeling dynamics following the infusion of different
substrate concentrations of hyperpolarized [1-13C]acetate.
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Figure 2.2: Graphical scheme of the setup and timing of in vivo DNP experiments described in
this chapter. A metabolic precursor, in this case [1-13C]acetate, was dynamically polarized in a
5T magnet for 2.5 hours. This hyperpolarized sample is quickly dissolved in heated D2O and
automatically transferred to a separator-infusion pump located inside a 9.4T horizontal bore
magnet. The hyperpolarized solution is injected within 5 seconds into a subject and the NMR
acquisition is triggered automatically.
2.2 Materials and Methods
Sample preparation and hyperpolarization protocol of [1-13C]acetate
The hyperpolarized signal decays with time constant T1, which is one of the determining
factors of the measurement window of the hyperpolarized in vivo experiment. Because of
T1 considerations, the acetate was
13C labeled in position C1 which has a T1 of 40 seconds
compared to 3 seconds in the C2 position.
All chemicals were purchased from Sigma-Aldrich, Basel, Switzerland. [1-13C] sodium
acetate was dissolved in a concentration ranging from 1.0 to 4.5 M in a 1:2 mixture of d6-
EtOD/D2O containing 33mM of TEMPO (2,2,6,6-Tetramethyl-1-piperidinyloxy) free radical.
300 uL of the resulting solution was rapidly frozen in liquid nitrogen to form 10 µLbeads
that were placed in a 5 T custom-designed DNP polarizer29;30. The 13C nuclear spins were
dynamically polarized at 1.02 ± 0.03 K for 2 h using 30 mW of microwave power at 140.18
GHz. The sample was consecutively rapidly dissolved using 6.0 mL of superheated D2O
and transferred within 2 s to a separator/infusion pump located inside a 9.4 T horizontal
bore magnet containing 0.6 mL of phosphate buffered saline and heparin. Subsequently,
1.0 mL of the room-temperature hyperpolarized acetate solution was automatically infused
into the animal within 5 s (Figure 2.2). From in vitro measurements performed inside the
separator/infusion pump, it was determined that the 13C polarization at the time of injection
was 13 ± 2% 31. No physiological changes were observed during the injection.
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Figure 2.3: Picture of experimental set-up for performing hyperpolarized in vivo experiments.
The polarizer magnet (left) is 4m apart from the animal imager (right). A detailed graphical
depiction and timing of such experiments are shown in Figure 2.2.
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Figure 2.4: Influence of repeated RF excitations with flip angle θ on the longitudinal and
transversal magnetization of [1-13C]acetate. In these curves a T1 of 40 seconds was assumed
and a repetion time of 3 seconds. (A) Magnetization decay for a flip angle of 10◦ (solid lines), 45◦
(dotted lines), and (B) 30◦. The decay of Mz without application of RF pulses is indicated with
the green line.
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Animals
All animal experiments were conducted according to federal ethical guidelines and were ap-
proved by the local regulatory body. Male Sprague Dawley rats (275 - 325 g) were anesthetized
with 1.5% isoflurane in oxygen (n=19). A catheter was placed into the femoral vein for intra-
venous delivery of the hyperpolarized acetate solution. The respiration rate and temperature
were monitored and maintained during the experiment.
Choice of flip angle and repetition time
The choice of flip angle and repetition time TR needs to be carefully considered for each
type of hyperpolarized in vivo experiment. With each 30◦ excitation pulse, the magnetization
vector M will be tipped away by 30◦ from the z axis. The z component of the magnetization
after excitation with flip angle θ equals Mz =M cosθ, resulting in a 13% polarization loss with
each excitation. More generally, the initial magnetization M0 will decay as a result of T1 and n
excitations with flip angle θ as follows:
Mz =M0e−t/T1 cosθn (2.4)
where n = t/TR . Initial experiments were conducted with a 10◦ flip angle, resulting in a
2% polarization loss per excitation, however this was not sufficient to detect the metabolic
products. Application of a 30◦ flip angle excites the acetylcarnitine to detectable levels while
preserving the initial polarization levels long enough to obtain timecourses of both metabolites
(Figure 2.4). Calibration measurements are described in Appendix A.2.
In vivo magnetic resonance spectroscopy
All experiments were performed with a Direct Drive spectrometer (Agilent, Palo Alto, CA, USA)
interfaced to an actively shielded 9.4 T magnet with a 31 cm horizontal bore (Magnex Scientific,
Abingdon, UK). A home-built 1H/13C probe consisting of a pair of 10 mm diameter 1H surface
coils in quadrature and a 10 mm diameter 13C surface coil was placed over the hind leg of the
rat (Figure 2.5) to selectively excite and detect skeletal muscle tissue, more specifically, the
gastrocnemius muscles.
A hollow glass sphere with a 3 mm inner diameter (Wilmad-LabGlass, NJ, USA) was filled
with a 1 M [1-13C]glucose solution and used to adjust the pulses power and set the reference
frequency. Once the animal was positioned inside the magnet, ten axial 1 mm thick slices
were acquired using a gradient echo sequence (TR = 50 ms, TE = 3 ms, field of view = 30 x
30 mm, matrix = 128 x 128, flip angle = 30◦) from which the volume of interest was selected.
The static magnetic field was homogenized in a 600 µL (6 mm x 10 mm x 10 mm) voxel to
reduce the localized proton line width to 20 Hz using the FASTESTMAP shimming protocol 32.
Series of single-pulse 13C acquisitions were sequentially recorded starting 12 s after dissolution
using 30◦adiabatic RF pulses (BIR4) applied every 3 s with 1H decoupling during acquisition
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Figure 2.5: Anatomical scout image of the rat skeletal muscle showing the placement of the
surface carbon coil.
(WALTZ). Decoupling is needed to remove the 1H-13C scalar coupling induced splitting of the
13C metabolite resonances. For example, the resonance of [1-13C]acetylcarnitine is a doublet
of a quartet when not 1H decoupled (Figure 1.9 in section 1.2.9). The adiabatic pulses offset
and power was set such as to ensure a homogeneous 30◦excitation of substrate and metabolite
resonances in the entire volume of interest (for calibration measurements see Appendix A.2).
At the end of each in vivo experiment, 200 µL of the residual solution was collected from
the infusion pump and the [1-13C]acetate concentration was measured in a high-resolution
400 MHz NMR spectrometer (Bruker BioSpin SA, Fallanden, Switzerland) by comparing the
signal with a [1-13C]pyruvate reference sample of a known concentration. To reduce the T1 of
[1-13C]acetate and [1-13C]pyruvate and thus the measurement time, Omniscan was added to
a final concentration of 1 mM, which reduced the T1 about 15 fold (Figure 2.6). Measurements
were performed using a pulse acquire experiment with a 90◦flip angle, TR = 20 s, 1H decoupling
and 12 scan averages.
The animals blood volume was calculated using the relation between total blood volume
and body weight published by Lee and Blaufox 33 and the blood [1-13C]acetate concentration
was obtained accordingly.
T1 measurement of [1-
13C]acetylcarnitine
The in vitro spin-lattice relaxation times of [1-13C]acetylcarnitine were also measured at 400
MHz in D2O and in freshly collected rat blood at 37◦C using a saturation recovery sequence
with proton decoupling during acquisition. The saturation recovery sequence used to measure
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Figure 2.6: (A) Longitudinal relaxation time T1 measurements of [1-
13C]acetate and [1-
13]pyruvate in D2O at 400 MHz at several concentrations of Omniscan. (B) The corresponding
relaxation rate R1 = 1/T1 was calculated and used to determine the relaxivity r . These mea-
surements were performed to determine the Omniscan concentration needed to reduce the
T1’s to such extend that reasonable TR ’s could be employed to measure the hyperpolarized
[1-13C]acetate concentration in the separator infusion pump.
T1 is described in section 1.2.7. This T1 relaxation time is needed as an input value in the
kinetic model of acetate metabolism in skeletal muscle as described in section 2.3. A small
amount of heparin was added to the solution to avoid coagulation.
Data analysis
A non-linear least-squares quantification algorithm, AMARES, as implemented in the jMRUI
software package34, was used to fit the 13C NMR data. The spectra were corrected for the
phases and DC offset. Soft constraints were imposed to peak frequencies (182.55 -182.65 ppm
for acetate and 173.85 -173.95 ppm for acetylcarnitine) and line widths (FWHM = 10 - 30 Hz)
and the relative phases were fixed to zero. The acetylcarnitine peak areas were normalized
to the maximum acetate signal in each experiment to account for varying polarization levels
across experiments. The time courses of quantified peak areas were analyzed with the kinetic
model described in section 2.3, implemented in Matlab (The MathWorks, Natick, MA, USA).
2.3 Kinetic model of hyperpolarized acetate metabolism in skeletal
muscle
The uptake of acetate by skeletal muscle tissue as a function of the arterial concentration
is described in18;19 . Acetate transport across the cellular membrane occurs by facilitated
diffusion, and thus net transport of acetate between the plasma and the tissue depends on
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the concentration gradient. We therefore assumed that the measured kinetic parameters
are independent of processes related to membrane transport. As a result, the variations
in conversion rates as a function of the injected concentration are expected to be directly
correlated to ACS and CAT activity.
In the simplest model of a biochemical reaction, the conversion from substrate to product
in a tissue can be described with a rate constant k that depends on substrate and enzyme
concentrations. The assumption is that the enzyme concentration is not influenced by the
substrate in the short time scale of the experiment, which is about 1 minute. Therefore, the
13C (?) label flow between the substrate acetate (Ace) and the metabolites acetylCoA (A.CoA)
and acetylcarnitine (A.Car) inside the cytosol of skeletal muscle can be described with the
following equations:
d [Ace?]
d t
=−VAC S [Ace
?]
[Ace]
(2.5)
d [A.Co A?]
d t
=VAC S [Ace
?]
[Ace]
−V fC AT
[A.Co A?]
[A.Co A]
+V bC AT
[A.C ar?]
[A.C ar ]
(2.6)
d [A.C ar?]
d t
=V fC AT
[A.Co A?]
[A.Co A]
− (V bC AT +VOU T )
[A.C ar?]
[A.C ar ]
(2.7)
where [Ace], [A.CoA], [A.Car] represent total metabolites concentrations (sum of 13C labeled
and unlabeled molecules), [Ace?], [A.CoA?], [A.Car?] the 13C labeled concentrations, V fC AT
and V bC AT are the forward and the backward fluxes through CAT, respectively, VAC S is the flux
through ACS and VOU T is the flux out of the acetylcarnitine pool into the mitochondrion
(2.1). Since the physiological plasma acetate concentration is lower than 0.2 mM5, it can
be assumed that the acetate blood pool was fully labeled following the bolus injection, i.e.
[Ace?]/[Ace]≈ 1. Summing Equation 2.6 and 2.7 leads to:
d [A.C ar?]
d t
+ d [A.Co A
?]
d t
=VAC S −VOU T [A.C ar
?]
[A.C ar ]
(2.8)
The acetylCoA pool size is well regulated and is typically more than 10 times smaller
than the acetylcarnitine pool15, i.e. a small pool approximation35;36 can be used, there-
fore d [A.Co A?]/d t << d [A.C ar?]/d t . The last term in Equation 2.8 can be neglected since,
within the short experimental time frame, the acetylcarnitine pool is only partially labelled and
thus a minute amount of 13C label will reach the mitochondrial acetylCoA pool. This is further
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supported by a previous study showing that the contribution of acetate to the TCA cycle in
skeletal muscle was an order of magnitude smaller than our observed rate of acetylcarnitine
formation37. Condensing the previous statements, the 13C flow from acetate to acetylcarni-
tine in the cytosolic compartment of skeletal muscle can be described by the following two
equations:
d [Ace?]
d t
=−VAC S =−kAC S[Ace?](t ) (2.9)
d [A.C ar?]
d t
=VAC S = kAC S[Ace?](t ) (2.10)
where the kinetic rate constant of ACS is introduced. Based on these conditions, it was
concluded that the observed kinetic rate observed in these experiments corresponds to the
enzymatic activity of ACS.
The acetate 13C NMR signal measured in skeletal muscle tissue following the injection of
hyperpolarized [1-13C]acetate decayed with time as a consequence of a combination of (a) the
loss of spin polarization related to longitudinal relaxation and characterized by an exponential
decay rate R1, (b) the loss of longitudinal magnetization due to radiofrequency excitations,
and (c) the conversion of acetate into acetylcarnitine characterized by the kinetic rate constant
kAC S . The acetylcarnitine signal also decays because of (a) and (b), but (c) leads to an increase
in signal. The time evolution of the carbonyl 13C longitudinal magnetization of acetate, MA ,
and acetylcarnitine, MC , can thus be written as:
d MA
d t
=−RA[MA−MA,eq ]−kAC S MA (2.11)
d MC
d t
= kAC S MA−R1,C [MC −MC ,eq ] (2.12)
where RA , is the acetate signal decay comprising the carbonyl 13C longitudinal relaxation
rate R1,A as well as the potential [1-13C]acetate flow of signal in and out of the volume of
interest; R1,C is the carbonyl 13C longitudinal relaxation rate of acetylcarnitine: Finally, MA,eq
and MC ,eq are the thermal equilibrium magnetizations of the carbonyl sites of acetate and
acetylcarnitine, respectively. The contributions of MA,eq and MC ,eq to the acetate and acetyl-
carnitine signals can be neglected since MA >>MA,eq and MC >>MC ,eq when the resonances
are detectable. Equation 2.11 and 2.12 now become:
52
2.3. Kinetic model of hyperpolarized acetate metabolism in skeletal muscle
d MA
d t
=−RA MA−kAC S MA (2.13)
d MC
d t
= kAC S MA−R1,C MC (2.14)
These Bloch-McConnell differential equations38 are identical to the ones derived for the
one-compartment non steady-state metabolic model for one site exchange, which has already
been shown to be applicable to hyperpolarized substrates39. From the initial conditions MC
(t=0) = 0 and MA (t=0) = M0 and taking into account the signal losses due to RF excitations, the
hyperpolarized acetate and acetylcarnitine signals, S A(t ) and SC (t ), measured at t = nTR , TR
being the repetition time, are given by:
S A(t )∝MA(t )(cosθ)t/TR =M0e(−kAC S−RA )t (cosθ)t/TR (2.15)
SC (t )∝MC (t )(cosθ)t/TR =M0(be(−kAC S−RA)t −be−R1,C t )(cosθ)t/TR (2.16)
where
b = kAC S−kAC S −RA+R1,C
,
and θ is the RF pulse flip angle. The time point of the first acetate observation, which
also corresponds to the maximum acetate signal, was set to t=0 prior to fitting the data with
the kinetic model. To relate the signals measured in the sensitive volume of the surface coil
described by Equation 2.15 and 2.16 to the cytosolic concentrations described by Equation
2.8 and 2.9, it was assumed that the blood volume in the VOI was small enough to neglect its
contribution to the measured 13C acetate signal. This was supported by anatomical proton
images taken prior to the injections and previous PET studies which determined a small blood
volume in this area40. This assumption is strengthened by a reported acetate removal of 50%
by skeletal muscle in a single passage of blood 5.
The dependence of the reaction kinetics on the hyperpolarized substrate concentration was
analyzed using the standard Michaelis-Menten equation,
v0,AC S =Vmax [Ace]/(KM + [Ace]) (2.17)
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where KM and Vmax are the Michaelis constant and the maximum reaction rate and the
initial reaction rate v0 is the product of the initial acetate concentration and the kinetic rate
constant, i.e,
v0,AC S = kAC S[Ace]. (2.18)
2.4 Mathematical Derivation of the Signal Ratio
It has been observed that there exists a linear relationship between the kinetic rate constants
obtained using mathematical modelling and the ratio of the areas of acetylcarnitine and
acetate, a linearity also observed in studies using hyperpolarized pyruvate 41. This linearity in
case of hyperpolarized acetate was investigated by analysing the system of coupled equations
defined by Equation 2.15 and 2.16 which has only 3 free parameters, namely kAC S , RA and
R1,C .
The transient magnetization of hyperpolarized acetate and it metabolic product acetylcar-
nitine can be described as follows:
MA(t )=M0e(−kAC S−RA)t (2.19)
MC (t )=M0(be(−kAC S−RA)t −be−R1,C t ) (2.20)
with b = kAC S/(−kAC S −RA+R1,C ). Integration of both equations from t=0 to infinity results
in the following: It is possible to eliminate RA by integrating the two equations over from t=0
to infinity and by taking their relative ratio, yielding the following relationship between the
signal ratio and the kinetic rate constant kAC S :
∫ ∞
0
MA(t )d t =M0
∫ ∞
0
e(−kAC S−RA)t d t =M0 e
(−kAC S−RA )t
−kAC S −RA
|∞0 =−
M0
kAC S +RA
∫ ∞
0
MC (t )d t = bM0
∫ ∞
0
e(−kAC S−RA)t d t −bM0
∫ ∞
0
e(−R1,C )t d t =− M0b
kAC S +RA
+ M0b
R1,C
54
2.5. Results
∫∞
0 MC (t )d t∫∞
0 MA(t )d t
=
− M0bkAC S+RA +
M0b
R1,C
− M0kAC S+RA
= b
(
1− kAC S
R1,C
− RA
R1,C
)
=
=
(
kAC S
−kAC S −RA+R1,C
)(−kAC S −RA+R1,C
R1,C
)
= kAC S
R1,C
kAC S = R1,C
∫∞
0 MC (t )d t∫∞
0 MA(t )d t
∼= R1,C
∑N
n=1 SC ((n−1)TR )/cosθ(n−1)∑N
n=1 S A((n−1)TR )/cosθ(n−1)
(2.21)
where SC (nTR ) and S A(nTR ) are the signal intensity obtained at the nth of the N acquisitions,
corrected for the loss of signal due to the RF pulses for acetylcarnitine and acetate, respectively,
by the term cosθ(n−1) .
2.5 Results
The incorporation of hyperpolarized 13C label into acetylcarnitine was detected in all animals
(n=19). The average line width of the acetate resonance at 182.6 ppm was 21 ± 6 Hz and that
of the acetylcarnitine resonance at 173.9 ppm was 6 ±1 Hz (2.7).
The first acetate signal measured corresponds to the maximum observed signal which
appeared 13.5 ± 2.3 s after the beginning of the injection and no progressive build-up of the
signal was observed. The maximimum acetylcarnitine signal was detected at a later time, 26.2
± 3.9 s after the beginning of the injection. The maximal SNR of acetylcarnitine was 10 with
zero line broadening and we imposed a minimum SNR threshold of 3 below which the signal
was not taken into account for data analysis. In each experiment 1.0 mL of hyperpolarized
acetate solution, with a concentration ranging from 40 to 290 mM was injected into the femoral
vein. It was estimated that the injected hyperpolarized acetate doses resulted in a plasma
acetate concentration ranging from 1.8 to 15.0 mM33 . Using a previously reported relation
between plasma and tissue acetate concentration in rat skeletal muscle18, it was estimated
that the tissue acetate concentration ranged from 0.12 to 1 mM.
To determine kAC S from the system of coupled equations defined by Equation 2.11 and 2.12,
the longitudinal relaxation time of [1-13C]acetylcarnitine was set to its in vitro value at 9.4 T,
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Figure 2.7: Transient 13C NMR spectra of hyperpolarized acetate (182.6 ppm) and its metabolic
product acetylcarnitine (173.9 ppm) in healthy skeletal muscle in vivo. The transfer of the 13C
label is catalyzed by the enzymes ACS and CAT. Spectra were acquired every 3 seconds using
adiabatic 30◦ excitation pulses and 1H decoupling during acquisition, a 1.0 mL solution of a
110 mM hyperpolarized acetate was injected. Inset: summation of the spectra as described in
Equation 2.21 which was used to calculate the kinetic rate constants.
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Figure 2.8: Signal integral of [1-13C]acetylcarnitine in plasma following a saturation recovery
experiment. Data of a single measurement are shown.
T1,C = 1/R1,C of 14.9 ± 0.7 s determined in blood at physiological temperature (310 K, 37◦C)
(Table 2.1, Figure 2.8). The T1of acetylcarnitine in D2O had a value similar to the T1in plasma
at 310 K. Its T1decreases with decreasing temperature (Table 2.1).
The kinetic rate constant kAC S was determined by fitting Equation 2.15 and 2.16 to the time
evolution of the acetate and acetylcarnitine signal integrals (Figure 2.9) yielding kAC S and RA .
The observed decay of the acetate signal is mono exponential with a time constant of 16.2
±1.4 s. The values of kAC S were determined as a function of the tissue acetate concentration
deduced from the infused acetate dose and the animal weight (Figure 2.10). Yielding the initial
reaction rates as a function of the tissue acetate concentration, used to derive the Michaelis-
Menten kinetic parameters (Figure 2.10): The conversion of acetate into acetylcarnitine was
characterized by a Michaelis constant KM = 0.35 ± 0.13 mM, as obtained with the model
and a maximal reaction rate, Vmax , of 0.199 ± 0.031 µmol/g/min. The summation approach
estimated a KM = 0.32 ± 0.12 mM and Vmax , of 0.190 ± 0.029 µmol/g/min.
To further demonstrate that the kinetic rate constant is uniquely determined if the relaxation
rate of acetylcarnitine R1,C is fixed, kAC S was calculated for all experiments using Equation
2.21 and plotted them against the kinetic rate constants obtained from the fitting procedure
(Figure 2.11). The residual differences are most likely due to the fitting errors inherent to the
limited signal-to-noise ratio.
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Table 2.1: Longitudinal relaxation times of [1-13C]acetylcarnitine determined at a magnetic
field strength of 9.4 T in plasma and D2O at different temperatures.
Solvent T1in seconds
Blood T = 310 K (37C) (n = 4) 14.9 ± 0.7
D2O T=295 (n = 4) 10.3 ± 0.4
D2O T=305 K (n = 4) 14.3 ± 0.5
D2O T = 310 (n = 4) K 15.5 ± 0.5
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Figure 2.9: Time course of the normalized peak integrals of hyperpolarized acetate and its
metabolic product acetylcarnitine. The kinetic model described with Equation 2.15 and 2.16
was used to fit (—) the hyperpolarized time courses to determine the kinetic rate constant kAC S ,
and the decay rate of acetate RA . The time courses were normalized to their maximum signal.
In the data shown here 1.0 mL of a 110 mM hyperpolarized acetate solution was injected.
58
2.5. Results
0.2 0.4 0.6 0.8 1 1.2 1.40
Vmax= 0.190 +/- 0.029 µmol/g/min
KM = 0.32 +/- 0.12 mM
0.2 0.4 0.6 0.8 1 1.2 1.40
0.05
0.10
0.15
0.20
v
0
,A
C
S
[µ
m
o
l/
g
/m
in
]
Vmax= 0.199 +/- 0.031 µmol/g/min
KM= 0.35 +/- 0.13 mM
Tissue acetate concentration [mM]
k
[m
s-
1
]
Model "tting Sum ratio
Vmax
Vmax
KMKM
Tissue acetate concentration [mM]
0
1
2
3
4
5
6
7
8
0.2 0.4 0.6 0.8 1 1.2 1.40.2 0.4 0.6 0.8 1 1.2 1.40
1
2
3
4
5
6
7
8
0.05
0.10
0.15
0.20
Figure 2.10: The relation between the initial reaction rates v0,AC S (top row) and kinetic rate
constants kAC S (bottom row) with the hyperpolarized [1-13C]acetate concentration. Every
hyperpolarized experiment provided one kinetic rate constant kAC S () and associated standard
deviation as derived from the fit to the kinetic model (left column) or using the summation
approach (right column). The initial reaction rate was obtained by multiplying the fitted
kinetic rate constant kAC S with the corresponding substrate concentration. Michaelis-Menten
parameter fits are represented by the dashed line. Using model fitting a KM of 0.35 ± 0.13 mM
and Vmax of 0.199 ± 0.031 µmol/g/min were estimated. Using the summation approach a KM
of 0.32 ± 0.12 mM and Vmax of 0.190 ± 0.029 µmol/g/min was obtained.
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Figure 2.11: The linear relationship between the kinetic rate constants kAC S obtained with
mathematical modeling of the metabolite time courses and the ratio of the sum of RF corrected
peak integrals of acetylcarnitine C (t ) and acetate A(t ) was used to calculate an integral derived
kinetic rate constant (Equation 2.21 ). The integral derived kinetic rate constant equals the
integral ratio times the longitudinal relaxation rate of acetylcarnitine R1,C . The relationship
between the kinetic rate constants derived from the metabolic model versus the kinetic rate
constants derived using the relative areas of hyperpolarized acetylcarnitine and acetate are
shown below.
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2.6 Discussion
The present study demonstrates that kinetic rates for the conversion of acetate to acetylcarni-
tine can be derived from in vivo hyperpolarized magnetic resonance experiments and that
these rates are in very good agreement with the ones determined in in vitro experiments. The
plasma acetate concentrations used in the current study (1.8 - 15.1 mM) have been previously
shown to linearly scale with the uptake of acetate in skeletal muscle tissue and thus with the
cellular acetate concentration18;19. This implies that the kinetic parameters extracted from
the in vivo real-time measurements presented herein are independent of processes related
to membrane transport since acetate uptake by resting skeletal muscle is proportional to
the arterial concentration. Therefore, the variations in conversion rates as a function of the
injected concentration are thus directly correlated to the biochemical transformations regu-
lated by ACS and CAT in the cytosol. CAT also resides in the mitochondria where it converts
acetylcarnitine back into acetylCoA followed by entry into the TCA cycle (2.1).
The tissue concentrations used in the present study (0.12 - 1.00 mM) were approximately
an order of magnitude lower than those used to maximally acetylate free carnitine and CoA
in canine skeletal muscle16 and human skeletal muscle at rest42–44. This indicates that the
observed acetylcarnitine formation was not hindered by a decrease in carnitine availability
to CAT. The observed kinetic rate constants range from 2 to 6 ms−1, showing that substrate
concentration is an important parameter to take into account while designing a study using
hyperpolarized acetate as a metabolic tracer. It was also observed that this conversion is not
saturated even at a tissue concentration of acetate as high as 1 mM.
Our analysis based on the assumption that, during the experimental time frame, the acetate
pool is fully labeled and the time variation of the acetylCoA pool labeling is much smaller
than the one of acetylcarnitine led to the conclusion that the kinetic rates corresponds to the
conversion rate associated with the enzyme acetylCoA synthetase. This is further supported by
the fact that the transformation catalyzed by ACS is the rate-limiting step in the transformation
of acetate into acetylcarnitine4. It needs to be mentioned that the reaction through ACS is
irreversible and there is no direct exchange between acetate and acetylcarnitine. Previous
reported ACS activity suggested an in vitro KM of 0.2 mM for acetate21. Following acetate
infusions in rat and sheep, the Michaelis constant for acetate in the ACS reaction was between
0.28 and 0.39 mM, based on tissue extracts, with no marked differences between species, tissue
or the intracellular location of the enzyme activity 5. These values of KM are in agreement with
our observed Michaelis constant.
Based on the linear relationship between the ratio of signal integrals and the kinetic rate
constants, two approaches were used to extract kAC S from the data: One was based on time
evolution fitting of the signal integrals (Equation 2.15 and 2.16 ) and the other on the relative
ratio of the sum of both substrate and product (Equation 2.21 ). Note that, while the first
requires the use of mathematical modeling, the summation approach is simpler but less
accurate because each individual spectrum has to be divided by a factor of according to
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Equation 2.21, where n is the acquisition number, leading to an increase in noise noise
error propagation, whereas the fit of the time series takes into account the RF decay and
only relies on raw data where the weight of the noise is not changed. Other approaches
based on mathematical modeling of the metabolic time course were previously proposed to
determine the conversion rates from hyperpolarized 13C labeled pyruvate to its downstream
metabolites 39;45;46.
Acetylcarnitine 13C labeling in the heart has been previously reported following the infusion
of hyperpolarized [2-13C]pyruvate27;28 , but unlike pyruvate, acetate is independent of PDH
flux. The utilization of acetate by the TCA cycle is strictly aerobic and depending on the
delivery of both acetate and oxygen 5, the conversion rate constants are expected to be strongly
dependent on the oxygenation of the tissue under investigation and TCA cycle activity: It was
previously shown that intense muscle activity lead to an accumulation of acetylcarnitine10,
and that a decreased exchange between acetylcarnitine and acetate was a relevant marker for
ischemia26. The possibility to monitor the acetylcarnitine kinetics in vivo in a measurement
window of one minute in a non-invasive manner and the extraction of specific enzymatic
activities can be expected to be a valuable tool for differentiating between healthy and patho-
logical metabolism, in particular since the conversion rate regulated by ACS is implicated in
disorders like diabetes 47 or cancer 48.
2.7 Incorporation of a substrate build-up in the kinetic model
All experimental observations in this chapter show a jump in the acetate signal from 0 to its
maximum in a time frame consisting of one TR , while its metabolic product, acetylcarnitine
is observed at a later time point. Our metabolic modeling approach used in this study was
chosen based on the assumption of an instantaneous distribution of the acetate and fitting of
the the metabolic time courses started at the maximum observed acetate signal. This approach
ignores a potential acetate build up within 3 s, one TR , before the maximum is observed.
In this section was investigated whether the incorporation of an exponential substrate
build-up influences the estimation of the kinetic rate constant kAC S . More precisely, the model
would incorporate an acetate signal increase from 0 to its maximum during a single TR .
Metabolic time courses of acetate and acetylcarnitine were simulated for a range of expo-
nential build up rates B and kinetic rate constants kAC S . The differential equations for the
build up and decay of both acetate and acetylcarnitine can be described by:
d MA
d t
=Be−B t −kAC S MA−RA MA (2.22)
d MC
d t
= kAC S MA−R1,C MC (2.23)
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Figure 2.12: Influence of the incorporation of an acetate build up on the estimation of kAC S .
Simulations were performed for a range of kinetic rate constants kAC S and build up rates B to
determine the influence on the formation of acetylcarnitine and resulting fitting errors with the
model described by Equation 2.16 which assumes an instant distribution of acetate.
Note that these are similar to Equations 2.13 and 2.14 with addition of an exponential build
up B for acetate. During simulations the initial conditions were set to MC (t = 0) = 0 and
MA(t = 0)= 0. The simulated data set of acetylcarnitine, MC (t ), was subsequently fitted to the
analytical solution of MC (t ) (given by equation 2.16) which assumes an instant distribution
of acetate. The error percentage between the simulated and fitted kAC S was calculated for a
range of build up rates and kinetic rate constants.
The simulation showed that in the range of our observed kinetic rate constants, between
0.01 and 0.001 ms−1, the error on the estimation of kAC S is about 1% . It can be seen that for
substrates undergoing faster enzymatic conversion, i.e., larger kinetic rates, inclusion of a
build up parameter is necessary to avoid errors in the estimation of the rate constant.
2.8 Independence and sensitivity of fitting parameters kAC S and RA
In order to characterize the enzymatic activity of ACS, a mathematical model with two free
parameters, kAC S and RA , was used to fit the metabolite time courses of [1-13C]acetylcarnitine
and [1-13C]acetate. Since the analytical solutions of both time courses consist of several
exponentials and the rate constant RA appears in both equations, there exists a correlation
between the two parameters. By using correlation matrixes it can be investigated to what
extend both parameters are dependent on each other. If both parameters are highly dependent,
several combinations of kAC S and RA values can result in a good line fit of the data, meaning
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that a change in one parameter will affect the other directly. Correlation matrices were
calculated for all experiments and an average correlation between kAC S and RA was found to
be 0.15.
Additionally, a sensitivity analysis was performed to investigate the sensitivity of each fitted
parameter to the metabolite time courses. Such an analysis gives insight in how reliable and
stable the fitted parameters are to changes in the metabolite time courses and to what extend
the estimated values can be trusted.
After model fitting of the metabolite time courses, the estimated values of kAC S and RA were
obtained. Simulations were performed using the same equations, the analytical solutions
given earlier, as to which the data was fitted. In these simulations, one of the estimated
parameters kAC S or RA were fixed while the other was varied stepwise to change from -50% to
+50% the estimated value. The simulated metabolite time courses were overlain with the data
and with the fit to the data for comparison (Figure 2.13 ).
It can be seen that the value of the kinetic rate constant kAC S is very sensitive, meaning that
small changes in its value affect the final time course of acetylcarnitine tremendously. This
means that the fitting of kAC S is relatively stable. On the other hand, a change in the decay
rate of acetate RA does not affect the simulated time course meaning that this parameter is
very insensitive.
2.9 Conclusion
The conversion rates from hyperpolarized acetate into acetylcarnitine can be quantified in
vivo, and although separated by two enzymatic reactions, these rates define uniquely the
activity of acetylCoA synthetase. It was further shown that these rates can be obtained using
either fitting of time courses, or an analysis based on time course integration, both approaches
yielded similar enzymatic activity. This study showed the feasibility of measuring the activity
of acetylCoA synthetase in vivo.
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Figure 2.13: Simulation of the sensitivity of the fitting parameters kAC S and RA for changes in
their estimated value. Time courses of the peak integrals of hyperpolarized acetate (bottom row)
and its metabolic product acetylcarnitine (top row) are shown as function of time indicated
with the circles. The fit to the metabolic model is shown with the black line. The two parameters
which were fitted were changed up to 50% their estimated value (red) or less than 50% their
estimated value (blue), and resulting time courses were simulated using the same equations.
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3In vivo real time cardiacmetabolism usinghyperpolarized acetate
Abstract
The heart relies on continuous energy production via the Krebs cycle and imbalances herein
impair cardiac functioning directly. Advances in hyperpolarized 13C magnetic resonance
have provided the means to measure normal and pathological metabolism in tissues in real-
time. Unlike in skeletal muscle, fatty acids are the preferred substrates for oxidation in the
myocardium. Since the heart has a large ventricular blood pool, substrate location impairs
characterization of absolute rate constants. The aim of this study was to develop methods for
hyperpolarized cardiac 13C spectroscopy, investigate short chain fatty acid metabolism in the
healthy heart in vivo and construct a kinetic modeling approach which is independent of the
injected substrate.
In this study, [1-13C]acetate was dynamically polarized and injected intravenously in healthy
animals. The propagation of 13C label from the carboxyl groups of acetate, acetylcarnitine and
citrate could be measured using hyperpolarized 13C MRS in vivo in real time in the beating
rat heart. The substantial spectral resolution at 9.4T and a triggered shimming and NMR
acquisition protocol allowed for the detection of citrate for the first time in vivo after injection
of hyperpolarized [1-13C]acetate.
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3.1 Introduction
Fatty acids are the preferred substrates for myocardial oxidation and fluxes in biochemical
pathways in the heart are abnormal in many forms of heart disease. Acetate, with a 2C carbon
chain is a short chain fatty acid and its uptake occurs by simple diffusion, and thus exchange
of acetate between plasma and tissue only depends on the concentration gradient 1. This fatty
acid is an effective oxidizable substrate and can be formed endogenously from acetylCoA via
acetylCoA synthetase and acetylCoA hydrolase both present in cytosol and mitochondria, and
also from ethanol2. Acetate has been a successful tracer in assessing myocardial oxidative
metabolism in PET3 and MRS 4;5 and has been suggested as a marker of myocardial viability.
Simultaneous uptake and release of acetate indicate rapid intracellular exchange of acetate
with the intracellular acetylCoA pool, as seen in humans 1, dogs 6;7 and rat livers8.
After extraction from plasma (Figure 3.1), acetate is activated to acetylCoA (Equation 2.1)
which crosses the mitochondrial membrane as acetylcarnitine (Equation 2.2) through the
carnitine shuttle complex after which it enters the TCA cycle as citrate via an irreversible
condensation with oxaloacetate 9;10 which is catalyzed by citrate synthase (CS):
Acet ylCo A+Oxal oacet ate+H2O C S−−→Ci tr ate+Co ASH (3.1)
After incorporation into different TCA cycle intermediates, 13C labeling equilibrates very
rapidly with aspartate and glutamate 11. It was suggested that the shuttling of acetylcarnitine
to the mitochondria, which is a carnitine/acetylcarnitine exchange process mediated by
acetylcarnitine translocase (ATL) is not rate-limiting for carnitine promoted processes within
the mitochondria12–14.
The formation of acetylCoA and acetylcarnitine, an important shuttle and buffer of acetyl
groups, was previously detected in vivo after the infusion of hyperpolarized acetate 15;16. The
use of hyperpolarized acetate as a substrate for fatty acid metabolism in resting skeletal muscle
studies is described in the previous chapter. It was shown that the rate of acetylcarnitine
formation reflects that of the enzyme acetylCoA synthetase.
The dynamical aspect of 13C NMR in vivo and its chemical shift range provides additional
capacity to obtain kinetic information compared with 1H MRS. However, labeling of TCA
cycle intermediates are rarely detected in vivo because of their inherent low concentrations.
Therefore, intermediate metabolic reactions taking place before the 13C labeling of the gluta-
mate pool are in general overlooked, since they cannot be measured. Glutamate is labeled
through an isotopic exchange with the TCA cycle intermediate α-ketoglutarate. Nevertheless,
the 13C labeling of glutamate is often used as a measure for the labeling of TCA cycle interme-
diates 17, and an interpretation which is supported by the fact that the exchange rate between
α-ketoglutarate and glutamate is equal to or higher than the TCA cycle rate 11. Based on these
observations, glutamate 13C labeling is used as a marker for estimating TCA cycle rates.
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Hyperpolarized 13C MRS via dissolution DNP 18 increases the sensitivity of the 13C nucleus
by several orders of magnitude and allows for the detection of intermediate reactions involving
TCA cycle intermediates. Hyperpolarized 13C MRS has provided unique insights into important
questions regarding myocardial functioning and allows for the study of fast biochemical
processes and enzymatic pathways and gives the ability to differentiate between normal and
pathological metabolism in the heart 15;19–21.
Here we report the measurement of the 13C label transfer from hyperpolarized [1-13C]acetate
into [1-13C]acetylcarnitine and [5-13C]citrate, a TCA cycle intermediate, in cardiac muscle in
vivo. A kinetic analysis of the observed metabolic reactions was performed using a modeling
approach which is independent of the injected substrate. The TCA cycle intermediate citrate
could be detected at high field using gated shimming after injection of hyperpolarized acetate
. The conversion of acetylcarnitine to citrate can be used as an estimate of the TCA cycle rate.
Since particular conversion patterns were observed in diseased tissue, the proposed method
may aid in targeting regions of pathology for biopsy or focal therapy and/or better characterize
the extent or aggressiveness of disease present prior to or after treatment.
3.2 Methods
The sample preparation and hyperpolarization protocol of [1-13C]acetate is identical to the in
vivo skeletal muscle studies performed earlier and are described in section 2.2.
3.2.1 Cardiac triggering for MR imaging and spectroscopy
In MR spectroscopy and imaging a homogeneous field and a steady sample is required. Mo-
tion of the sample or tissue during data-acquisition distorts the MR images and results in
broader line widths in MR spectra. Heart muscle is in continuous motion which makes MR
spectroscopy and imaging challenging. Shimming, used to obtain a homogeneous field needs
to be well-timed at specific points in the cardiac cycle, as well as the MR measurements. Using
sequences which are triggered at specific phases in the cardiac cycle aid in the measurement
of the same time point and spatial location of the voxel of interest22. To measure the cardiac
motion several physiological markerscan be used (Figure 3.2 ).
Common techniques are the application of electrodes to measure the electrocardiogram
(ECG) or mesaurement of the arterial blood pressure by insertion of a pressure sensor in the
artery. The blood pressure is a more stable and reliable signal compared to ECG since experi-
ments are performed at high magnetic fields which distort the ECG signal. Since experiments
were performed in rats, the arterial blood pressure was chosen as a means to monitor the heart
rate and generate a cardiac trigger signal. In mice, measurement of arterial blood pressure is
challenging and ECG is the preferred method.
Besides the motion of the heart, the animals breathing results in a respiratory movement.
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Figure 3.1: Scheme depicting the metabolism of acetate in healthy myocardium. Acetate dif-
fusion freely into the cardiomyocyte, a process driven by a concentration gradient. Acetate is
transformed via acetylCoA synthetase (ACS) to acetylCoA in the cytosol. Carnitine acetyltrans-
ferase (CAT) converts acetylCoA to acetylcarnitine. Acetylcarnitine translocase (ATL) transports
the acetylcarnitine to the mitochondrion where CAT converts acetylcarnitine back to acetylCoA
for further utilization by the TCA cycle. Citrate synthase (CS) condenses oxaloacetate with acetyl-
CoA to form citrate. The grey boxes indicate the 13C labeled metabolites which were detected in
this study. Both cytosolic and mitochondrial processes are measured.
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Figure 3.2: A Wiggers diagram, showing the cardiac cycle events occuring in the left ventricle.
In the atrial pressure plot: wave "a" corresponds to atrial contraction, wave "c" corresponds to
an increase in pressure from the closed mitral valve bulging into the atrium during ventricular
systole, and wave "v" corresponds to passive atrial filling. In the electrocardiogram: wave "P"
corresponds to the onset of atrial depolarization, waves "QRS" (aka QRS complex) correspond to
the onset of ventricular depolarization, and wave "T" corresponds to ventricular repolarization.
In the phonocardiogram: The sound labeled 1st contributes to the S1 heart sound and is the
reverberation of blood from the sudden closure of the mitral valve (left A-V valve) and the sound
labeled "2nd" contributes to the S2 heart sound and is the reverberation of blood from the
sudden closure of the aortic valve. Adapted from23
Figure 3.3: Physiological parameters monitored for MR triggering used in this study. The arterial
blood pressure signal is shown on top (orange) and the respiration signal at the bottom (white).
The respiration gate windows used in the cardiac 13C MRS experiments described in this chapter
are indicated with the green bars. Whenever the gating window overlaps with the desired cardiac
phase, a 5V TTL pulse is sent to the MR console (white tick marks) which acts as a trigger signal.
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This motion also has to be monitored and synchronized with the data acquisition, since it
results in the same kind of artefact if not taken into account. Therefore, double gating setups
are used in cardiac experiments, which is achieved by application of a respiratory gating
window in combination with the cardiac trigger (Figure 3.3). A trigger signal is generated in
form of a 5V TTL pulse and sent to the MR console when both the respiratory gating window
and the selected cardiac phase overlap.
However, the arterial blood pressure signal is a pressure wave, and this introduces a time
delay between the actual and the measured cardiac phase. Therefore it is not sufficient to
select the trigger moment based on the arterial blood pressure signal alone. The delay time
needs to be known to precisely select the desired cardiac phase for triggering. Initially the
trigger is placed at the beginning of the downslope detection in the pressure signal and a
series of cardiac images is acquired at evenly spaced time points in the entire cardiac cycle.
These images were then evaluated for the maximum ventricular volume observed in the time
series, a period also referred to as late diastole (Figure 3.5). The MR trigger was planned in the
more or less steady part of the diastolic phase as indicated with the orange arrow (Figure 3.5).
The diastolic phase is also used for cardiac triggering in 1H NMR studies of the heart in small
animals24.
Modification of the GEMS sequence
To speed up the acquisition process of the cinematographic images, an existing gradient
echo (GEMS) sequence was modified. A cardiac trigger module was placed after the phase
encoding loop and before the slice encoding module, so that with each cardiac trigger a single
k-space line is collected for each slice (Figure 3.4). When the repetition time TR is set to the
duration of one cardiac cycle and acquisitions are evenly distributed, the frame number of
cinematographic images is determined by the number of slices.
3.2.2 In vivo magnetic resonance spectroscopy
All animal experiments were conducted according to federal ethical guidelines and were ap-
proved by the local regulatory body. Male Sprague Dawley rats (275 - 325 g) were anesthetized
with 1.5% isoflurane in oxygen (n = 5). A catheter was placed into the femoral vein for intra-
venous delivery of the hyperpolarized acetate solution. A second catheter was placed in the
artery to monitor the blood pressure. The respiration rate, cardiac rhythm, and temperature
were monitored and maintained stable.
For cardiac 13C NMR studies performed in this thesis, an RF coil was designed with two
orthogonal receiving surface coils in quadrature mode. The design, construction and tests
of this coil are described in Appendix A.1. This home-built 13C/1H probe consisted of a pair
of 10 mm diameter 13C surface coils in quadrature and a single 10 mm diameter 1H surface
coil. Since the heart of the rat is not located in the middle of the chest, the animal is slightly
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Figure 3.4: Pulse sequence diagram of a triggered gradient echo multi slice (GEMS) pulse
sequence.
rotated. The RF coil is placed on top of the chest so that the left ventricle is located in the
middle of both 13C receiving coils (Figure 3.6), localizing signals from the cardiac muscle. A
hollow glass sphere with a 3 mm inner diameter (Wilmad-LabGlass, NJ, USA) was filled with an
aqueous 1 M [1-13C]glucose solution and used to adjust the pulses power and set the reference
frequency. All experiments were performed with a Direct Drive spectrometer (Agilent, Palo
Alto, CA, USA) interfaced to an actively shielded 9.4 T magnet with a 31 cm horizontal bore
(Magnex Scientific, Abingdon, UK).
Once the animal was positioned inside the magnet, ten axial 1 mm thick slices were acquired
using a non-triggered gradient echo sequence (TR = 50 ms, TE = 3 ms, field of view = 30 x
30 mm, matrix = 128 x 128, flip angle = 30◦, number of averages = 8) from which the correct
position of the animal was determined.
This was followed by a modified gradient echo sequence to confirm the timing of the cardiac
trigger in the end-diastolic phase as described in section 3.2.1 (field of view = 40 mm x 40 mm,
matrix= 256 x 256, TR = 140 ms, TE = 4.5 ms, number of averages = 8, number of frames (slices)
= 14, slice thickness = 1 mm). All scans were acquired using a cardiac trigger as indicated with
the arrow in Figure 3.5. This trigger was typically send 50 or 60 ms after the maximum blood
pressure was observed by the SA Monitoring and Gating System (Model 1025, Small Animal
Instruments, Stony Brook, NY).
With the selected cardiac trigger ten axial 1 mm thick slices were acquired using a triggered
gradient echo sequence to select a voxel of interest. The static magnetic field was homogenized,
generally, in a voxel of 4 mm x 5 mm x 5 mm, placed in the part of the myocardium closed to
the RF coil, using the FASTESTMAP shimming protocol25. The localized proton line width
was reduced to 30 Hz acquired with a STEAM sequence and the unlocalized proton line width
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Figure 3.5: A gradient echo sequence was used to acquire cinematographic MR images of the
cardiac cycle in a rat heart. Fourteen frames were acquired spaced by 10 ms in the cardiac cyle to
plan the timing of the trigger. One complete cycle is illustrated and for each frame the ventricular
volume was calculated. The cardiac trigger used for 1H shimming and 13C hyperpolarized MRS
acquisitions is planned towards the end of the diastolic phase as indicated with the orange arrow.
Image parameters: field of view = 40 mm x 40 mm, matrix= 256 x 256, TR = 140 ms, TE = 4.5 ms,
number of averages = 8, number of frames (slices) = 14, slice thickness = 1 mm, spectral width
5000 Hz, acquisition time 5.12 ms.
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Figure 3.6: The animal is turned in the holder so that the left ventricle is located in the middle of
both 13C receiving coils.
Figure 3.7: Several voxel positions, sizes and locations are used to optimize the localized and
unlocalized 1H linewidth.
to less than 100 Hz (Figure 3.7). The FASTESTMAP protocol as well as the STEAM sequence
were cardiac gated.
Series of single-pulse 13C acquisitions were sequentially recorded starting 6 s after dis-
solution using 30◦adiabatic RF pulses (BIR4) applied every 3 s with 1H decoupling during
acquisition (WALTZ16). Decoupling is needed to remove the 1H induced splitting of the 13C
metabolite resonances, for example, the resonance of [1-13C]acetylcarnitine is a quartet of
doublets when not 1H decoupled (Figure 1.9 in section 1.2.9). The adiabatic pulses offset and
power were set such as to ensure a homogeneous 30◦ excitation of substrate and metabolite
resonances in the entire volume of interest (for calibration measurements see Appendix A.2).
At the end of each in vivo experiment, 200 µL of the residual solution was collected and
analysed as described in section 2.2.
Data analysis
A non-linear least-squares quantification algorithm, AMARES, as implemented in the jMRUI
software package26, was used to fit the 13C NMR data. The spectra were corrected for the
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phases and DC offset. Soft constraints were imposed to peak frequencies (182.55 -182.65 ppm
for acetate, 173.85 -173.95 ppm for acetylcarnitine and 179.65 - 179.75 ppm for citrate) and
line widths (FWHM = 10 - 30 Hz) and the relative phases were fixed to zero. The acetylcarnitine
and citrate peak areas were normalized to the maximum acetate signal in each experiment to
account for varying polarization levels across experiments. The time courses of quantified
peak areas were analyzed with the kinetic model described in section 3.3, implemented in
Matlab (The MathWorks, Natick, MA, USA).
3.3 Kinetic model of hyperpolarized acetate metabolism in the heart
As discussed in section 2.3, it is assumed that measured kinetic parameters are independent
of processes related to membrane transport of acetate. The assumption is that the enzyme
concentration are not affected during the time frame of the experiment, which is about 1
minute. Therefore, the 13C(?) label flow between the substrate acetate (Ace) and the metabo-
lites acetylCoA (A.CoA) and acetylcarnitine (A.Car) inside the cytosol (c) and mitochondria (m)
of cardiac muscle, and citrate (Cit) in the mitochondria can be described with the following
flow scheme:
[Ace?]
kAC S−−−→ [A.Co A?]c
k fC ATc−−−−*) −−
kbC ATc
[A.C ar?]c
k fAT L−−−*)−−
kbAT L
[A.C ar?]m
k fC ATm−−−−*) −−
kbC ATm
[A.Co A?]m
kC S−−→ [Ci t?] (3.2)
These reactions can be described with the following differential equations:
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d [Ace?]
d t
=−VAC S [Ace
?]
[Ace]
(3.3)
d [A.Co A?]c
d t
=VAC S [Ace
?]
[Ace]
−V fC ATc
[A.Co A?]c
[A.Co A]c
+V bC ATc
[A.C ar?]c
[A.C ar ]c
(3.4)
d [A.C ar?]c
d t
=V fC ATc
[A.Co A?]c
[A.Co A]c
− (V bC ATc +V
f
AT L)
[A.C ar?]c
[A.C ar ]c
+V bAT L
[A.C ar?]m
[A.C ar ]m
(3.5)
d [A.C ar?]m
d t
=V fAT L
[A.C ar?]c
[A.C ar ]c
− (V bAT L +V fC ATm )
[A.C ar?]m
[A.C ar ]m
+V bC ATm
[A.Co A?]m
[A.Co A]m
(3.6)
d [A.Co A?]m
d t
=V fC ATm
[A.C ar?]m
[A.C ar ]m
−V bC ATm
[A.Co A?]m
[A.Co A]m
−VC S [A.Co A
?]m
[A.Co A]m
(3.7)
d [Ci t?]
d t
=VC S [A.Co A
?]m
[A.Co A]m
(3.8)
where [Ace], [A.CoA], [A.Car], [Cit] represent total (sum of 13C labeled and unlabeled
molecules) metabolites concentrations in the mitochondrial (m) or cytosolic (c) compart-
ments, [Ace?], [A.CoA?], [A.Car?], [Cit?] the 13C labeled concentrations, V fC AT and V
b
C AT are
the forward and the backward fluxes through CAT, respectively, VAC S is the flux through ACS,
V fAT L and V
b
AT L are the backward and forward fluxes across the mitochondrial membrane,
VC S is the flux through CS . Here the forward fluxes indicate all reactions going towards the
tricarboxylic acid cycle.
Since no distinction can be made between mitochondrial and cytosolic acetylcarnitine in
13C MRS measurements, Equation 3.5 and 3.6 are combined to yield a description for total 13C
labeled acetylcarnitine:
d [A.C ar?]tot
d t
=V fC ATc
[A.Co A?]c
[A.Co A]c
−V bC ATc
[A.C ar?]c
[A.C ar ]c
+V bC ATm
[A.Co A?]m
[A.Co A]m
−V fC ATm
[A.C ar?]m
[A.C ar ]m
(3.9)
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Summing this description with Equation 3.4 and 3.7 yields:
d [A.C ar?]tot
d t
=VAC S [Ace
?]
[Ace]
− d [A.Co A
?]c
d t
−VC S [A.Co A
?]m
[A.Co A]m
− d [A.Co A
?]m
d t
(3.10)
Based on a small pool approximation27;28 as described in section 2.3 we can assume that
d [A.Co A?]/d t << d [A.C ar?]/d t . Since the physiological plasma acetate concentration is
lower than 0.2 mM 2, it can be assumed that the acetate blood pool was fully labeled following
the bolus injection, i.e. [Ace?]/[Ace]≈ 1.Condensing the previous statements, the 13C flow
from acetate to acetylcarnitine and citrate in the cytosolic and mitochondrial compartments
of cardiac muscle can be described by the following equations:
d [Ace?]
d t
=−VAC S [Ace
?]
[Ace]
(3.11)
d [A.C ar?]tot
d t
=VAC S [Ace
?]
[Ace]
−VC S [A.Co A
?]m
[A.Co A]m
(3.12)
d [Ci t?]
d t
=VC S [A.Co A
?]m
[A.Co A]m
(3.13)
Since the labeled concentration of acetylCoA could not be measured, the term [A.Co A
?]m
[A.Co A]m
was eliminated via the following substitution derived from Equation 3.7:
[A.Co A?]m
[A.Co A]m
=
V fC ATm
[A.C ar?]m
[A.C ar ]m
− d [A.Co A?]md t
V bC ATm +VC S
(3.14)
Using a small pool approximation and substituting Equation 3.14 in Equations 3.12 and 3.13
result in the following expressions:
d [A.C ar?]tot
d t
=VAC S [Ace
?]
[Ace]
−VC S
V fC ATm
V bC ATm +VC S
[A.C ar?]m
[A.C ar ]m
(3.15)
d [Ci t?]
d t
=VC S
V fC ATm
V bC ATm +VC S
[A.C ar?]m
[A.C ar ]m
(3.16)
In these equations the mitochondrial fraction of labeled acetylcarnitine remain, however,
the 13C hyperpolarized experiments described here cannot distinguish between different
cellular compartments. Since previous studies suggest that the shuttling of acetylcarnitine
to the mitochondria via ATL is not rate-limiting for carnitine promoted processes within
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the mitochondria12–14 a single cellular acetylcarnitine pool will be employed, yielding the
following 13C label flow scheme:
[Ace?]
kAC S−−−→ [A.Co A?]c
k fC ATm−−−−*) −−
kbC ATc
[A.C ar?]
k fC ATm−−−−*) −−
kbC ATm
[A.Co A?]m
kC S−−→ [Ci t?] (3.17)
The differential equations for 13C labeling in acetate, acetylcarnitine and citrate will be
similar to respectively Equation 3.11, 3.15 and 3.16 with removal of the compartmentation
suffix for acetylcarnitine. A flux V can be described as a kinetic rate constant k times the
substrate concentration. Introducing kinetic rate constants yield the following expressions for
the 13C labeling in observed metabolites:
d [Ace?]
d t
=−kAC S[Ace] [Ace
?]
[Ace]
=−kAC S[Ace?] (3.18)
d [A.C ar?]
d t
= kAC S[Ace?]−kC S [A.Co A]m
[A.C ar ]
V fC ATm
V bC ATm +VC S
[A.C ar?]
= kAC S[Ace?]−k ′C S[A.C ar?] (3.19)
d [Ci t?]
d t
= k ′C S[A.C ar?] (3.20)
with k ′C S the apparent kinetic rate constant representing kC S
[A.Co A]m
[A.C ar ]
V fC ATm
V bC ATm+VC S
and kAC S the
kinetic rate constant representing the enzyme ACS. Besides the influence of enzymatic re-
actions on the observed metabolite time courses as described above, the 13C NMR signals
measured in the cardiac muscle tissue will decay as a consequence of relaxation processes
and repeated RF excitations. The evolution of the magnetization of the carbonyl 13C in ac-
etate, MAce , acetylcarnitine, MA.C ar , and citrate, MCi t , can be described with the following
differential equations:
d MAce
d t
=−RAce MAce −kAC S MAce +MAce logcosθ/TR (3.21)
d MA.C ar
d t
= kAC S MAce −k ′C S MA.C ar −R1,A.C ar MA.C ar +MA.C ar logcosθ/TR (3.22)
d MCi t
d t
= k ′C S MA.C ar −R1,Ci t MCi t +MCi t logcosθ/TR (3.23)
where RAce is the acetate signal decay comprised of the longitudinal relaxation rate of the
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Figure 3.8: Spectral time course of hyperpolarized [1-13C]acetate (182.6 ppm) and acetylcarni-
tine (173.9 ppm) in the heart.
carbonyl 13C acetate as well as the flow of signal in and out of the volume of interest; R1,A.C ar is
the longitudinal relaxation rate of acetylcarnitine. The thermal equilibrium magnetizations of
the carbonyl sites of acetate, acetylcarnitine and citrate, respectively and can be neglected as
described in section 2.3; The term logcosθ/TR constitutes the decay rate of the magnetization
as a result of repeated RF excitations with a repetition time TR and flip angle θ. From the initial
conditions MA.C ar (t=0) = 0, MCi t (t=0) = 0 and MAce (t=0) = M0 the analytical solutions to
Equation 3.21, 3.22 and 3.23 can be obtained. These analytical solutions were used to fit the
metabolic time courses where the time point of the first acetate observation, corresponding to
the maximum acetate signal, was set to t=0 prior to fitting the data.
3.4 Results
The metabolic time courses of hyperpolarized acetate (182.6 ppm) and its metabolic products
citrate (179.7 ppm) and acetylcarnitine (173.9 ppm) were recorded in healthy myocardium in
vivo (Figure 3.8 and 3.9).
Using the FASTESTMAP shimming protocol, 1H line widths of 20 to 30 Hz were obtained
in a voxel size of 4x6x6 mm3. The observed 13C FWHM measured during the hyperpolarized
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Figure 3.9: The spectral sum of (t=21 s to 30 s) reveals the presence of a third metabolite at 179.7
ppm. This spectrum is assigned to [5-13C]citrate.
MR experiments were between 30 and 40 Hz (localization achieved by placing the surface coil
on top of the mouse heart). Peak areas were extracted using jMRUI to obtain metabolite time
courses of acetate, acetylcarnitine and citrate (Figure 3.10 and 3.11). The observation of citrate
is the first in vivo real time detection of [1-13C]citrate after using acetate as substrate.
The maximum peak integral of acetate was observed 9 s after the beginning of the infusion,
the maximum acetylcarnitine about 12 s later and the maximum citrate approximately 6 s after
acetylcarnitine. This observation supports the role of carnitine as a shuttle for acetyl groups
across the mitochondrial membrane. A three-compartment non steadystate metabolic model
was used to fit the metabolic time courses (Figure 3.10 and 3.11). This model takes into account
the effect of repeated excitations and contains 4 free parameters (RAce , kAC S , k ′C S , RCi t ). The
kinetic rate constant k ′C S should be considered an apparent rate constant since it not only
reflects the flux through the enzyme citrate synthase but also carnitine acetyltransferase, since
k ′C S = kC S [A.Co A]m[A.C ar ]
V fC ATm
V bC ATm+VC S
.
The kinetic rate constant k ′C S could be representative for TCA cycle activity and thus my-
ocardial oxidation. The T1 relaxation time of [1-
13C]acetylcarnitine in blood was measured to
be 14.9 s and used as a constant 16. The kinetic parameters obtained from the fitting are kAC S
= 1.5 ± 0.2 ms−1, k ′C S = 21 ± 4.5 ms−1.
3.5 Discussion
In this study hyperpolarized acetate was used to probe short chain fatty acid metabolism
in the rat heart in vivo. The detection of the citrate resonance showed that mitochondrial
acetylCoA, ultimately derived from the injected acetate, continued into the TCA cycle and
that acetate can be used as a metabolic probe for myocardial oxidation. When injected in
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Figure 3.10: Time course of the peak integrals of the substrate [1-13C]acetate and its metabolic
products [1-13C]acetylcarnitine and [5-13C]citrate. (- - -) The corresponding fit to the kinetic
model.
Figure 3.11: Time course of the peak integrals of the metabolic products [1-13C]acetylcarnitine
and [5-13C]citrate and the corresponding fit (—) to the kinetic model.
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resting rat skeletal muscle citrate was not detected16, which is related to the substantially
higher activity of ACS in the heart29 where acetate is oxidized at a much faster rate 30.
However, in skeletal muscle studies performed in this thesis (see results in Chapter 2,
Figure 2.10 ), kAC S values were ranging between 3 and 7 ms−1, which appears much larger.
This can be attributed to the location of the hyperpolarized substrate acetate, which resides
mainly in the tissue compartment in the previous skeletal muscle study, and mainly in the
ventricular compartment of the cardiac muscle study described here. The relatively lower
value of kAC S found in this study is resulting from the acetate signal being mainly located
inside the ventricles.
The increased spectral resolution at 9.4 T allowed us to observe citrate compared to earlier
investigations in cardiac muscle in mice at 2.35 T15. The aforementioned study reported the
detection of the acetylCoA resonance at 202 ppm in mice heart and liver after a 90◦ excitation
but was never detected in the experiments performed in this study. The use of adiabatic
pulses which provides identical excitation for all metabolites enables observation of true ratios
independent of their location in the myocardium.
The real-time kinetic measurements through citrate synthase, a measure of TCA cycle
activity, as performed here does not depend on isotopic steady state, a necessity for thermal
equilibrium 13C MRS. Hyperpolarized [1-13C]acetate can be used as a PDH independent
metabolic probe for myocardial viability and elucidate changes in Krebs cycle metabolism
during impaired heart function Since both acetylcarnitine and citrate are located in the
myocardium, both markers can be used as a direct indicator of TCA cycle activity.
Detectable quantities of 13C labeled glutamate were expected since 60% of the activity was
found in glutamate 2 minutes after injection of 14C labeled acetate31 , and only 8% in total
labeled TCA cycle metabolites. However, due to overlapping resonances it was not possible to
detect [5-13C]glutamate.
Conclusion
We conclude that by using hyperpolarized [1-13C]acetate it is possible to study the in vivo
real-time formation of acetylcarnitine and TCA cycle intermediates and thus directly measure
energy metabolism in healthy myocardium. This method could be applied to study models of
cardiac ischemia-reperfusion.
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4Myocardial substrate competition usinghyperpolarized 13CMR
Abstract
Cardiac energy is derived primarily from oxidation of fatty acids and to a lesser extent carbo-
hydrates and ketone bodies. Cardiac dysfunction is often associated with a shift in substrate
preference, for example in ventricular hypertrophy and heart failure where carbohydrate oxida-
tion is upregulated. Diagnostic radiotracer methods such as 18FDG-PET provide information
on substrate uptake and not directly about oxidation of either carbohydrates or alternative
fuels. Hyperpolarization enables the metabolism of 13C labeled substrates to be detected by
magnetic resonance with high sensitivity and specificity. The aim here was to demonstrate
the feasibility of simultaneously measuring lipid and carbohydrate competition in vivo using
hyperpolarized magnetic resonance and to assess the sensitivity of the method to a metabolic
perturbation. To study substrate competition in the rat heart in vivo, we injected hyperpo-
larized [1-13C]pyruvate (n=10), [1-13C]butyrate (n=12), or both (n=14) as representatives of
carbohydrates and fatty acids respectively. The appearance of bicarbonate, lactate, alanine,
glutamate, citrate, acetylcarnitine, β-hydroxybutyrate and acetoacetate could be assigned
exclusively to pyruvate or butyrate oxidation, allowing for independent monitoring of their
metabolism in a single experiment. The sensitivity of this method was tested by comparing
the fed to the fasted state. Fasting led to significant changes in preference for the injected
substrates in separate experiments as well as in co-injection. Combining hyperpolarized 13C
technology and co-administration of [1-13C]pyruvate and [1-13C]butyrate enables noninvasive
and simultaneous monitoring of myocardial oxidation of both fatty acid and carbohydrates in
vivo and is a sensitive indicator of metabolic shift.
Adapted from:In vivo myocardial substrate competition using hyperpolarized 13C magnetic resonanceJessica AM Bastiaansen, Matthew E Merritt , Arnaud Comment
Submitted manuscript
Chapter 4. Myocardial substrate competition using hyperpolarized 13C MR
4.1 Introduction
Cardiovascular disease is still the number one cause of death in the US and the industrial-
ized world 41. An emerging treatment avenue for ischemic heart disease is modulation of the
substrate preference of the myocardium to improve the production of the ATP necessary for
supporting continuous mechanical activity23;36. The heart uses a variety of fuel sources to
meet its energy requirements, namely fatty acids, ketone bodies, and carbohydrates; the con-
sumption of the latter being up-regulated in the failing heart 8. Since the complete oxidation of
a single glucose molecule provides more molecules of ATP per mole of oxygen than any other
substrate, including fatty acids or ketones29, metabolic approaches for increasing cardiac
efficiency include suppressing fatty acid oxidation and increasing glucose oxidation. Plasma
substrate concentrations can vary dramatically depending on the physiological state of the
body and as a result the myocardium modulates its substrate selection in order to maintain
high levels of ATP49. For instance, fasting leads to an increase of free fatty acids (FFA)3, an
acceleration of lipid oxidation and a reduction of glycolysis 25, as well as an elevation of ketone
body concentration, which eventually inhibit carbohydrate and fatty acid oxidation 4;38. Acetyl-
CoA is the metabolite formed at the crossroads between lipid and carbohydrate metabolism
and it is located at the entry of the tricarboxylic acid (TCA) cycle (Figure 4.1).
It is produced from fatty acids viaβ-oxidation and from carbohydrates through the glycolytic
pathway, via the intramitochondrial pyruvate dehydrogenase (PDH) complex, which is the
irreversible rate limiting step in carbohydrate oxidation. Substrate selection is regulated by
many mechanisms, including the intramitochondrial acetylCoA to CoA ratio. An increased
ratio results in the inhibition of PDH activity whereas a decreased ratio activates PDH. PDH is
also modulated by the intramitochondrial NADH/NAD+ ratio as well as phosphorylation by
pyruvate dehydrogenase kinase14. When acetyl groups are abundant they can be stored as
acetylcarnitine, a reaction catalyzed by carnitine acetyl transferase (CAT).
Substrate selection is a clinically important variable that is known to vary with the severity of
the myocardial pathology and is subject to manipulation by pharmacokinetic intervention 24.
Upregulation of glucose metabolism should theoretically make the heart more efficient. The
possibility of assaying substrate selection in vivo would constitute a fundamental advance
in the diagnosis and treatment of heart failure and could help in correctly choosing the most
effective intervention in a single patient, i.e., personalized healthcare. Positron emission
tomography (PET) is widely used to study heart failure, both with 18FDG and 11C labeled
fatty acids22;48, but the formulation of a protocol to measure substrate competition in a
simultaneous sense is nearly impossible, since 18F and 11C both produce 511KeV electrons
and their respective signals are thus indistinguishable. Using other radionuclides with different
annihilation energies in addition to the 18F and 11C compounds would be cost prohibitive.
Recent developments in hyperpolarized 13C magnetic resonance (MR) allow the study of
real-time metabolism of 13C labeled pyruvate, providing a direct measurement of the flux
through PDH by the formation of carbon dioxide and bicarbonate 15;33;46.
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Figure 4.1: The metabolic pathways of [1-13C]pyruvate and [1-13C]butyrate in the myocardium
in vivo. The propagation of the 13C label from pyruvate to its downstream metabolites is
indicated with red arrows and those of butyrate with blue arrows. The 13C label of pyruvate
will not enter the TCA cycle or dilute the acetyl-CoA pool. After an overnight fast ketone body
uptake will increase the intracellular acetoacetate and β-hydroxybutyrate concentrations. CAT:
carnitine acetyltransferase; AAT: acetoacetylCoA thiolase; OAT: 3-oxoacid CoA transferase; PT:
pyruvate transporter; PDH: pyruvate dehydrogenase.
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Hyperpolarized 13C pyruvate alone, as a mimic of carbohydrate metabolism in general, has
been used in promising pre-clinical investigations of myocardial metabolism in a perfused
heart model of myocardial ischemia47 and in vivo15. The effect of increased fatty acid avail-
ability on the metabolism of hyperpolarized pyruvate have been studied in perfused heart 33;35.
Hyperpolarized [1-13C]butyrate was recently proposed as a substrate to study cardiac fatty acid
metabolism 2. This short chain fatty acid does not need carnitine acyl transferase to enter the
mitochondrion, unlike long chain fatty acids, and it effectively competes with long chain fatty
acids for β-oxidation. Metabolism of hyperpolarized [1-13C]butyrate provides information
about flux through the tricarboxylic acid (TCA) cycle via the formation of [5-13C]glutamate,
the enzymatic activity of carnitine acetyl transferase (CAT) and pseudoketogenenesis11 via
the formation of [1-13C]β -hydroxybutyrate (BHB) and [1-13C]acetoacetate (AcAc).
The considerable advantage of the hyperpolarized 13C MR method over PET in the context of
substrate competition is that chemical reactions are immediately detected, not simple uptake
and export. To date, pyruvate, lactate and acetate are the only hyperpolarized substrates
that have been used to probe real-time cardiac metabolism in vivo. The aim of the present
study was to assess, in vivo and in real time, the competition between carbohydrate and fatty
acid utilization in the fed and fasted metabolic states of the rat heart using hyperpolarized
[1-13C]pyruvate and [1-13C]butyrate.
4.2 Materials and Methods
Samples preparation and hyperpolarization protocol
Sodium [1-13C]butyrate, sodium [1-13C]pyruvate and TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy)
nitroxyl radicals were obtained from Sigma-Aldrich (Buchs, Switzerland). Sodium [1-13C]pyruvate
was dissolved to a concentration of 3.0 M and sodium [1-13C]butyrate to a concentration of
4.5 M, both with a TEMPO concentration of 33 mM in a 1:2 mixture of d6-EtOD/D2O. The
solutions were rapidly frozen in liquid nitrogen to form 10 µLbeads that were inserted into
a sample cup in a 2:3 butyrate/pyruvate mixture to have the same concentration of both
substrates. The sample cup was further cooled to 1 ± 0.05 K in a 5 T custom-designed DNP
polarizer10, where the 13C nuclei were dynamically polarized for 2.5 h. Then, using an auto-
mated process9 the sample was rapidly dissolved using 6.0 mL of pressurized, heated D2O
and transferred within 2 s of dissolution to a separator/infusion pump, containing 0.6 mL
of phosphate buffered saline and heparin, located inside a 9.4 T horizontal bore magnet.
Subsequently, 1.0 mL of the hyperpolarized solution yielding physiological temperature and
pH was automatically infused into the animal during 7 s. The polarization level was 12 ± 1
% in the liquid state at the time of the injection. Animals All animal studies conformed to
institutional guidelines. Wild-type male Sprague Dawley rats (277 ±26 g) were anesthetized
with 1.5% isoflurane in oxygen. A catheter was placed into the femoral vein for intravenous
delivery of the hyperpolarized solution. A second catheter was placed in the artery to monitor
the blood pressure. The respiration rate, cardiac rhythm, and temperature were monitored
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Table 4.1: Average glucose levels and body weight of all animals used in this study
Parameter Fed Fasted
Body weight [gram] 288± 18 265 ± 22
Glucose [mM] 9.0 ± 0.7 4.5 ± 1.0
and maintained stable. Six groups of animals were studied and each animal was injected once.
Each group was exposed to an injection of hyperpolarized butyrate (n = 12), pyruvate (n =
10) or both (n = 14) and the animals were either in a fed or fasted state. The animals were
fasted overnight by placing them in a clean cage without food the day before the experiment
at around 6 pm. All experiments on fasted animals were performed in the morning and the
experiments on fed animals early in the afternoon. Glucose levels were measured to determine
the levels of fasting and are displayed in table 4.1.
Animal physiology was not affected by the injections and body temperature as well as
respiration and heart rates were stable through all experiments.
in vivo magnetic resonance spectroscopy
Measurements were carried out on a 9.4 T / 31 cm actively shielded animal scanner (Varian/-
Magnex). A custom-made radiofrequency (RF) hybrid probe consisting of a 10 mm diameter
proton surface coil and a quadrature 10 mm diameter 13C surface coil was positioned over the
chest of the rat for transmission and reception, localizing the signals from the cardiac muscle
(Appendix A.1). To generate an external reference signal, a small sphere filled with a water
solution saturated with [1-13C]glucose was placed in the center of the carbon coil. Acquisition
of gradient echo proton images confirmed the correct position of the heart. Shimming was
performed to reduce the localized proton line width in a myocardial voxel of 4x5x5 mm to
20-30 Hz using FASTESTMAP16. The NMR console was triggered to start acquisition at the
beginning of the automated injection process, 3 s after dissolution of the hyperpolarized
sample. Series of single pulse acquisitions were recorded using 30 degree adiabatic RF pulses
(BIR4) applied every 3 s with 1H decoupling using WALTZ. Typically 40 - 60 FIDs were acquired
with 4129 complex data points over a 20000 Hz bandwidth. All acquisitions were cardiac
triggered and respiratory gated. The adiabatic pulse offset and power was calibrated to ensure
a 30◦ excitation pulse for all observed metabolites in the entire tissue of interest. Following
data acquisition, 200 uL liquid samples were extracted from the separator/infusion pump to
precisely determine the infused [1-13C]butyrate and [1-13C]pyruvate concentration using a
high resolution 400 MHz NMR spectrometer.
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Table 4.2: Chemical shifts of observed metabolites following the injection of hyperpolarized
sodium [1-13C]butyrate and sodium [1-13C]pyruvate.
Metabolite Chemical Shift (ppm)
[1-13C]butyrate 185.0
[1-13C]lactate 183.5
[5-13C]glutamate 182.45
[1-13C]β-hydroxybutyrate 181.6
[1-13C]pyruvate hydrate 179.8
[5-13C]citrate 179.7
[1-13C]alanine 177.0
[1-13C]acetoacetate 176.5-176.0
[1-13C]acetylcarnitine 173.9
[1-13C]pyruvate 171.4
13C bicarbonate 161.3
13CO2 126
Data analysis
The 13C NMR spectra of each time series were summed for the time period during which
the hyperpolarized resonances were visible and the resulting summed spectra were fitted
to Lorentzian line shapes using Bayesian analysis. The infused substrates and their corre-
sponding metabolic products were assigned according to the chemical shifts reported in table
4.2.
The total integral of alanine was used as a reference for cardiac tissue specific metabolism,
instead of pyruvate or butyrate, and has been shown to be a representative marker for in-
tracellular pyruvate concentration . Statistical differences between the ratios of observed
metabolites were calculated using a two-tailed t-test for unpaired data with equal variance.
Error bars in figures and in the manuscript indicate ± standard error of the mean (SEM).
4.3 Results
Substrate competition was studied in healthy rat hearts in vivo in the fed and fasted state.
Fasting induces a shift from carbohydrate to fatty acid oxidation and blood glucose levels
decrease42. In the present study, overnight fasting resulted in a 50% decrease in plasma
glucose compared with animals which were fed ad libitum (Table 4.1).
4.3.1 Hyperpolarized [1-13C]pyruvate injection
Hyperpolarized [1-13C]pyruvate metabolism lead to the detection of [1-13C]lactate, [1-13C]alanine,
13CO2, 13C bicarbonate and the impurity pyruvate hydrate (Figure 4.2a, Table 4.2). The mea-
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Figure 4.2: In vivo cardiac 13C spectrum recorded after the injection of hyperpolarized [1-
13C]pyruvate (A). The following resonances were observed and are displayed using the same
scale: [2-13C]pyruvate, [1-13C]lactate, [1-13C]pyruvate hydrate, [1-13C]alanine, [1-13C]pyruvate,
13C bicarbonate and 13CO2. Signal ratios of lactate, bicarbonate and acetylcarnitine relative to
alanine (B) in all 4 animal groups where hyperpolarized [1-13C]pyruvate was either injected
separately (Fed pyruvate, P, or Fast P) or co-injected with hyperpolarized [1-13C]butyrate (B) (Fed
PB or Fast PB) in both fed and fasted animals. Asterisks denote statistical significant differences
in metabolite ratios where *** p<0.00005, ** p<0.005, * p<0.05. Significant changes were only
reported between groups where one single condition was altered.
sured ratios between the total bicarbonate and pyruvate signal integrals ( 3%) were consistent
with the in vivo data previously acquired in fed rat hearts19;46. To avoid misinterpretations
resulting from the ubiquitous [1-13C]pyruvate signal and its compartment specific down-
stream metabolites, metabolite signals were normalized to the total area of alanine. Alanine is
preferred as a marker for intracellular pyruvate concentration occurring specifically in cardiac
tissue28. After an overnight fast, the ratio of bicarbonate to alanine was markedly reduced
from 0.93 ± 0.18 to 0.00 ±0.00 and a significant increase in the lactate to alanine ratio (2.23 ±
0.37 to 4.89± 0.72) associated with an increase in the NADH/NAD+ ratio was observed (Figure
4.2b). The fact that the bicarbonate signal decreased dramatically in fasted animals is due to a
reduction in PDH flux, an observation made previously and confirmed in this study.
4.3.2 Hyperpolarized [1-13C]butyrate injection
[1-13C]butyrate was used to study cardiac short-chain fatty acid metabolism in vivo. The C1
of butyrate has a relatively long longitudinal relaxation time (T1) compared with other fatty
acids ( 25 s at 9.4 T), and its resonance signal does not overlap with that of [5-13C]glutamate
like [1-13C]acetate does (Figure 4.3a).
The following metabolites were detected in vivo: [5-13C]glutamate, [1-13C]β-hydroxybutyrate,
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Figure 4.3: In vivo cardiac 13C spectrum recorded after the injection of hyperpolarized [1-
13C]butyrate in the fed and fasted state (A). The following metabolites were observed: [1-
13C]butyrate, [5-13C]glutamate, [1-13C]β-hydroxybutyrate, [5-13C]citrate, [1-13C]acetoacetate
and [1-13C]acetylcarnitine. The relative signal ratios of acetylcarnitine, glutamate and acetoac-
etate to their precursor butyrate (B) and glutamate and acetoacetate relative to acetylcarnitine
(C) in all 4 animal groups following a hyperpolarized [1-13C]butyrate injection (Fed B or Fast B)
and coinjection with hyperpolarized [1-13C]pyruvate (Fed BP or Fast BP) in both fed and fasted
animals. Asterisks denote statistical significant differences between metabolite ratios where ***
p<0.0005, ** p<0.005, * p<0.05. Significant changes were only reported between groups where
one single condition was altered.
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[5-13C]citrate, [1-13C]acetoacetate, and [1-13C]acetylcarnitine. The signal-to-noise ratio (SNR)
of glutamate, acetoacetate and acetylcarnitine was sufficient to be reliably detected in all the
hyperpolarized butyrate injections. This is the first observation of TCA cycle intermediates
following fatty acid oxidation in vivo. In terms of absolute flux into glutamate, it should be
noted that the appearance of label at the 5-position undercounts butyrate oxidation by half,
since the 3-position of butyrate is not enriched. Butyrate β -oxidation produces two units of
acetylCoA, only one of which is labeled and hyperpolarized.
Since butyrate, like pyruvate, is not uniquely located in the myocardium, acetylcarnitine was
additionally used as an internal reference. It was observed that the glutamate to acetylcarnitine
ratio was significantly lower in fasted animals compared to fed animals, from 0.41 ± 0.06 to
0.25 ± 0.03 (Figure 4.3c). Additionally, a significant increase (0.24 ± 0.07 to 0.63 ± 0.05) of
the ketone body acetoacetate relative to acetylcarnitine was observed (4.3c) . The ratio of
acetylcarnitine relative to butyrate did not show a significant difference (Figure 4.3b).
4.3.3 Hyperpolarized [1-13C]pyruvate and [1-13C]butyrate co-injection
The third type of experiment aimed at studying the competition between carbohydrates
and fatty acids by co-injecting both [1-13C]pyruvate and [1-13C]butyrate as substrates. All
metabolites observed in the separate injections could be detected since the carbon line widths
were narrow enough to avoid overlaps with the exception of [5-13C]citrate, which overlaps
with the [1-13C]pyruvate hydrate peak (Figure 4.4b).
The hyperpolarized solutions were prepared such as to inject an equal amount of both sub-
strates. Injected pyruvate and butyrate concentrations were determined via high-resolution
NMR following the in vivo experiments. The average concentration ratio was 0.98 ± 0.08, and
thus assumed equal.
The number of significant differences between the fed and fasted animals generated by the
dual injection approach is large, and choice of the order of presentation was made by first
looking at carbohydrate metabolism, followed by fatty acid metabolism.
From the data obtained in the fed state with and without co-injection of butyrate, it appears
that its transport is not sufficiently fast to completely out-compete pyruvate for the production
of acetylCoA. All data was analyzed in terms of ratios to the alanine signal (see Figure 2). The
results reveal significant changes in the lactate to alanine ratio between the fed and fasted state
during co-injection, 3.30 ± 0.33 to 4.87 ± 0.43 (p=0.02), as well as in the ratio of acetylcarnitine
to alanine (p=0.05, Figure 4.3b) and highly significant changes in bicarbonate to alanine ratios
(p=0.00005).
As a result of the co-injection with the fatty acid butyrate in fed animals, the relative bicar-
bonate to alanine ratio decreases as one would expect (p=0.01), and marginally significant
changes in the lactate to alanine ratio were noted, 2.23 ± 0.38 to 3.30 ± 0.33 (p=0.07).
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Figure 4.4: Spectral time course of myocardial metabolism in vivo following the co-injection of
hyperpolarized [1-13C]butyrate and [1-13C]pyruvate (A). The acquisition started simultaneous
with the co-injection with a time interval of 3 s. The first two spectra were omitted since
no metabolites were observed. A spectral sum is shown in (B) revealing the detection of [1-
13C]butyrate, [1-13C]lactate, [5-13C]glutamate, [1-13C]pyruvate hydrate, [1-13C]alanine, [1-
13C]acetoacetate, and [1-13C]acetylcarnitine, unidentified [2-13C]pyruvate and 13C bicarbonate.
Horizontal time course of the hyperpolarized signals showing similar decay and acute substrate
delivery (C).
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Figure 4.5: Signal ratios of lactate, alanine and bicarbonate relative to hyperpolarized [1-
13C]pyruvate in all 4 animal groups where pyruvate was either injected uniquely (Fed P or
Fast P) or co-injected with hyperpolarized [1-13C]butyrate (Fed BP or Fast BP) in both fed and
fasted animals. Asterisks denote statistical significant differences in metabolite ratios where ***
p<0.00005, ** p<0.05, * p<0.5. Significant changes were only reported between groups where one
condition was altered.
From the perspective of butyrate metabolism, the co-injection of pyruvate decreases the
glutamate to acetylcarnitine ratio (both metabolites derived exclusively from butyrate) signifi-
cantly in both fed and fasted states (Figure 4.3c). Taking into consideration the acetylcarnitine
to butyrate ratio (Figure 4.3b) in the fed state, which increases significantly from 0.008 ±
0.001 to 0.017 ± 0.003, the change in glutamate to acetylcarnitine ratio (Figure 4.3c) decreased
significantly upon introduction of pyruvate. Additionally, the presence of pyruvate completely
quenches the appearance of acetoacetate derived from butyrate.
4.4 Butyrate and Pyruvate Flux Analysis
In this section is briefly described how to interpret the signal ratios following the injection of
hyperpolarized [1-13C]butyrate. This was done by looking at the isotope balance equations
and the corresponding metabolic fluxes.
The 13C labeling in acetylCoA (A.CoA), acetylcarnitine (A.Car) and glutamate (Glu) can be
described with the following equations after the injection of hyperpolarized [1-13C]butyrate,
where ? refers to the 13C labeled metabolite and otherwise its total pool size:
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(4.3)
Where VBet a refers to theβ-oxidation flux, VC AT the flux through carnitine acetyl transferase
and VTC A the flux through the tricarboxylic acid cycle. Combining the first 2 equations leads
to:
d [A.C ar?]
d t
+ d [A.Co A
?]
d t
=VBet a [Ac.Ac.Co A
?]
[Ac.Ac.Co A]
−VTC A [A.Co A
?]
[A.Co A]
(4.4)
Combining Eq 3 and 4:
d [A.C ar?]
d t
+ d [A.Co A
?]
d t
=VBet a [Ac.Ac.Co A
?]
[Ac.Ac.Co A]
− d [Gl u
?]
d t
(4.5)
Based on small pool size approximation, d [A.Co A]/d t << d [A.C ar ]/d t we can neglect
changes in the acetylCoA pool and Eq. 5 becomes
d [A.C ar?]
d t
=VBet a [Ac.Ac.Co A
?]
[Ac.Ac.Co A]
− d [Gl u
?]
d t
(4.6)
Note that VBet a constitutes the flux through the acetoacetylCoA thiolase reaction, the last
enzymatic reaction in theβ-oxidation pathway. The flux VBet a should not be affected by fasting
and is therefore constant. However, fasting would increase the unlabeled acetoacetylCoA
pool and simultaneous pyruvate oxidation increases the unlabeled acetylCoA pool. Therefore
our results can be explained using Eq. 4 and 6. The glutamate to acetylcarnitine ratio can be
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described as follows:
[Gl u?]
[A.C ar?]
=
VTC A
[A.Co A?]
[A.Co A]
VBet a
[Ac.Ac.Co A?]
[Ac.Ac.Co A] −VTC A [Ac.Co A
?]
[Ac.Co A]
(4.7)
Given that VBet a and VTC A remain constant the ratio of [A.Co A?]/[A.Co A] must decrease,in
order to decrease the ratio of glutamate to acetylcarnitine. Meaning that the ratio of detected
glutamate to acetylcarnitine is related to the ratio of labeled to unlabeled acetylCoA.
4.5 Discussion
4.5.1 Pyruvate Injections
The pyruvate doses in this study were well below the level at which perturbations in cardiac
metabolism were previously reported1;35;44. The detection of both bicarbonate and carbon
dioxide in the fed animals with the injection of hyperpolarized pyruvate allowed us to deter-
mine the pH applying the Henderson-Hasselbach equation13.
Tissue pH can be determined from the concentration ratio of endogenous 13C labeled
bicarbonate and 13CO2 as follows:
pH = pKa + log10
[HCO−3 ]
[CO2]
(4.8)
where pKa is the acid dissociation constant of CO2, which was assumed to be 6.15 43.
A stable value of 7.3 ± 0.1 was observed and demonstrated that the injections did not
significantly disturb the body’s pH during the experiment (Figure 4.6). The reduction of
the bicarbonate intensity after overnight fasting was more pronounced in our experiments
(declined 50%) compared to an earlier study46 where the plasma glucose concentration
only dropped 30%. It can be inferred that FFA’s were higher in the current rats, which would
explain the decreased bicarbonate signal. Significant changes in lactate to alanine ratios were
observed, as reported in the liver18;32. In summary, the [1-13C]pyruvate injections produced
exactly the responses that would be expected given previous work in the literature.
4.5.2 Butyrate Injections
The heart is not a ketogenic organ. The 13Clabeling observed in β-hydroxybutyrate and ace-
toacetate is not a result of hepatic ketogenesis followed by shunting of ketone bodies to the
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Figure 4.6: Time course of the 13C labeled bicarbonate and carbon dioxide signal integrals. The
point by point ratio of these biomolecules were used to calculate the pH using equation 4.8.
heart, but due to exchange between acetoacetylCoA and free, unlabeled acetoacetate in the
heart itself 11. This is supported by the myocardial activity of 3-oxo-acidCoA transferase, which
is 60 times greater than the net myocardial uptake of ketone bodies 6. Also, these ketone bodies
were observed in vitro in a perfused heart injected with hyperpolarized [1-13C]butyrate2.
Finally, the line shape of the observed ketone bodies resembles that of metabolites present in
the myocardium and not in the ventricular blood pool. These observations suggest that the ob-
served ketone bodies are formed in the myocardium. The exchange between acetoacetate and
acetoacetylCoA is a mitochondrial process since bothβ-hydroxybutyrate dehydrogenase and
3-oxoacid CoA transferase are exclusively present in the mitochondrial space. AcetoacetylCoA
thiolase can be found in both cytosolic and mitochondrial compartments but since the mito-
chondrial activity is much larger it was assumed in this report that all three pseudoketogenic
enzymatic reactions are of mitochondrial nature.
The pulse bandwidth and power used here is in principle sufficient to excite the resonance
of [3-13C]acetoacetate at 209 ppm 34 but was not present in detectable amounts in this study.
The absence of the [3-13C]acetoacetate resonance suggest that during the timeframe of our
experiment the label scrambling due to acetyl group circulation through the acetylCoA pool
is negligible, and thus no flux from acetylCoA to acetoacetate via acetoacetylCoA is observ-
able. In previous studies using hyperpolarized acetate, which is not β-oxidized, ketone body
formation from acetylCoA in cardiac and skeletal muscle was also absent5;20. This indicates
that acetoacetylCoA, a product of β-oxidation, is a key metabolite to the formation of the
observable ketone bodies (Figure 1).
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Comparing fed versus fasted state, the glutamate to acetylcarnitine ratio is lower while
the acetylcarnitine to butyrate ratio remains unchanged, indicating a decrease in labeling of
glutamate. Also, the levels of acetylcarnitine and acetylCoA change only moderately. Since
cardiac glutamate pool sizes remain unchanged over a fasting period for up to 48h in cardiac 49
and skeletal muscle21, and the ratio of acetylcarnitine to free carnitine remains unchanged
after 48h of fasting7, it is most likely that the observed decrease in glutamate labeling is not
a result of a change in pool size (See the section about the flux analysis). Conversely, the
acetoacetate resonances are more intense in fasted animals. The formation of ketone bodies
from butyrate is positively stimulated with increasing ketone body concentrations50, as is
the case during fasting since the pool sizes of acetoacetate and β-hydroxybutyrate increase
5 fold after 24h of fasting25. Increases in ketone body concentrations are accompanied by
an increase in the acetoacetylCoA concentration, which was observed during acetoacetate
infusion in perfused hearts31. In summary, it is believed that the presence of additional
intracellular unlabeled acetoacetate contributes to an increase in ketone body labeling from
hyperpolarized butyrate via pseudoketogenesis, which constitutes an isotopic exchange with
acetoacetylCoA and not a net formation of ketone bodies 11. The amount of label flow through
β-oxidation in both nutritional states seems to be unchanged since the sum of 13C label
from acetylcarnitine, glutamate and acetoacetate relative to butyrate is constant (Figure 4.3b),
an indication that the rate of butyrate oxidation is not affected after overnight fasting. This
means that in both nutritional states the same amount of label ends up in acetoacetylCoA, but
the label propagation from there onwards is changed as a consequence of competition with
unlabeled ketone bodies, FFA’s, and the larger unlabeled acetoacetylCoA pool during fasting.
Based on comparisons relative to the butyrate signal, acetylcarnitine is not significantly
changed and the fluxes maintaining the acetylcarnitine pool acting as storage for excess mito-
chondrial acetylCoA does not seem to be affected. Therefore, the glutamate to acetylcarnitine
ratio is meaningful for assessing the flow of acetylCoA derived from butyrate through the TCA
cycle as opposed to that which is deposited in the cellular energy reserve of acetylcarnitine.
Because both acetylcarnitine and glutamate are generated from the same pool of 2-carbon
acetyl-subunits, the relative ratios should not have to be scaled for the 1 to 2 conversion
of butyrate to acetylCoA. It was clearly observed that this ratio is substantially reduced in
fasted animals (Figure 4.3c), indicative of the competition between the injected butyrate and
the increased, unlabeled ketones and FFA’s present in the fasted state. The increased signal
associated with the hyperpolarized acetoacetate upon fasting is a further indication of the
increased concentration of ketones available for pseudoketogenesis; pseudoketogenesis from
[1-13C]butyrate is facilitated by the higher concentration of acetoacetate in the fasted state.
4.5.3 Competition between pyruvate and butyrate
Competition between butyrate and pyruvate in the fed animals caused a reduction in the
observed [13C]bicarbonate signal (p=0.01, Figure 4.2b), [5-13C]glutamate signal (p=0.02 rel-
ative to butyrate and p=0.0001 relative to acetylcarnitine, Figure 4.3b), a nearly absent [1-
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13C]acetoacetate signal (p=0.03 relative to butyrate and p=0.01 relative to acetylcarnitine,
Figure 4.3b,c), an increase in the [1-13C]acetylcarnitine signal (p=0.02 relative to butyrate,
Figure 4.3a), and in the [1-13C]lactate signal that did not quite reach statistical significance
(p=0.07, Figure 4.2b). In fasted animals, co-injection resulted in a decrease in the acetylcarni-
tine to alanine ratio (p=0.05). All of these observations fit into a detailed narrative of substrate
competition in the myocardium.
It is known that the presence of medium chain fatty acids can severely restrict the entry
of pyruvate into the TCA cycle as well as increase the lactate pool size in perfused hearts33.
These results are largely duplicated in vivo, with the caveat that the pyruvate and butyrate
co-injection did not take place over a period long enough to establish a metabolic steady
state. High concentrations of pyruvate ( 5 mM) can partially overcome PDH inhibition by high
fatty acid concentrations37. Assuming an instantaneous distribution of the hyperpolarized
substrate, the maximum attainable plasma concentration of pyruvate was on the order of
4 mM. Hence, the production of [13C]bicarbonate was only halved as opposed to abolished
when butyrate was also present, and lactate pool size changed only marginally. Nevertheless
these results indicate an almost instantaneous adaptation of myocardial substrate utilization.
These changes are also a direct reflection of butyrate uptake in the myocardium. In a conju-
gate sense, the increase in [1-13C]acetylcarnitine and the decrease of the [5-13C]glutamate and
[1-13C]acetoacetate signals, all derived initially from butyrate metabolism, are modulations
due to competition from pyruvate for the limited number of CoA units in the mitochondria.
Acetylcarnitine serves as a buffer for extra acetyl units that exceed the capacity of the TCA cycle
for oxidation and this circulation of acetyl groups is a fast, well equilibrated process12;40;45.
When pyruvate is co-injected, it is surmised that free CoA is rapidly reacted to acetylCoA, and
the extra acetyl units derived from butyrate oxidation are stored by reaction with carnitine,
resulting in the increased observed acetylcarnitine. The lowering of the [5-13C]glutamate
signal is a result of the same phenomena. Note that entry of pyruvate into the TCA cycle results
in removal of the hyperpolarized [1-13C] label and subsequent oxidation of the unlabeled C2
and C3 positions, which cannot produce labeling in the C5 of glutamate, hence the lower total
glutamate signal. In the case of fasting, co-injection results in a decrease in 13C labeling in
acetylcarnitine because of reduced flux of 13C label from butyrate into acetylCoA, another
example of the real-time effect of substrate competition.
The phenomenon of pseudoketogenesis in the myocardium seems the most likely expla-
nation for the appearance of acetoacetate and β-hydroxybutyrate when hyperpolarized [1-
13C]butyrate is injected 11. Understanding the mechanism of pseudoketogenesis (Figure 4.1)
reveals why it is subject to manipulation by the presence of supra-physiological concentra-
tions of pyruvate. Following transformation of [1-13C]butyrate to acetoacetylCoA, pseudoke-
togenesis results in the exchange of free acetoacetate in the mitochondria with the labeled
acetoacetylCoA27, giving rise to the ketone signals observed when only butyrate is injected
(Figure 3). However, an explanation for the complete lack of ketone signal when butyrate is
co-injected with pyruvate is more complicated. Pyruvate transport into the mitochondria can
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actually be mediated not only by the antiporting of hydroxide but also by a variety of other
compounds 17;39. One compound that is particularly effective in this function is acetoacetate.
It is hypothesized that the injection of pyruvate not only competes with butyrate for oxidation,
but also results in a depletion of unlabeled acetoacetate from the mitochondria during the mi-
tochondrial pyruvate transport process. The consequent lack of a free unlabeled acetoacetate
for exchange with the hyperpolarized acetoacetylCoA dramatically reduces the concentration
of free, hyperpolarized ketones. Further experiments, for example blocking the mitochondrial
pyruvate transporter, would be required to confirm this hypothesis.
These experiments demonstrate that the chemical selectivity inherent to magnetic reso-
nance, when paired with the sensitivity enhancement of hyperpolarization, can be harnessed
to produce a protocol that assesses substrate competition in real time, in vivo, in the func-
tioning heart. A simple modification of substrate availability via fasting produced significant
changes in pyruvate and butyrate metabolism, both when administered separately and in
competition. Butyrate metabolism appears to be subject to the phenomenon of pseudoketoge-
nesis, over a time period of seconds. Interestingly, co-administration of pyruvate with butyrate
appeared to block this phenomenon, most likely due to acetoacetate anti-porting caused
by the bolus of pyruvate. The clinical potential of the use of 13C hyperpolarized magnetic
resonance techniques to probe in vivo metabolism has been recently discussed and the first
trials in humans for application in cancer monitoring and diagnosis has already started26.
Applications in cardiology also seem at least as promising, and are expected to affect both
preclinical and clinical practice 30. The protocol suggested here should augment the usefulness
of hyperpolarized imaging further.
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5Hyperpolarized lactatemetabolism inresting skeletal muscle in vivo
Abstract
Resting skeletal muscle has a preference for the oxidation of lipids compared to carbohydrates
and a shift towards carbohydrate oxidation is observed with increasing exercise. Lactate is
not only an end product in skeletal muscle but also an important metabolic intermediate for
mitochondrial oxidation. Carbohydrate metabolism in healthy rat skeletal muscle at rest was
studied in different nutritional states using hyperpolarized [1-13C]lactate, a substrate that can
be injected at physiological concentrations and leaves other oxidative processes undisturbed.
13C label incorporation from lactate into bicarbonate in fed animals was observed within
seconds but was absent after an overnight fast, representing inhibition of the metabolic
flux through pyruvate dehydrogenase. A significant decrease in 13C labeling of alanine was
observed comparing the fed and fasted group, and was attributed to a change in cellular
alanine concentration and not a decrease in enzymatic flux through alanine transaminase. We
conclude that lactate can be used to study carbohydrate oxidation in resting skeletal muscle
at physiological levels and that the observed pyruvate, alanine, and bicarbonate signals are
sensitive markers to probe changes in metabolism as demonstrated by the observed effect of a
simple alteration of the nutritional state
Adapted fromHyperpolarized [1-13C]lactate metabolism in skeletal muscleJessica AM Bastiaansen, Hikari Yoshihara, Yuhei Takado, Rolf Gruetter and Arnaud Comment
Submitted manuscript
Chapter 5. Hyperpolarized lactate metabolism in resting skeletal muscle in vivo
5.1 Introduction
To meet its energy demands resting skeletal muscle has a preference for the oxidation of
lipids compared to that of carbohydrates 1;2. With increasing exercise intensity, a fuel shift is
observed from lipid towards carbohydrate utilization and during intense exercise nearly 100%
of oxidative capacity is used for the oxidation of carbohydrates1;2. Lactate concentrations in
skeletal muscle and plasma are known to increase during exercise, and skeletal muscle is a
major producer of lactic acid in the body. However, lactate is not only the product of anaerobic
metabolism but also a source of pyruvate, and resting skeletal muscle is even viewed as the
most likely primary consumer of lactic acid as a respiratory fuel3–5. Lactate enters the cell
via monocarboxylate transporters and by free diffusion at higher concentrations (>10mM) 6;7.
Changes in cellular lactate concentrations are affected by the cytosolic redox potential, thus
affecting production and utilization of pyruvate. In the cytosol it is transformed into pyruvate
by lactate dehydrogenase (LDH) and pyruvate is converted to alanine via alanine transaminase
(ALT) (Figure 5.1). Pyruvate is shuttled into the mitochondria and transformed via pyruvate
dehydrogenase (PDH) into acetylCoA, a key entry molecule for the tricarboxylic acid cycle. The
flux through PDH also results in the formation of CO2 which equilibrates with bicarbonate.
These aforementioned metabolic pathways can be studied using 13C magnetic resonance
spectroscopy (MRS), and lactate, being a simple carbohydrate, has previously been used as a
substrate for carbohydrate metabolism in resting skeletal muscle and was shown to be readily
oxidized8;9. Only the most abundant metabolites can be detected by conventional 13C MRS.
Recent developments in hyperpolarized 13C MRS allow for the detection of less abundant
metabolites by increasing the signal-to-noise ratio by several orders of magnitude 10. However,
pyruvate, which has been the most widely used substrate for hyperpolarized 13C studies of
carbohydrate metabolism, has some disadvantages in the applicability to skeletal muscle.
Hyperpolarized pyruvate administration results in supraphysiological levels and pyruvate also
influences the oxidation of other metabolic substrates. Excess pyruvate of 10mM inhibits the
oxidation of palmitate as well as lactate. Conversely, 10mM excess lactate fails to inhibit the
oxidation of palmitate and pyruvate 11 and does not influence the uptake of glucose, alanine
output, or the glycogen store up to 30 mM12. Lactate does not influence the metabolism of
other substrates, and endogenous lactate exceeds cytosolic pyruvate concentrations by an
order of magnitude. Another benefit of using lactate as a hyperpolarized 13C substrate is that
the formation and detection of the pyruvate resonance can be used directly as a marker of its
intracellular concentration. This can be used as an intracellular reference for scaling the signals
of the downstream metabolites alanine and bicarbonate, and for metabolic modeling studies.
The applicability of hyperpolarized [1-13C]lactate as a metabolic substrate has recently been
demonstrated13 and was used to measure the activity of LDH in tumors14, dichloroacetate
modulated changes in PDH flux in hearts15 and in the brain 16.
The aim of this study was to explore the use of hyperpolarized [1-13C]lactate as a suitable
probe for investigating carbohydrate oxidation in skeletal muscle in vivo. To determine
the sensitivity of hyperpolarized lactate metabolism to metabolic changes, two nutritional
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Figure 5.1: Scheme of [1-13C]lactate metabolism in rat skeletal muscle in vivo. The 13C label
propagation is indicated by the fat arrows and metabolites observed following [1-13C]lactate
oxidation are in bold typeface. Lactate enters the cell through MCT transporters and is converted
to pyruvate by LDH. Via a reversible transaminase reaction via ALT pyruvate is transformed to
alanine. Pyruvate in turn can enter the mitochondria via an irreversible reaction catalyzed by
PDH resulting in acetylCoA and bicarbonate. ALT: Alanine transaminase; LDH: lactate dehy-
drogenase; PDH: pyruvate dehydrogenase; TCA: tricarboxylic acid cycle; MCT: monocarboxylate
transporter; CA: carbonic anhydrase.
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situations were studied: the fed and fasted states.
5.2 Experimental Procedures
Sample preparation and hyperpolarization protocol
Sodium [1-13C]lactate and TEMPOL nitroxyl radicals were obtained from Sigma Aldrich (Buchs,
Switzerland). Sodium [1-13C]lactate was mixed with d8-glycerol in a 2:1 weight ratio to a
concentration of around 4.0 M with a final radical concentration of 50 mM. The solutions
were rapidly frozen in liquid nitrogen to form 10 uL beads that were inserted into a sample
which was further cooled to 1 ± 0.05 K in a 7 T custom-designed DNP polarizer17, where
the 13C nuclei were dynamically polarized with microwave irradiation (197.25 MHz and 55
mW) for 90 min, with a buildup time of 60 min. Using an automated process, the sample was
rapidly dissolved using 6.0 mL of pressurized, heated D2O and transferred within 2 s following
dissolution to a separator/infusion pump, containing 0.6 mL of PBS and heparin, located
inside a 9.4 T horizontal bore magnet 17;18. Subsequently, 1.5 mL of the hyperpolarized solution
at physiological temperature and pH was automatically infused into the animal during 8 s.
The 13C polarization level at the time of the injection was 17 ± 2 %.
Animals
All animal studies conformed to institutional guidelines. Wild type male Spraque Dawley rats
(293 ± 19 g) were anesthetized with 1.5% isoflurane in oxygen. A catheter was placed into the
femoral vein for intravenous delivery of the hyperpolarized solution. A second catheter was
placed in the artery to monitor the blood pressure and to measure plasma glucose and lactate
concentrations. The respiration rate and temperature were monitored and maintained during
the experiment. Two groups of animals were studied, fed animals (n = 5) and fasted animals
(n = 5). The animals were fasted overnight in case of a fasted state study, by placing them in
a clean cage without food the day before the experiment at around 5 pm. All animals were
measured in the morning. Each animal was injected three times with hyperpolarized lactate.
Animal physiology was not disturbed by the injections and the respiration and heart rates
were stable through all experiments.
In vivo magnetic resonance spectroscopy
Measurements were carried out on a 9.4 T / 31 cm actively shielded animal scanner (Varian/-
Magnex). A custom-made radiofrequency (RF) hybrid probe consisting of a 10 mm diameter
carbon surface coil and a quadrature 10 mm diameter 1H surface coil was positioned over
the hind leg of the rat for transmission and reception, localizing the signals from the skeletal
muscle. Acquisition of gradient echo proton images confirmed the correct position of the
muscle tissue. Shimming was performed to reduce the localized proton line width in a voxel
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of 6x10x10 mm to 20-30 Hz using FASTESTMAP19. The NMR console was triggered to start
acquisition at the beginning of the automated injection process, 6 s after dissolution of the
hyperpolarized sample. Series of single pulse acquisitions were recorded using 30◦adiabatic
RF pulses (BIR4) applied every 3 s with 1H decoupling using WALTZ-16. Typically 40 to 60
FIDs were acquired with 4129 complex data points over a 20000 Hz bandwidth. The adiabatic
pulse offset and power was calibrated to ensure a 30◦excitation pulse for all observed metabo-
lites in the entire tissue of interest. Following data acquisition, 200 µL liquid samples were
extracted from the separator/infusion pump to precisely determine the infused [1-13C]lactate
concentration using a high resolution 400 MHz NMR spectrometer.
Data analysis
The infused substrates and their corresponding metabolic products were assigned according
to the chemical shifts. 13C NMR time courses were summed for the time period during which
the hyperpolarized lactate resonance had a signal to noise ratio higher than 5, typically 15
spectra satisfied that criterion. The resulting summed spectra were fitted to Lorentzian line
shapes using Bayesian analysis. These summed integrals were used to determine the ratios of
one substrate relative to the other. Metabolite time courses were obtained by applying a 10 Hz
line broadening on the raw data, followed by fitting in jMRUI. Statistical differences between
the ratios of observed metabolites were calculated using a two-tailed t-test for unpaired data
with equal variance. Error bars in figures and in the manuscript indicate ± standard error of
the mean (SEM).
5.3 Results
Carbohydrate metabolism was studied in healthy resting skeletal muscle in vivo in fed and
fasted animals using hyperpolarized [1-13C]lactate. Overnight fasting resulted in a 30% de-
crease in plasma glucose and a 41% decrease in plasma lactate compared with animals which
were fed ad libitum. Lactate metabolism was detected in the skeletal muscle of healthy rats in
vivo (n = 10) and the following metabolite resonances were observed: [1-13C]pyruvate (171.2
ppm), [1-13C]alanine (177.0 ppm) and 13C bicarbonate (161.3 ppm). The spectral time courses
of fed animals injected with hyperpolarized [1-13C]lactate showed (Figure 5.2A) that within
seconds, lactate was transformed into pyruvate in the cytosol. The observation of bicarbonate
in summed spectra (Figure 5.2B) indicates the transport of pyruvate into the mitochondrion
for subsequent oxidation in the tricarboxylic acid (TCA) cycle.
The time evolution of the signal integrals of lactate, alanine, pyruvate and bicarbonate
(Figure 5.3 ) show that alanine attained higher signal intensities compared to pyruvate but
the maximum was reached at a later time point compared with pyruvate in all experiments.
On average, alanine reached its maximum at 28 ± 4 s and pyruvate at 22 ± 4 s in the fed state
(± standard deviation). In the fasted state, the maximum for alanine was reached at 28± 3 s
and for pyruvate at 22 ± 2 s. There were no significant differences in the time to maximum for
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Chemical Shift [ppm]
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Figure 5.2: Transient spectra acquired from the rat skeletal muscle using 30◦adiabatic pulses
applied every 3 s after the injection of hyperpolarized [1-13C]lactate show the formation of
[1-13C]alanine, [1-13C]pyruvate and 13C bicarbonate. Spectra shown here were line broadened
with 10 Hz (A). Representative summed spectrum acquired from rat skeletal muscle in vivo
after hyperpolarized [1-13C]lactate injection in a fed (top) and fasted (bottom) animal. Fifteen
spectra were summed and are displayed using a 5 Hz line broadening. *The resonance on the
shoulder of alanine observed at 177.5 ppm is due to an impurity in the [1-13C]lactate solution
(B).
118
5.3. Results
6 12 18 24 30 36 42 48 54 60 66 72 78 84
0
2
4
6
8
10
6 12 18 24 30 36 42 48 54 60 66 72 78 84
[1-13C]alanine
[1-13C]pyruvate
13C bicarbonate
[1-13C]lactate/15
FastedFed
[1-13C]alanine
[1-13C]pyruvate
13C bicarbonate
[1-13C]lactate/15
Time [s] Time [s]
In
te
g
ra
l 
[a
.u
.]
0
2
4
6
8
10A B
Figure 5.3: Timecourses of integrated spectra showing the evolution of the injected hyperpolar-
ized substrate [1-13C]lactate and its downstream metabolites pyruvate, alanine and bicarbonate
in a fed (left) and a fasted (right) animal. The hyperpolarized lactate integrals were scaled by a
factor of 1/15. Spectral acquisition started 6 s after the dissolution process with a repetition time
of 3 seconds.
both metabolites in both metabolic states. The linewidths of detected 13C resonances were on
average 22 Hz.
The injected lactate concentration was between 100 and 250 mM. After a rapid elevation
to 8.2 ± 1.5 mM following the delivery of the hyperpolarized solution, the arterial lactate
concentration returned to its baseline level within 20 minutes (Figure 5.4 ). The resonance of
13C bicarbonate was absent in animals which were fasted overnight (n = 5). In the fed group (n
= 5), bicarbonate was only detected in nine out of fifteen experiments because of the low SNR
in experiments with lower lactate dose. In both groups, the same relationship was observed
between the SNR of the lactate signal and the injected dose.
The signals were also expressed relative to the two other intracellular 13C enriched metabo-
lites, namely [1-13C]pyruvate and [1-13C]alanine. These ratios are independent of variations
in the initial polarization level of [1-13C]lactate. Comparing fed and fasted, the bicarbonate
signal was undetectable in the fasted group (p<0.0005), whereas the ratio of bicarbonate to
lactate in the fed group was 0.003± 0.000, the ratio relative to pyruvate was 0.10± 0.00 and the
ratio relative to alanine 0.04 ± 0.00. The ratio of pyruvate to lactate increased marginally from
0.030 ± 0.000 to 0.034 ± 0.001 (p<0.2) and alanine decreased significantly from 0.072 ± 0.001
to 0.058 ± 0.001 when comparing fed with fasted animals (p<0.05). The ratio of pyruvate to
alanine increased significantly (p < 0.005) by 42% from 0.43 ± 0.01 to 0.61 ± 0.01 (Figure 5.5 ).
The influence of the injected lactate dose on the formation of bicarbonate, alanine and
pyruvate was also investigated: The metabolite ratios were compared to the administered
lactate dose and no relationship was observed (Figure 5.7 ). There was no influence of repeated
lactate injections in the same animal on the ratio of alanine and bicarbonate relative to
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Figure 5.4: Lactate concentrations measured in arterial plasma samples extracted during
experiments before and after a hyperpolarized 13C labeled lactate injection. An average of
interpolated lactate measurements is shown with the shaded grey area representing ± standard
deviation.
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Figure 5.5: Signal ratios of pyruvate and bicarbonate relative to alanine. Asterisks denote
statistical significant differences compared to the fed state between metabolite ratios where *
p<0.05, ** p<0.005, *** p< 0.0005, **** p<0.00005.
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Figure 5.6: Influence of repeated injections of hyperpolarized lactate on observed metabolism.
The signal ratios of bicarbonate relative to pyruvate are shonw in the left panel. On the right the
signal ratios of alanine relative to pyruvate are shown in both fed and fasted states. Bicarbonate
was not observed in fasted animals and is therefore omitted.
pyruvate in the fed and fasted situation (Figure 5.6).
5.4 Discussion
In this study it was shown for the first time that lactate is readily taken up by resting skeletal
muscle in vivo and quickly converted to pyruvate for subsequent oxidation in the mitochon-
drion. The metabolic conversion rate of lactate was sensitive to a simple alteration of nutri-
tional state. Significant changes were observed in 13C labeling of bicarbonate and alanine after
an overnight fast. The absence of 13C bicarbonate signal in the fasted group is a result of the in-
hibition of metabolic flux through PDH during fasting 20. Increases in the acetylCoA/CoA ratio
or the NADH concentration further inhibit PDH. This is consistent with the reduction in PDH
flux in the rat heart after a fasting period observed using hyperpolarized [1-13C]pyruvate21.
In general, alanine attained higher 13C signal intensities compared to pyruvate, as was also
observed in the abdomen and the rat heart13;15. This is attributed to the much larger pool
size of alanine compared to pyruvate in both nutritional states22;23. It also suggests that the
fractional enrichment of the cellular pyruvate pool was high enough to ensure efficient 13C
label transfer into the cellular alanine pool. Contribution to the signal from surrounding
organs was expected to be negligible and has been discussed previously 24.
It has been shown that, after administration of hyperpolarized pyruvate or lactate, there
is a rapid exchange of 13C label between the pyruvate and lactate pools, and that observed
changes in 13C labeling of lactate and pyruvate is representative of the metabolite’s pool size
at the time of the measurements rather than originating from a net enzymatic flux through
lactate dehydrogenase (LDH) 25–27. Since, like LDH, alanine transaminase (ALT) is a reversible
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enzyme, fast isotope redistribution between the pyruvate and alanine pools implies that the
variation in alanine to pyruvate 13C signal ratio is essentially a consequence of changes in the
endogenous relative concentrations of both metabolites. The significant reduction of this ratio
observed in fasted fed animals could result from an increased in pyruvate signal, a decrease in
alanine signal or a combination of both.
An increase in endogenous pyruvate concentration in the fasted state could be due to
inhibition of pyruvate oxidation20, or due to increased NAD+ levels which shift the LDH-
catalyzed reaction towards the formation of pyruvate28. However, as mentioned above, the
slight increase in pyruvate to lactate 13C signal ratio observed in our experiments was not
statistically significant (p < 0.2). The largely significant decrease in alanine to pyruvate 13C
signal ratio observed in the fasted state is thus most likely mainly a consequence of a decrease
of the alanine pool size.
In previous studies where hyperpolarized [1-13C]pyruvate was used as a substrate, a de-
crease in the 13C alanine signal was observed in a perfused liver model, the heart and in the
liver in vivo after a fasting period and this reduction was ascribed to a cellular redox state
change and a reduction in alanine transaminase activity respectively 29–31. However, a direct
comparison with results obtained using pyruvate as a hyperpolarized substrate is challenging
since different metabolite pools are enriched and the reaction pathways and directions probed
are different. Moreover, the liver takes up alanine for gluconeogenic purposes while the muscle
releases it.
There have been reports of decreased skeletal muscle tissue concentrations of alanine after
a 24h fast32 and alanine concentrations were also diminished in overnight fasted animals in
a different study conducted in our lab33 based on 1H NMR measurements of tissue extracts.
Therefore, a decrease in 13C alanine labeling can be most likely ascribed to a change in cellular
alanine concentration. The endogenous alanine concentration is reduced in fasted muscles
because of an enhanced alanine efflux 34;35.
It is known that during fasting conditions and other situations of negative nitrogen balance,
muscle is the major source of carbon and nitrogen for the synthesis of glucose and urea in the
liver 36;37. In such conditions, amino acid catabolism increases 38 and alanine is the principal
amino acid released by skeletal muscle. Moreover, it was shown that the alanine release
reflects the rate of de novo synthesis39, and changes in alanine synthesis and release are
related to pyruvate formation from amino acids 40, which increases during fasting. Although
the formation and efflux of alanine is stimulated during fasting, the decreased hyperpolarized
13C label transfer to alanine observed in this study is clearly not only dependent on the
enzymatic flux through ALT but coupled with changes in fractional enrichments, pool sizes and
formation of intermediate substrates. Since these factors are affected in several diseases, such
as in diabetes where the release of lactate and alanine is increased 22;39, ketotic hypoglycemia
where gluconeogenesis is impaired due to insufficient release of alanine41, or maple syrup
urine disease where decarboxylation of amino acids is impaired and alanine levels are 3- to
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10-fold lower42, the alanine-to-pyruvate ratio could be a sensitive biological marker for the
detection of skeletal muscle metabolic disorders. The time evolution of the lactate resonance
shows a buildup followed by decay and this is different from hyperpolarized acetate injections
in skeletal muscle using an identical injection protocol 24. This difference could be attributed
to a different uptake of both substrates. Acetate enters the cell via concentration gradient
facilitated diffusion while lactate mainly enters via monocarboxylate transporters and also by
free diffusion at concentrations >10 mM6;7. Since the concentrations used in this study were
8 mM, lactate was assumed to enter the cell largely via MCT transport.
The hyperpolarized lactate injections resulted in a 5-fold elevation of endogenous lactate
( 8mM) compared to the resting state. Tissue concentrations of lactate can increase up to 10 -
50 mM in a state of exercise and our injected values are thus within physiological range43;44.
Lactate was cleared from the blood within minutes (Figure 5.4). The ability to uptake and
process lactate at these concentrations is also reflected by the high KM values for MCT across
the cellular membrane which were found to be between 13 and 40 mM 45. MCT1 and MCT4 are
the predominant isoforms expressed in skeletal muscle. No dose dependencies were observed
in the metabolite-to-lactate ratios, which is indicative of lactate transport being proportional
to blood lactate concentration and in agreement with the higher KM value compared to the
lactate concentrations.
Previous studies in the literature show that after a 24h and a 48h fast, plasma lactate con-
centrations decrease but the concentration of lactate in rat skeletal muscle tissue remains
unchanged 46;47. In a study using overnight fasted rats, a 30 min infusion of lactate increased
plasma lactate levels 4-fold but did not increase the plasma concentrations of free fatty acids
and alanine48. Infusing lactate up to 30 mM did not affect glucose uptake, pyruvate up-
take/output, and alanine output in canine skeletal muscle12. Therefore, we conclude that
the observed changes in 13C label propagation are a likely consequence of an actual shift in
lactate metabolism in skeletal muscle upon fasting.
Conclusion
The significant changes observed in 13C labeling of bicarbonate and alanine after an overnight
fast were attributed to decreased PDH flux and a decrease in cellular alanine concentration, in
agreement with previous ex vivo analysis of tissue extracts. We conclude that lactate can be
administered at physiological concentrations without disturbing other oxidative processes
and is readily oxidized in resting skeletal muscle. Moreover, the downstream metabolite
pyruvate can be used as an intracellular reference. Therefore hyperpolarized [1-13C]lactate
is well suited for studying carbohydrate metabolism in skeletal muscle in vivo. The ratio of
alanine to pyruvate is not only dependent on the enzymatic flux through ALT, but also on
changes in fractional enrichments and pool size of intermediates. It has potential to be a
metric to probe skeletal muscle metabolic disorders
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5.5 Metabolic flux analysis of alanine labeling
Alanine can be formed by transamination of pyruvate in a reaction catalyzed by the enzyme
alanine transaminase, and the rate of efflux resembles that of alanine synthesis. This makes
that the forward flux through ALT, VALT , is of the same order as the flux of alanine release
from the muscle, Vefflux. The pool size of alanine (Ala) can be represented by the following
equation:
d [Al a]
d t
=VALT −Ve f f lux (5.1)
Taking into account the 13C label flow, indicated with ?, the 13C alanine pool can be de-
scribed as follows:
d [Al a?]
d t
=VALT [P yr
?]
[P yr ]
−Ve f f lux
[Al a?]
[Al a]
(5.2)
It can be assumed that within each nutritional state the endogenous alanine pool is relatively
constant, i.e. metabolic steady state, and therefore VALT equals Ve f f lux . Considering equal
fluxes and equal 13C enrichment of pyruvate between the fed and fasted state, Equation 5.2
shows clearly that a change in endogenous pool size of alanine has a direct effect on the rate
of 13C alanine formation. Note that when an isotopic steady state is reached, d [Al a?]/d t = 0,
the fractional enrichment of alanine cannot exceed that of pyruvate and thus a decreased
pool size will result in a decrease of alanine that can be 13C enriched and detected by NMR
spectroscopy.
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Figure 5.7: Pyruvate and bicarbonate ratios relative to alanine as function of the adminstered
lactate dose in fed and fasted animals.
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6Hyperpolarized acetylcarnitine as aprobe for myocardial metabolism in vivo
Abstract
Acetylcarnitine is known to facilitate the influx and efflux of acetylgroups across the mitochon-
drial membrane and buffers an excess in acetylCoA in both cytosolic and mitochondrial com-
partments. Acetylcarnitine is a necessary intermediate for mitochondrial acetate metabolism.
Since the detection of [5-13C]citrate and [5-13C]glutamate] in the heart is hindered by the
close proximity of the [1-13C]acetate resonance, acetylcarnitine could be an interesting sub-
strate for hyperpolarized MR. Acetylcarnitine crosses the mitochondrial membrane easily,
while acetate undergoes two enzymatic transformations in order to cross the membrane.
Moreover, [1-13C]acetylcarnitine would not interfere with the detection of [5-13C]glutamate
and [5-13C]citrate. The aim of the present study was to explore the use of hyperpolarized
[1-13C]acetylcarnitine as a tracer myocardial substrate oxidation. [1-13C]Acetylcarnitine was
successfully hyperpolarized and despite its short T1 it was possible to detect the formation
of [5-13C]glutamate in the heart in vivo. Due to the absence of the [5-13C]citrate resonance,
we hypothesized the existence of an intricate relationship between reaction, transport and
relaxation rates in the choice of hyperpolarized substrates.
Adapted fromHyperpolarized [1-13C]acetylcarnitine as a tracer for cardiac metabolism.Jessica AM Bastiaansen, Tian Cheng, Rolf Gruetter, Arnaud CommentPresented at: Proc. Intl. Soc. Mag. Reson. Med. 21, 1936 (2013)Manuscript in preparation
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Figure 6.1: Illustration showing the metabolism of [1-13C]acetylcarnitine and [1-13C]acetate,
both labeled at the C1 position, and the corresponding label propagation. Acetylcarnitine
readily enters the mitochondrion and skips two biochemical transformations needed for acetate
to enter.
6.1 Introduction
Acetylcarnitine is known to facilitate the influx and efflux of acetylgroups across the mito-
chondrial membrane and buffers an excess in acetylCoA in both cytosolic and mitochon-
drial compartments5. Acetylcarnitine is a necessary intermediate for mitochondrial acetate
metabolism3 and has been shown to easily cross the blood brain barrier and act as a neuro-
protective agent 4. It is also being used for Alzheimer’s disease treatment in humans 2.
The conversion of hyperpolarized acetate into acetylcarnitine, acetylCoA 1 and citrate (Chap-
ter 3) have been observed in vivo in cardiac muscle and reflect the enzymatic activities of
acetylCoA synthetase (ACS), citrate synthase (CS) and carnitine acetyltransferase (CAT). The
13C labeling in these downstream metabolites appear with a time delay and typically decay
corresponding to their T1. Following the injection of hyperpolarized [1-
13C]acetate, the detec-
tion of [5-13C]citrate in the heart as described in Chapter 3 is hindered by the close proximity
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of the [1-13C]acetate resonance, which also obscures the detection of [5-13C]glutamate.
In summary, acetylcarnitine could be an interesting substrate for myocardial oxidation,
since it crosses the mitochondria easily, skipping two metabolic steps needed for acetate to
cross the membrane (Figure 6.1 ). This would result in less signal losses compared to the
use of acetate. Moreover, it does not interfere with the detection of [5-13C]glutamate and
[5-13C]citrate, which could provide a reliable estimation of TCA cycle flux. The possibility
to detect 13C labeled acetylCoA would provide information about the flux through carnitine
acetyl transferase (CAT).
The aim of the present study was to explore the use of hyperpolarized [1-13C]acetylcarnitine
as a tracer myocardial substrate oxidation. Secondly, the use of hyperpolarized acetylcarnitine
could help elucidate the backflux through the reaction from acetylcarnitine to acetylCoA to
describe the entire system of enzymatic reactions in more detail.
6.2 Methods
Sample preparation and in vitro magnetic resonance spectroscopy
Acetyl-1-13C-L-carnitine hydrochloride (1.5M) solved in a 1:2 mixture of d6-EtOD/D2O con-
taining 33mM TEMPO free radical were turned into frozen glassy beads and subsequently
polarized in a custom-designed 5T DNP polarizer for 2 h. Following dissolution, the samples
were transferred within 2 s into a home-built infusion pump located inside the magnet bore
(9.4T) and connected to a catheter inserted into a D2O filled phantom. The 5 s long infusion
of 1 mL hyperpolarized [1-13C]acetylcarnitine solution was triggered 1 s later. The entire
procedure was computer controlled in order to obtain an identical timing for all experiments.
Series of single pulse acquisitions were recorded using 10◦ adiabatic RF pulses applied every 3
s starting with proton decoupling during the acquisition. MR acquisition started at the end of
the infusion with a homebuilt surface coil with 13C in quadrature mode.
In vivo magnetic resonance spectroscopy
The animal preparation (n=3) and in vivo MRS procedure are identical to the heart studies
performed earlier and are described in Section 3.2.2.
Data analysis
A non-linear least-squares quantification algorithm, AMARES, as implemented in the jMRUI
software package, was used to fit the 13C NMR data. The spectra were corrected for the phases
and DC offset. Soft constraints were imposed to peak frequencies (182.35 -182.45 ppm for
glutamate and 173.85 -173.95 ppm for acetylcarnitine) and line widths (FWHM = 10 - 30 Hz)
and the relative phases were fixed to zero.
133
Chapter 6. Hyperpolarized acetylcarnitine as a probe for myocardial metabolism in vivo
In vitro data were corrected for repeated RF excitations and fitted to the following equation
to obtain the longitudinal relaxation time T1:
S ∝Mz =M0e−t/T1 cosθt/TR (6.1)
6.3 Results and Discussion
[1-13C]acetylcarnitine was dynamically polarized with a buildup constant of 1390 s. After
dissolution in a D2O loaded phantom and data acquisition, the hyperpolarized time integrals
were corrected for repeated adiabatic 10◦ excitations and the resulting decay was fitted to
Equation 6.1. A T1 value was obtained of 14.7 ± 1.0 s (Figure 6.2). This value is similar to the T1
values of [1-13C]acetylcarnitine measured in blood plasma and D2O as discussed in Section
2.5 and Table 2.1.
1 mL 100 mM [1-13C]acetylcarnitine was infused in healthy rats and the time evolution of
substrate and metabolic products were measured in 3 animals (Figure 6.3). The linewidth
of acetylcarnitine observed at 173.9 ppm was between 25 and 30 Hz. As expected given the
relative short relaxation time, the acetylcarnitine signal could be observed during 20 to 40
seconds, exhibiting a mono-exponential decay of around 3 s regardless of the TR (Figure
6.3). The uptake and enzymatic conversion of acetylcarnitine into [5-13C]glutamate was
successfully detected in the heart in vivo. The resonance of [5-13C]glutamate appeared at
182.4 ppm (Figure 6.4).
The [5-13C]glutamate resonance cannot be observed using hyperpolarized [1-13C]acetate
as a tracer because their resonances overlap (182.6 ppm vs. 182.4 ppm). Surprisingly [5-
13C]citrate, resonating at 179.7 ppm was not observed in these experiments. The absence
indicates that the disappearing polarization due to T1 effects is relatively faster than the
formation of citrate. An additional resonance appeared at 177.7 ppm. High resolution NMR
on the infused solution revealed that this resonance originates from natural abundance 13C in
acetylcarnitine.
Conclusion
Despite its short T1 it was possible to detect the formation of glutamate from hyperpolarized
[1-13C]acetylcarnitine. [5-13C]citrate was not detectable in the current time frame. This study
highlights the intricate relationship between reaction, transport and relaxation rates in the
choice of hyperpolarized substrates.
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Figure 6.2: (A) Polarization buildup of [1-13C]acetylcarnitine with a time constant τ. (B)
Following dissolution in a D2O loaded sample, the decay of the hyperpolarized signal was
measured. Data was corrected for repeated 10◦ RF excitations and was fitted to Equation 6.1 to
obtain the longitudinal relaxation time T1.
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Figure 6.3: Integrated time course of cardiac NMR spectra following the infusion of 1 mL of 100
mM hyperpolarized [1-13C]acetylcarnitine.
Figure 6.4: In vivo cardiac 13C NMR spectrum at t = 6 s. [5-13C]Glutamate is observed at 182.4
ppm and a natural abundance 13C resonance at 177.7 ppm.
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7Acetylcarnitine turnover measurements inskeletal muscle in vivo using localizedsensitivity enhanced 13CMRSat 14.1 T
Abstract
Acetate has been widely used as a metabolic probe for measuring TCA cycle kinetics in vivo
in skeletal muscle. In order to cross the mitochondrial membrane , acetate needs to be
transformed into acetylcarnitine, which also functions as a storage for excess mitochondrial
acetylCoA. Because of the relatively small poolsizes of acetylcarnitine in skeletal muscle,
approximately one order of magnitude lower than glutamate, it has only been observed in
vivo using hyperpolarized 13C MRS techniques. Non-hyperpolarized 13C MR studies of skeletal
muscle are challenging because of large unwanted natural abundance 13C lipid resonances. In
this study, [2-13C]acetate was infused in healthy, fasted rats and metabolic data was acquired
using localized 13C MRS in combination with a heteronuclear 1H-13C polarization transfer
sequence to enhance the polarization level with a factor γ1H /γ13C . The choice of sequence in
combination with the sensitivity increase at high field allowed for the first time the observation
of [2-13C]acetylcarnitine in vivo at 21.5 ppm, and the determination of the metabolic turnover.
The acetylcarnitine resonance assignment was confirmed by performing experiments infusing
13C labeled glucose. Other metabolites such as glutamate (C2, C3 and C4), creatine (CH2 and
CH3), taurine (C1 and C2) and citrate were also clearly observed, without lipid contamination.
Localized 13C NMR spectroscopy at high field enables an improved characterization of acetate
oxidation in skeletal muscle in vivo, with sufficient time resolution for further modeling
studies. Characterization of metabolic fluxes incorporating acetylcarnitine could give novel
insights in metabolic disorders such as diabetes where carnitine deficiency occurs.
Adapted fromAcetylcarnitine turnover in rat skeletal muscle measured in vivo using localized 13C NMR at 14.1 TJessica AM Bastiaansen, Joao MN Duarte, Arnaud Comment, Rolf GruetterPresented at: Proc. Intl. Soc. Mag. Reson. Med. 21, 0120 (2013)Manuscript in preparation
Chapter 7. Acetylcarnitine turnover measurements in skeletal muscle in vivo using localized
sensitivity enhanced 13C MRS at 14.1 T
7.1 Introduction
Acetate has been widely used as a metabolic probe for measuring TCA cycle kinetics in vivo in
skeletal muscle1–3. It has a relatively simple metabolism and enters the cells via facilitated
diffusion4;5. In order to cross the mitochondrial membrane for subsequent utilization in the
TCA cycle, acetate needs to be transformed into acetylcarnitine6. Acetylcarnitine plays an
important role in the transport of acetate across the mitochondrial membrane as well as for
long chain fatty acids and acts as a storage for excess acetylgroups which are not needed for
the tricarboxylic acid (TCA) cycle6;7. It has relatively small poolsizes of in skeletal muscle,
approximately one order of magnitude lower than glutamate8;9. The tremendous gain in
signal to noise ratio (SNR) and recent developments in hyperpolarized 13C NMR spectroscopy
in vivo allowed the visualization of acetylcarnitine after the infusion of hyperpolarized acetate
in liver, skeletal and cardiac muscle 10;11.
Energy metabolism in skeletal muscle has been frequently studied by 13C NMR in vivo.
The conversion of 13C labeled compounds can be measured using this method, since the 13C
label propagates through a cascade of enzymatic reactions from one biomolecule to the other.
The rate at which other metabolites are labeled can be quantified by fitting the metabolite
timecourses to mathematical models describing the biochemical pathways in differential
equations 12;13.
13C MR spectroscopy is hampered by a relative low sensitivity. Additionally, 13C MR spec-
troscopy in skeletal muscle is challenging since the contamination of signals from naturally
abundant 13C in lipids, originating from subcutaneous fat tissue, hampers the detection of
other compounds, such as glutamate and glutamine. A majority of skeletal muscle studies
rely on subtraction schemes where a baseline 13C spectrum is acquired, which is subtracted
from the spectra acquired after the infusion of 13C labeled substrates. This leads to SNR
losses and potential errors due to subtraction. Those could be avoided by using localization
schemes. In the past, several methods besides hyperpolarized techniques were introduced
to increase the sensitivity by polarization transfer. While indirect Proton Observed Carbon
Edited (POCE) spectroscopy generates the highest sensitivity, the direct 13C acquisition by
cross polarization14 or Distortionless Enhanced Polarization Transfer (DEPT)15;16 yields a
larger chemical shift dispersion.
Polarization transfer sequences have been used in 13C NMR studies in vivo for their gain in
sensitivity. In the current study, a 1H-13C polarization transfer sequence was used to enhance
the SNR of the 13C nucleus four fold. Additionally, a localization scheme was used to suppress
subcutaneous fat resonances, thereby increasing the detectability of resonances in the 30
ppm region, and the inherent SNR was increased by performing the measurements at 14.1T.
The power of 13C NMR to probe the TCA cycle and its intermediates was used to investigate
whether acetylcarnitine could be observed in vivo by improving the detection method at
thermal equilibrium polarization levels. To this end, [2-13C]acetate was infused in rat skeletal
muscle using 13C MR spectroscopy at 14.1T using localized DEPT, in order to enable improved
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characterization and description of the system of enzymatic reactions involved in acetate
oxidation.
7.2 Methods
7.2.1 Animal preparation
Male Sprague-Dawley rats (n = 3, obtained from Charles River Laboratoires, France) were
fasted overnight. Animals were anesthetized using 2% isoflurane (Attane, Minrad, NY, USA) in
30% oxygen in air. Catheters were inserted into a femoral artery for monitoring blood gases,
glucose, lactate, and arterial blood pressure, and into a femoral vein for infusion of saline
solutions containing [2-13C]acetate (Isotec, Sigma-Aldrich, Basel, Switzerland).
Animals were immobilized in a homebuilt holder to minimize potential motion. Body tem-
perature was maintained between 37.0 and 37.5◦C with a warm water circulation system based
on the feedback obtained from a homebuilt rectal temperature probe. Arterial blood pressure,
heart rate, and respiratory rate were continuously monitored with an animal monitoring
system (SA Instruments, NY, USA). Arterial pH and pressures of O2 and CO2 were measured
using a blood gas analyzer (AVL Compact 3, Diamond Diagnostics, MA, USA). Plasma glucose
and lactate concentrations were quantified with the glucose or lactate oxidase methods, re-
spectively, using two multi-assay analyzers (GW7 Micro-Stat, Analox Instruments, London,
UK).
7.2.2 Saline and [2-13C]acetate infusion procedure
During the preparation of the MR acquisition, such as the animal positioning, shimming and
13C MR baseline acquisition, saline was infused at a rate of 0.2 mmol/kg/min. Infusing saline
before the start of the actual [2-13C]acetate experiment greatly improved the preservation of
the shim parameters. [2-13C]labeled acetate was dissolved to a concentration of 1.0 M in a
saline solution with pH = 5. The saline infusion was stopped when the acetate infusion started
with the same rate of 0.2 mmol/kg/min. This infusion rate was reduced during the experiment
by 25% every hour on average. Plasma samples were taken at regular intervals throughout the
experiments and were stored at -80◦C for determination of substrate fractional enrichments
(FE). Arterial pH and blood gases were maintained within the normal physiological range by
adjusting respiratory rate and volume.
7.2.3 In vivo MR spectroscopy
All in vivo NMR experiments were carried out in a DirectDrive spectrometer (Agilent, Palo
Alto, CA, USA) interfaced to a 14.1 T magnet with a 26-cm horizontal bore (Magnex Scientific,
Abingdon, UK), using a homebuilt coil consisting of a 1H quadrature surface coil and a 13C
linearly polarized surface coil. A glass sphere filled with 13C formic acid placed in the centre of
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Figure 7.1: Measurements conducted on a [2-13C]labeled acetate phantom to investigate the
effect of OVS and ISIS on signal localization.
the 13C surface coil was used for pulse calibrations. The skeletal muscle was positioned in the
isocenter of the magnet and fast-spin-echo images with repetition time of 5 s, echo time of
52 ms and echo train length of eight allowed to identify anatomical landmarks, which were
used to place the volume of interest (VOI) of 6 x 12 x 10 mm3 in the muscle. Shimming was
performed with FASTESTMAP 17 untill a 1H linewidth of 30 Hz was obtained. 13C NMR spectra
were acquired with 128 averages (5 min) using semi-adiabatic distortionless enhancement
by polarization transfer (DEPT) combined with 3D-ISIS 1H localization15 and outer volume
suppression (OVS), and broadband 1H decoupling using WALTZ-16 during the MR signal
acquisition.
ISIS 3D in combination with OVS localization was chosen based on phantom calibrations.
The localization method was tested on a phantom consisting of a syringe doped with [2-
13C]acetate. A voxel was selected to include the syringe, and exclude the formic acid reference
bubble. Results indicate that ISIS 3D in combination with OVS performs better in suppressing
the formic acid signal (Figure 7.1).
Spectral analysis was carried out using LCModel (Stephen Provencher Inc., Oakville, ON,
Canada) for 13C NMR spectra. Simulation of basis spectra for the observable isotopomers was
performed in Matlab (The MathWorks, Natick, MA, USA)18. In vitro 13C NMR spectra from
standard solutions including the metabolites of interest allowed correcting for the relative dif-
ferences in signal enhancement by polarization transfer with DEPT. Then, relative intensities
in 13C NMR spectra were used to scale 13C concentrations for all carbon resonances through
all time courses.
7.2.4 In vitro MR spectroscopy
After each experiment, skeletal muscle tissue was excised and placed immediately in liquid
nitrogen and rats were sacrificed. Skeletal muscle tissue was immediately stored at -80 C until
extraction. Water-soluble metabolites from brain and plasma samples were extracted with 7%
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(v/v) perchloric acid (PCA) as previously described19 and dried with a sample concentrator
(SpeedVac DNA 120, Thermo Fisher Scientific, Wohlen, Switzerland). The dried extracts were
dissolved in 2H2O (99.9% 2H, Sigma-Aldrich) and 1.2 mmol sodium fumarate (Sigma-Aldrich)
was added as internal standard for quantification by 1H NMR spectroscopy. 1H and 13C NMR
spectra were acquired on a 14.1 T DRX-600 spectrometer equipped with a 5-mm cryoprobe
(Bruker BioSpin SA, Fallanden, Switzerland) to determine the fractional enrichments and
metabolite concentrations in the plasma and tissue samples. Peak areas were quantified by
curve fitting.
7.2.5 Fractional enrichments and turnover calculations
Fractional 13C enrichments and absolute concentrations of acetate were determined from the
1H NMR spectra taken from tissue extracts. The ratios of the acetate doublet to its singlet was
used as a measure for fractional enrichment of [2-13C]acetate versus the natural abundance
of acetate in plasma. A similar approach was used for the fractional enrichment calculation
of lactate and alanine C3. The 13C acetate concentration measured in extracts was cross
referenced with the 13C acetate signal in the last in vivo measurement and used as a scaling
factor to determine time courses of the 13C concentrations of other metabolites in vivo, such
as that of [2-13C]acetylcarnitine.
The FE of glutamate C2, C3 and C4 were determined by analysing the multiplets, or iso-
topomers of each resonance (see Figure 1.17 in Section 1.5). Using the 13C-13C J coupling
induced splitting (Section 1.2.9) of the C4 resonance when the neighbouring C3 position is
also 13C labeled, the FE of Glu C3 can be determined from the C4 isotopomers in 13C spectra
of tissue extracts, with the following expression: F E(C 3) = C 4D34/(C 4S +C 4D34). Where
C 4S+C 4D34 is the total area of the Glu C4 resonance. The last 8 scans of the in vivo time
courses of Glu C2, C3 and C4 were scaled to the fractional enrichments determined in the
tissue extracts.
Similarly, the FE of C2 acetylCoA, FEC 2, was determined using the following equation as
described in20:
F EC 2 = C 4D34
C 4
C 4
C 3
(7.1)
where C4D34 is the area of the doublet resonance of C4 glutamate and C4 and C3 the total
areas of the C4 and C3 glutamate resonances respectively.
The concentrations of 13C labeled acetylcarnitine C2 were calculated based on the concen-
tration of acetate C2, determined form high resolution 1H and 13C MRS on tissue exctracts.
To determine the turnover time τ, the following equation was fitted to the time course of 13C
labeling of acetycarnitine C2:
[Acet yl car ni t i ne]C 2(t )= [Acet yl car ni t i ne]C 2,max ∗ (1−e−t/τ) (7.2)
143
Chapter 7. Acetylcarnitine turnover measurements in skeletal muscle in vivo using localized
sensitivity enhanced 13C MRS at 14.1 T
where [Acet yl car ni t i ne]C 2,max is the steady state acetylcarnitine C2 concentration. The
turnover rate of the acetylcarnitine pool can be determined by dividing the total concen-
tration of acetylcarnitine by the turnover time τ. The total concentration of acetylcarnitine,
non-labeled plus labeled, can be determined by dividing the steady state concentration of
acetylcarnitine C2 by its FE.
7.3 Results
The in vivo 13C MR spectra demonstrated an excellent voxel localization using 3D ISIS in
combination with OVS. The broad natural abundance 13C lipid signals resonating around 30
ppm are suppressed without affecting the signals of natural abundance 13C labeled creatine
(Cre CH2, CH3) and taurine (Tau C1, C2), when using the localization module (Figure 7.2).
The specific protocol of 13C-enriched acetate infusion raised plasma acetate to about 2.5
mM in 60 min and then remained constant. The plasma FE of acetate C2 reached a steady
value of about 0.75 (Figure 7.3). In tissue extracts, prepared at the end of the experiment, the
FE of acetate C2 was 0.55 and that of lactate C3 was 0.04. Signal contributions from lactate
C3 were thus assumed to have a minor contribution to the labeling patterns observed in this
study.
The in vivo spectral quality and sensitivity increase achieved at 14.1 T, in combination with
the polarization transfer signal enhancement allowed the detection of 13C labeling after [2-
13]acetate infusion in glutamate (Glu C2, C3, C4), citrate (Cit C2 C4), β-hydroxybutyrate (BHB
C2, C4), glutamine (C2, C3, C4), acetate (Ace C2), with a time resolution of 5 min (Figure 7.4).
The in vivo FE of glutamate C2, C3 and C4 were calculated after isotopomer analysis of 13C
spectra of the tissue extracts (Figure 7.5 ). Glutamate C4 is enriched at a faster rate compared
with Glu C3 and C2. This is in agreement with the 13C label flow of [2-13C]acetate metabolism,
which dictates that Glu C4 is labeled in the first turn of the TCA cycle (Figure 1.16, Section
1.5). Glutamate C2 and C3 appeared more slowly than glutamate C4 as a consequence of the
additional turns of the TCA cycle, which are necessary to scramble the C4 label into C2 and
C3. Steady state isotopic enrichments in these metabolites were achieved in the experimental
time frame.
Another metabolite was observed at 21.5 ppm and was tentatively assigned to that of
acetylcarnitine C2 (Figure 7.4). Since the acetylcarnitine C2 resonance (21.5 ppm) is close to
that of lactate C3 (21.0 ppm), the data obtained in this study was compared with that of data
obtained in earlier brain studies by colleagues where [1,6-13C2]glucose was infused. Since 13C
labeling in lactate and glutamate are generated from the metabolism of glucose, the chemical
shifts of both could be compared (Figure 7.6).
When aligning both spectra using the glutamate resonances, the lactate C3 resonance does
not correspond with that of acetylcarnitine C2. Since brain tissue is not equivalent to that of
skeletal muscle tissue a similar glucose experiment was conducted in skeletal muscle. Since
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Figure 7.2: Difference between unlocalized and localized 13C MR spectra in skeletal muscle.
Baseline 13C MR spectra were acquired without localization (top) and with localization via
OVS and ISIS (middle). A plethora of lipid resonances are observed in the unlocalized baseline
acquisition as indicated. The grey squares indicate natural abundance 13C labeled (1%) creatine
and taurine. By using ISIS and OVS localization (middle) the lipids are successfully suppressed.
Comparison of the unlocalized baseline acquisition (top) with that of a [2-13C]acetate infusion
(bottome) shows clearly that the detection of 13C labeling in glutamate C3 and C4 is challenging
due to overlapping lipid resonances. Spectra were apodized with 5 Hz for SNR enhancement.
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Figure 7.3: Fractional enrichment of 13C in acetate C2 in plasma samples taken at regular
intervals during the experiment. The FE was determined from high resolution 1H NMR of
extracted plasma metabolites.
the glutamate labeling was relatively low following glucose infusion, the chemical shifts of
creatine were also used to align both spectra (Figure 7.7).
Again, it is clear that the lactate C3 resonance is not overlapping with the resonance of
acetylcarnitine C2. Based on its chemical shift and the comparisons with [1,6]13C2]glucose ex-
periments in the brain and muscle, the resonance observed at 21.5 ppm was positively assigned
to that of acetylcarnitine C2. The time evolution of the concentration of [2-13C]acetylcarnitine
in vivo revealed a turnover time τ of 37 minutes (Figure 7.8). Assuming that the FE in acetylCoA
C2 of 0.49, as determined with Equation 7.1, is similar to the FE of acetylcarnitine C2, the total
acetylcarnitine pool size was 0.21 µmol/g. The resulting turnover rate of the acetylcarnitine
pool was calculated to be 0.34 µmol/g/hr.
The high spectral resolution at 14.1 T enabled the distinction of all metabolites in the skeletal
muscle, but was not sufficient to detect homonuclear 13C-13C J coupling induced multiplets in
the glutamate C2, C3 and C4 resonances in vivo. NMR of tissue extracts revealed the presence
off all metabolites observed in vivo, besides that of Cit C2-C4. Interestingly, the resonances
of glutamine (C2, C3 and C4) which were of the same order of magnitude as the glutamate
resonances (Figure 7.9) could be observed. Glutamine intensities in the in vivo 13C spectra
were too low to be reliably quantified.
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Figure 7.4: Typical time course of 13C labeling of metabolites following [2-13C]acetate
metabolism in skeletal muscle in vivo at 14.1T allowed the detection of the 13C labeling in
glutamate (Glu C2, C3, C4), citrate (Cit C2 C4), β-hydroxybutyrate (BHB C2, C4), glutamine (C2,
C3, C4), acetate (Ace C2). 13C MR spectra were acquired with a time resolution of 5 minutes and
displayed with a 20 min time resolution for visual clarity. Spectra were apodized with 5 Hz for
SNR enhancement.
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Figure 7.5: The time course of the fractional enrichment of the 13C label in glutamate positions
C2, C3, and C4 during the [2-13C]acetate infusion. The FE’s were obtained from isotopomer
analysis of the high resolution 13C NMR of tissue extracts. These FE’s were scaled with the last in
vivo acquisition.
7.4 Discussion
In this study we showed improved detection of acetate metabolism in skeletal muscle in vivo
by increasing the sensitivity using a polarization transfer sequence at high field. The technical
challenge to suppress unwanted lipid resonances, which obscure the quantification of several
metabolites, were adequately met using ISIS and OVS localization. Although a small fraction
of lipid resonances are still visible around 30 ppm, it does not hinder with the quantification
of metabolites present in that spectral region. An important advantage of the DEPT sequence
is that the localization can be performed on protons. Namely, direct 13C localization suffers
from large chemical shift displacement errors especially at higher fields. Since the chemical
shift range of all metabolite 1H resonances are much less dispersed, 1H localization minimizes
the chemical shift displacement errors.
This allowed for the first time the in vivo visualization of [2-13C]acetylcarnitine, an important
intermediate metabolite in the oxidation of acetate. Also, the suppression of lipid resonances
was sufficient to allow for an accurate determination of glutamate labeling in C4 and C3. The
turnover time of acetylcarnitine was found to be 0.34µmol/g/hr. Since acetylcarnitine is an
intermediate of acetate oxidation, it is possible to make a comparison with the turnover of
acetate. In human skeletal muscle, the flux from acetate to acetylCoA, which in fact has to pass
through the acetylcarnitine pool, was determined to be 3 nmol/g/min = 0.18 µmol/g/hr21.
In another study, it was found that acetate was oxidized at a rate of 8.5 µmol/kg/min, which
equals 0.51µmol/g/hr22. The values found in this study are comparable to the previously
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Figure 7.6: To verify the acetylcarnitine resonance assignment at 21.5 ppm, a comparison was
made between 13C spectra of a 13C labeled glucose and acetate infusion in brain and muscle
respectively. Top spectrum was apodized with 5 Hz and the bottom spectrum with 2 Hz for SNR
enhancement.
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Figure 7.7: To verify the acetylcarnitine resonance assignment at 21.5 ppm, a comparison was
made between 13C spectra of a 13C labeled glucose and acetate infusion in skeletal muscle.
Spectra were apodized with 5 Hz for SNR enhancement.
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Figure 7.8: Concentration of acetylcarnitine C2 in skeletal muscle in vivo after the infusion
of [2-13C]acetate was obtained by scaling with the acetate C2 signal which concentration was
determined from the tissue extracts. The corresponding fit (dashed line) to Equation 7.2 was
used to calculate the turnover time τ and the turnover rate.
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Figure 7.9: 13C NMR of a skeletal muscle tissue extract. The presence of all metabolites observed
in vivo was confirmed and fractional enrichments of glutamate C2, C3 and C4 could be cal-
culated using the multiplet structures and isotopomer analysis. The inset shows the multiplet
structure of Glu C3 and Gln C3, each of them consisting of a singlet (S), doublet (D) and a triplet
(T). Spectra were apodized with 0.5 Hz for SNR enhancement.
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reported values in the literature. In a study using 14C acetate in guinea pig muscle, a com-
bined turnover of acetylCoA and acetylcarnitine was found to be 8.23 nmol/g/min = 0.49
µmol/g/hr 23.
The poolsize of acetylcarnitine in this study was calculated based on the fractional enrich-
ment of acetylCoA, and the 13C concentration of acetylcarnitine. AcetylCoA can be formed
from other metabolic precursors, such as long chain fatty acid and carbohydrates, resulting
in an influx of unlabeled acetylCoA. This would cause a reduction in the FE of acetylCoA
compared to the FE in acetylcarnitine. Therefore the actual FE of acetylcarnitine might be
higher. This would mean that the estimation of the total acetylcarnitine pool size of 0.21
µmol/g could be overestimated. Previous studies in rat skeletal muscle, report acetylcarni-
tine concentrations of 0.13 µmol/g at rest and up to 0.63 µmol/g after fatty acid infusion in
perfused rat skeletal muscle 24. Those values are in the range of the findings in this study.
It has been reported that acetylCoA rapidly equilibrates with acetylcarnitine, based on
equal tracer incorporation in both acetylcanritine and acetylCoA after administration of 14C
labeled acetate 23. Therefore, for turnover rate calculations, acetylCoA and acetylcarnitine may
be considered a single high energy acetyl pool, since acetylcarnitine must be converted to
acetylCoA before entering metabolic pathways23. Given that the measurements performed
here require time averaging, allowing the pools of acetylcarnitine and acetylCoA to equilibrate,
the assumption that the fractional enrichment in acetylcarnitine is similar to that in acetylCoA
is valid.
Another interesting observation is that the resonance of glutamine is hardly visible in vivo
while the intensities of the C2, C3 and C4 resonances of glutamine in vitro in respect to
glutamate suggest sufficient 13C labeling for in vivo detection. However, this remains to be
further investigated. Also, the resonance of citrate (Cit C2 C4) was absent in the 13C MRS
spectra of tissue extract. The absence of citrate and presence of glutamine at similar levels
compared with glutamate has been observed before in tissue extracts2. To our knowledge,
glutamine has not been observed in vivo in skeletal muscle.
Although these experiments were conducted at high field, it was not possible to detect
the muliplet structures due to 13C-13C homonuclear scalar coupling in vivo, unlike in brain
studies. This was attributed to the extend at which the proton linewidth can be reduced in
skeletal muscle. The minimum attainable proton linewidth was 30-34 Hz, compared to 22-27
Hz in the brain at 14.1T.
In this study it was shown that it is possible to monitor the time courses of 13C enrichment
in glutamate C2, C3 and C4 in skeletal muscle. The temporal data acquired in this study can
be used as an index for TCA cycle flux. Together with the time courses obtained for acetylcar-
nitine, more detailed mathematical models can be constructed to enable the quantification of
biochemical processes in skeletal muscle in vivo.
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Conclusion
This study demonstrates for the first time, to our knowledge, the detection of [2-13C]acetyl-
carnitine in vivo and the acetylcarnitine turover using localized 13C NMR spectroscopy at high
field. A major improvement was the increased sensitivity relative to lower fields and the use
of a heteronuclear polarization transfer sequence. Sufficient time resolution was obtained
for future modeling studies incorporating the metabolite acetylcarnitine. This allows for a
more detailed characterization of acetate oxidation in skeletal muscle in vivo and in studies of
metabolic disorders such as diabetes where carnitine deficiency occurs.
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8Conclusion andOutlook
This thesis focused on the development of magnetic resonance methods and applications
to investigate energy metabolism in cardiac and skeletal muscle in vivo, using both DNP
hyperpolarized and conventional 13C spectroscopy. This ranged from development of the
experimental frame work to mathematical tools to quantify the 13C labeling time courses
which are needed to characterize metabolic processes. This work presents novel metabolic
information about skeletal and cardiac energy metabolism using the developed methods in
hyperpolarized and non-hyperpolarized 13C MRS. The results of these studies, which were
mainly performed in healthy subjects, open the way for further investigations of carbohydrate
and lipid oxidation in subjects where metabolic pathways are modified.
Initially, methods were developed to conduct hyperpolarized 13C MR experiments in skeletal
muscle in vivo. This enabled us to visualize the 13C labeling kinetics of [1-13C]acetylcarnitine in
resting skeletal muscle following the administration of hyperpolarized [1-13C]acetate (Chapter
2). With the aid of two different, novel, analytical approaches the kinetic rate constants
could be determined. Although separated by two enzymatic reactions, it was shown that the
conversion of acetate to acetylcarnitine was uniquely defined by the enzymatic activity of
acetylCoA synthetase (ACS) and we were able to derive the Michaelis constants KM and Vmax of
this reaction in vivo. ACS activity is altered in diseases such as diabetes and cancer. Therefore,
the implemented protocols can be used to gain insight in those pathological processes.
While [1-13C]acetate can be used to quantify the enzymatic rates of ACS, [1-13C]butyrate,
also a short chain fatty acid, might give novel information about mitochondrial oxidation in
resting skeletal muscle since the detection of [5-13C]glutamate is not hindered by its resonance,
as is the case when using [1-13C]acetate as a substrate. Skeletal muscle shifts its metabolism
towards carbohydrate oxidation with increasing exercise levels. In this context it would be
interesting to probe substrate competition (as described in Chapter 4) in resting and exercising
skeletal muscle while it undergoes a metabolic shift.
Cardiac 13C MRS methods were developed and implemented, which enabled the first
detection of [5-13C]citrate in the beating rat heart following the injection of hyperpolarized
[1-13C]acetate ( Chapter 3). Previously developed mathematical models were extended to
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include the mitochondrial formation of citrate. Although the VAC S could be derived from
the observed 13C labeling kinetics in the heart, the acetate signal mainly originates from the
ventricular pool and appropriate scaling factors would be needed to obtain the fraction of
acetate inside the tissue, and to estimate the actual VAC S . Metabolic rates were fitted using
the analytical solutions of the proposed model, taking into account the signal evolution of
acetate, acetylcarnitine and citrate. Since only acetylcarnitine and citrate are located in the
myocardium, it is currently investigated whether solving numerically the set of differential
equations based on the flow scheme given in Equation 3.17, and using [A.C ar?](t ) as an input
function, would give more reliable flux estimates for CAT and CS.
The results obtained in Chapter 3 opened the way to further studies in cardiac 13C MRS.
The heart uses a variety of substrates in a well-balanced manner and a shift in substrate
preference is observed at the onset of cardiac dysfunction and diseases such as left ventric-
ular hypertrophy and heart failure. It was demonstrated that following the injection of two
different hyperpolarized substrates, it is possible to estimate substrate competition in the
rat myocardium in vivo (Chapter 4). 13C labeled butyrate was used as a mimic for lipid oxi-
dation and 13C labeled pyruvate for carbohydrate oxidation. The sensitivity of the proposed
protocol was successfully tested in a model where a metabolic shift was induced by a simple
feed/overnight fast regime that produced significant changes in substrate selection. We pre-
sented a method which is sensitive and specific for simultaneous detection of the two primary
oxidative pathways in the heart, glycolysis and β-oxidation. Hyperpolarization is an emerging
technique for enhancing magnetic resonance sensitivity, and it has already undergone a suc-
cessful phase 1 clinical trial in the investigation of prostate cancer. The method, which should
be translatable to humans, could be used to assess the onset of metabolic changes associated
with LVH or heart failure or to monitor the response of the heart to metabolic treatment.
Carbohydrate metabolism in healthy rat skeletal muscle at rest was studied in different nutri-
tional states using hyperpolarized [1-13C]lactate (Chapter 5). Lactate was chosen since it can
be administered at physiological concentrations leaving other metabolic process undisturbed,
unlike pyruvate. 13C labeling of bicarbonate was observed within seconds in fed animals,
but was absent after an overnight fast, due to PDH inhibition. Also, significant decrease in
[1-13C]alanine was observed comparing both groups, attributed to a change in cellular alanine
concentration. Lactate, a carbohydrate, is not only a waste product in skeletal muscle, but
an important metabolic intermediate. The controversy that muscle produces more lactate
during exercise while conventional 13C MRS studies did not observe changes in [3-13C]lactate
metabolism in resting and exercising muscle, brings opportunities for hyperpolarized 13C
MRS which has the potential to sample the metabolic situation within a minute.
Besides detecting the metabolite acetylcarnitine after injecting suitable precursors, the
use of acetylcarnitine as a substrate for myocardial oxidation was explored (Chapter 6). [1-
13C]Acetylcarnitine was hyperpolarized and despite its short T1 it was possible to detect the
formation of [5-13C]glutamate in the heart in vivo. [5-13C]citrate detection was expected, since
cetylcarnitine crosses the mitochondrial membrane easily, while skipping a few metabolic
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steps needed for acetate to cross the membrane. Moreover, it does not interfere with the
detection of [5-13C]glutamate and [5-13C]citrate. Due to the absence of the [5-13C]citrate
resonance, we hypothesized the existence of intricate relationship between reaction, transport
and relaxation rates in the choice of hyperpolarized substrates. Another hypothesis is that
acetylcarnitine can cross the mitochondrial membrane, but not the cellular membrain easily,
but this remains to be investigated.
Finally, it has been demonstrated that [2-13C]acetylcarnitine can be detected in vivo at 14.1T
using a localized polarization transfer sequence (Chapter 7). The combination of the high
magnetic field and the DEPT sequence increased the sensitivity of the 13C carbon nucleus
to such extend that acetylcarnitine, which has relatively small poolsizes could be observed.
So far, it has only been observed using hyperpolarized 13C MRS techniques, and it has not
been possible to obtain reliable quantification of the metabolic turnover of acetylcarnitine in
vivo. The acetylcarnitine turnover of 0.34 µmol/g/hr was in agreement with earlier reports
in literature. Furthermore, the resonance assignment of acetylcarnitine was verified using
13C labeled glucose infusions in skeletal muscle. The measurement of the time courses of
Glu C4 and C3 were also clearly observed, without lipid contamination and with sufficient
time resolution. In combination with the time courses obtained for acetylcarnitine C2, more
detailed mathematical models will be constructed to enable the quantification of biochemical
processes in skeletal muscle in vivo, leading to an improved understanding of acetate oxida-
tion. This is currently an ongoing project. Characterization of metabolic fluxes incorporating
acetylcarnitine could give novel insights in metabolic disorders such as diabetes where carni-
tine deficiency occurs. Another interesting observation is the missing glutamine resonances
in the in vivo data, however, this remains to be investigated.
Hyperpolarized [1-13C]acetate allowed for the visualization of citrate in the heart and acetyl-
carnitine in the muscle (Chapter 3 and 2). Performing the same experiments at higher fields,
for example at 14.1 T, would increase the spectral resolution, meaning that the resonances of
[5-13C]glutamate and [5-13C]citrate are better resolved. With the installment of a DNP polar-
izer at the 14.1 T at our laboratory, the first in vivo DNP experiments are currently scheduled
to investigate the potential of skeletal muscle metabolism at high field using hyperpolarized
13C MRS. Since [2-13C]acetylcarnitine was also detected with conventional 13C MRS at the
same system (Chapter 7), both techniques could be combined to give a full description of
skeletal muscle metabolism in a single animal.
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AAppendix
A.1 RF coil design for hyperpolarized 13C NMR studies
A.1.1 Quadrature 13C coil for cardiac muscle applications
Efficient excitation and detection of the hyperpolarized signal can be achieved by employing
a quadrature surface coil design, as described by1 and as well in Section 1.4. In quadrature
mode, two orthogonal receiving surface coils, one with a 90◦ phase shift relative to the other,
should increase the signal to noise ratio (SNR) of an experiment by
p
2. A quadrature coil can
generate directly a circularly polarized field, which demands only half of the transmitter power
to excite the magnetization2. Combined with a better depth profile, the use of a quadrature
carbon coil may achieve even higher sensitivity in hyperpolarized measurements.The tuning
and matching circuit is set up in such a way that the RF coil can be adjusted to resonate at the
Larmor frequency of the carbon nucleus at a field strength of 9.4 T. The two wire loops, from
which the axes are at an angle of roughly 90◦, act as a receiver and as a transmitter. A picture
of the coil and its corresponding electrical circuit is given in figure A.1.
Figure A.1: Schematic representation of the tuning (T) and matching (M) circuit of the carbon
coil (a). A picture of the quadrature carbon coil (b).
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The quadrature properties of the constructed coil were tested initially by changing the
resonance frequency of the coil to that of the 23Na nucleus at 9.4 T (105.89 MHz). This because
the 13C nucleus has a low sensitivity and it takes longer measurement time for the same
calibrations. The acquisition of 23Na images (figure A.2) of a NaCl filled syringe with both
surface coils connected in phase and anti-phase show that the coil has the right geometrical
arrangement. One can see that when the surface coils are connected in phase, the sample is
well excited compared to when the coils are connected anti phase, where the signal is clearly
diminished. This excitation profile is distinct for quadrature coils.
Figure A.2: Gradient echo 23Na images of a NaCl phantom. Upper row without filters, bottom
row with 100 MHz bandpass filters, left column quadrature connected, right column anti-quad.
Signal to noise ratios are 21 (A), 8 (B), 79 (C) and 18 (D).
Using the same NaCl phantom, 23Na spectra were taking by applying adiabatic 90◦pulses.
The SNR for the coil in quadrature mode was 2688, while the SNR for each separate loop was
1838 and 1971 (figure A.3). As a result, the gain in SNR is on average 1.41, which corresponds
to
p
2. This is exactly the expected SNR gain for surface coils using quadrature detection.
Figure A.3: 23Na spectra of both surface coils in quadrature mode and each one separately.
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Pulse bandwidth calibrations were performed on a [1-13C]acetate phantom for adiabatic
10◦ pulses (which are used in the DNP experiments) and the quadrature carbon coil shows
the same profile as for single carbon coils. In these experiments, it is clearly shown that the
noise level is strongly reduced comparing both coils (figure A.8). While increasing the power
for the adiabatic 90◦ pulses an intensity plateau is reached at around 42 dB for the quadrature
coil (figure A.4) compared to 46 dB for the conventional single surface coil. This decrease
in transmit power is expected and desired in general for quadrature coils. The SNR of the
quadrature coil compared to the standard coil is also higher, as expected.
Figure A.4: Power calibration for an adiabatic 90◦ pulse on the quadrature coil
A.1.2 B1 mapping
B1 field maps (A.6) were acquired using a double flip angle method. Since the MR signal after
an RF pulse with flip angle θ is proportional to sinθ, the flip angle θ can be determined by
comparing the signals acquired by two flip angles, θ and 2θ, and can be calculated using,
θ = ar ccos I2
2I1
(A.1)
A.1.3 Sensitivity comparison with a conventional design
A.2 Adiabatic RF pulse calibrations and simulations
Initial experiments indicated that the bandwidth of the 10◦ BIR4 pulse is not sufficient to
excite acetate and acetylcarnitine in the same manner. It is important to know the excitation,
or flip angle, to predict the magnetization behavior of the hyperpolarized substrates and their
characteristic decay. Secondly it is important to assure that acetate does not receive a large
flip angle excitation because this would destroy the hyperpolarized signal which can not be
restored.
Bloch simulations of the used pulses were performed as well as experiments to look at the
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Figure A.5: 13C images of a 13C labeled acetate phantom with different nominal flip angles θ
were acquired using a gradient echo sequence with a 13C surface coil in quadrature mode.
Image parameters: field of view = 2 cm x 2 cm, matrix = 32 x 32, TR = 800 ms, TE = 2.5 ms, slice
thickness = 5 mm, averages = 1280, offset 6400 Hz. Gaussian pulse of 2 ms and 29.4 dB with
nominal flip angle of 90◦.
Figure A.6: B1 maps were calculated after acquiring gradient echo images with different nominal
flip angles θ.
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A.2. Adiabatic RF pulse calibrations and simulations
Figure A.7: Bloch simulation of the transversal Mx y magnetization as a function of the transmit
power amplitude of a 10◦ and 90◦ adiabatic pulse, bir4.10 and bir4.90 respectively (A). After
reaching a plateau, the simulated excitation bandwidth profiles for the transmit powers indi-
cated by colored dots in A are displayed in (B). Off resonance simulation of Mx y magnetization
(C)
behavior of the pulses. The simulations are shown in figure A.7. The left panel (A) shows
the Mx y magnetization as function of the applied power for the adiabatic 10
◦ and 90◦ pulses.
The middle panel (B) shows the resulting excitation bandwidth while using the power value
immediately after the plateau has been reached in (A). (B) shows that the bandwidth of the
10◦ pulse is not sufficient to excite the desired range of 10 ppm, which corresponds to 1000
Hz. The adiabatic 90◦ has an almost sufficient bandwidth after reaching a plateau. The right
panel (C) depicts the Mx y magnetization of resonances which do not correspond with the
resonance frequency of the applied pulse. It shows that when the power value is too low (< 2
kHz), components which are 0.5 kHz or 1.0 kHz off-resonance receive a much higher flip-angle
and this should certainly be avoided. It indicates that compared to the power value reached at
plateau in (A), you need at least twice as much power for a bandwidth of 10 ppm. This means
an addition of at least 6 dB at the console.
Adiabatic bir4.10 pulses
NMR experiments were performed on a [1-13C]acetate phantom with Omniscan to investigate
the excitation bandwidth of the adiabatic 10◦ pulses. This experiment was done on the
standard carbon coil and the new quadrature coil. It can be seen that a very large power is
needed to assure a similar excitation over a bandwidth of 10 ppm. However, these plots show
the absolute value of the complex signal so the influence of the phase is not visible. Taken the
phase into account it is not possible to obtain the desired bandwidth with the pulses used in
the DNP experiments performed until now, unless you increase the pulse duration from 3 ms
to 5 ms.
Comparing the single loop carbon coil with the quadrature design it is visible that the
excitation profiles are the same for both coils and the noise level is also reduced.
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Figure A.8: Bandwidth calibrations for the adiabatic bir4.10 pulses on the standard quadrature
proton coil and on the new quadrature carbon coil. Note that the difference in the noise level
and the similarity of the bandwidth profiles.
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Figure A.9: Bandwidth calibrations for the adiabatic bir4.90 pulses on a quadrature carbon coil.
Adiabatic bir4.90 pulses
NMR experiments were performed on the same phantom to investigate the excitation band-
width of the adiabatic 90◦ pulses. As expected from the simulations, less power is needed to
reach the desire bandwidth.
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